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Evaluating the cornea for epithelial fluorescein staining is a key element of the ocular examination of 
contact lens wearers and people with dry eye disease. It has long been viewed as a method of 
visualizing a break in the protective epithelial layer, the integrity of which is regarded as vital for 
protecting the eye and maintaining good vision.   
There has been very little reported on the typical staining presentation in dry eye. Understanding 
more about the distribution of epithelial staining in dry eye disease would be valuable to guide 
evaluation of a treatment’s physiological efficacy.  This thesis aimed to determine whether the 
corneal staining of subjects with symptomatic dry eye presents in a specific distribution pattern 
Since 2002, the epithelial staining phenomenon of solution induced corneal staining (SICS) has 
been investigated. The cause of this staining has been suggested to be due to molecular adhesion 
rather than physiological damage, but the current evidence is equivocal. More investigation of this 
phenomenon is warranted to understand the process and the clinical significance of SICS. This thesis 
aimed to investigate the type, severity and pattern of staining that occurs in SICS, and assess the 
impact on epithelial cells using in-vivo confocal imaging. 
 
METHODS 
Chapter 2 described the CORE corneal staining scale., which uniquely reports the type and extent of 
the corneal staining on a scale of 0-100. This was the staining scale used to record the level of 
solution induced corneal staining in all the clinical trials featured in Chapters 5 and 6.  
Chapter 3 reported an experiment which was conducted to assess the agreement among fifteen 
observers who used this scale, in two grading sessions, to grade the corneal staining illustrated in 22 
photographic images. Inter- and intra-observer agreement results were calculated. 
Chapter 4 presented a meta-analysis of the corneal staining observed in 368 subjects, across 13 
studies, with symptoms of dry eye. For each subject the corneal zone of worst staining was recorded 
to analyse which region of the cornea most frequently exhibited the most severe staining. 
In Chapter 5, 20 subjects were exposed to a lens/solution combination, known to induce SICS, in 
both eyes for a two hour period. In phase one, one lens was rinsed thoroughly before being worn; in 
 vi 
phase two, the eye itself was rinsed thoroughly post lens wear; in phase three, confocal microscopy 
was conducted on both eyes to look for hyper-reflective epithelial cells. In phases one and two, the 
epithelium was assessed for staining pre and post lens wear with and without fluorescein. 
Chapter 6 evaluated aspects of the staining data collected in several SICS-inducing studies. The 
frequency of the reported ‘donut’ pattern of staining was calculated, relative to a diffuse, pan-corneal 
staining pattern. Seven subjects were identified that had participated in three or more trials using the 
same SICS-inducing methodology. The data from these individuals were assessed to determine the 
repeatability of the level of induced corneal staining in these trials.  
 
RESULTS 
The CORE corneal staining scale agreement experiment, in Chapter 3, supported the benefit of 
training because the concordance of the naïve observer was markedly worse than the observers who 
had received prior training. The inter- and intra-observer agreement analyses provided valuable data 
which can be applied to the development a pictorial reference guide and better instructions. 
The Chapter 4 meta-analysis of the geographic distribution of corneal staining among subjects with 
symptomatic dry eye demonstrated that the greatest degree of staining was most frequently in the 
inferior zone. (52.5%) The zone affected least was determined to be the central zone (12.8%).  
In the SICS experiment of Chapter 5, rinsing the lens prior to wear and rinsing the eye post lens 
wear did not result in different staining to the non-rinsed condition. All eyes, irrespective of any 
rinsing treatment, presented with punctate staining over >84% corneal area. The SICS staining was 
visible before fluorescein was instilled as ‘white light staining’. Confocal images were obtained from 
34 of the 40 eyes, and hyper-reflective cells were visible in 33 of those 34 eyes. 
The meta-analysis in Chapter 6 concluded that the ‘donut-ring’ staining pattern, which is often 
described as typical of SICS, was actually far less common than a diffuse pan-corneal staining 
presentation. When SICS responding eyes were defined as exhibiting staining of ≥10% extent in at 
least four of the five corneal zones, 89% were identified as presenting with the pan-corneal pattern i.e. 
all five zones met the ≥10% extent criteria. When the SICS definition was tightened to include only 
those with ≥50% extent in at least four zones, 76% of subjects still identified as the pan-corneal 
staining pattern. There was minimal evidence of SICS presenting with a repeatable degree of staining 




This thesis investigated several aspects of corneal epithelial fluorescein staining and the chapters have 
furthered understanding in this field in several ways.  
The CORE corneal staining scale provides valuable data regarding the percentage of the corneal 
affected by staining. The results of the Chapter 3 agreement experiment provide useful information 
for the next steps in the development of this scale which will create a valuable corneal staining 
assessment tool.  
The evidence that the most severe corneal staining in patients with symptoms of dry eye most often 
presents in the inferior zone is invaluable to the design of future clinical trials of dry eye treatments. It 
highlights the importance of specifically assessing this region and the value in targeting fluorescein 
staining improvements in this zone as a key outcome measure. 
SICS has been suggested to be due to adhesion between PHMB (or other care system components) 
and the epithelial cells. The experiment in Chapter 5 confirmed that rinsing the lens does not remove 
enough PHMB from the lens to prevent SICS, and rinsing the eye afterwards is not effective at 
removing the bound molecules from the epithelial cells because SICS is still evident post rinsing. The 
presence of ‘white light staining’ and hyper-reflective cells on in-vivo confocal microscopy indicate 
that there are changes to the epithelial cells even before the fluorescein is instilled into the eye. More 
investigation of changes at the cellular level are required to understand what is happening.  
The meta-analysis of SICS data was able to provide evidence that SICS most commonly presents 
as a diffuse punctate staining that affects the entire cornea presenting in a pan-corneal pattern, rather 
than presenting in the commonly described pattern of a donut-ring, which implies central zone 
sparing. The examination of SICS in seven subjects across several studies questions the repeatability 




I would like to offer a special thank you to my supervisor, Dr. Lyndon Jones. You gave me the 
confidence to begin this journey and you helped me find the strength to continue through difficult 
times. Thank you for always making time for me and for your constant encouragement, guidance and 
enthusiasm. I am grateful for every opportunity you have offered me, and I am very proud to work 
alongside you. 
I am particularly thankful for the advice and direction from Dr. Natalie Hutchings. You helped me 
transform my insights and thoughts on the data into sound statistical reasoning. You generously 
shared your time and knowledge to improve my understanding of several statistical approaches. Your 
input was invaluable.   
I am grateful for the guidance and mentoring I received from Dr. Maud Gorbet and Dr. Luigina 
Sorbara. Your thoughtful suggestions and support throughout this process are sincerely appreciated.  
Thank you to everybody at the Centre for Ocular Research & Education, and CCLR as it was 
before. I am grateful every day for being a part of this wonderful ‘work-family’.  
I appreciate the assistance I received from the Graduate Coordinators; Krista Parsons, Lisa Baxter, 
Jennifer Cosentino, Stephanie Forsyth and Holly Forsyth. I also thank the Graduate Officers for their 
counsel; Drs. Vivian Choh, Trefford Simpson, Daphne McCulloch, Paul Murphy and, particularly, 
Dr. Benjamin Thompson. 
Finally, I am indebted to the many friends and colleagues who provided assistance along the way; 
personal, professional and academic. There are too many to list by name, but three people deserve 
specific mention. Debbie Jones and Kathy Dumbleton, you are two very special friends, who 
supported and encouraged me to continue this work. Daryl Torgrimson, your thoughtfulness, care and 





To my parents, Mary and Jim Griffiths. 
You taught me to believe in myself. I miss you both. 
 
To my ‘boys’, Josh and Sam. 
You are my inspiration and my strength. I love you both. 
 x 
Table of Contents 
Author's Declaration ......................................................................................................................... iii 
Statement of Contributions ............................................................................................................... iv 
Abstract .............................................................................................................................................. v 
Acknowledgements ......................................................................................................................... viii 
Dedication ......................................................................................................................................... ix 
Table of Contents ............................................................................................................................... x 
List of Figures ................................................................................................................................. xiv 
List of Tables .................................................................................................................................. xix 
List of Abbreviations...................................................................................................................... xxii 
Chapter 1 Background and Literature Search .................................................................................... 1 
1.1 Corneal structure and relationships .......................................................................................... 2 
1.1.1 Epithelium ......................................................................................................................... 3 
1.1.2 Bowman’s membrane ........................................................................................................ 6 
1.1.3 Stroma ............................................................................................................................... 6 
1.1.4 Descemet’s membrane ...................................................................................................... 7 
1.1.5 Endothelium ...................................................................................................................... 7 
1.2 Corneal innervation .................................................................................................................. 8 
1.3 Assessing corneal integrity....................................................................................................... 8 
1.4 Sodium fluorescein interaction with corneal epithelium ........................................................ 10 
1.4.1 Sodium fluorescein .......................................................................................................... 10 
1.4.2 Properties of sodium fluorescein ..................................................................................... 11 
1.4.3 Instilling fluorescein into the eye .................................................................................... 15 
1.4.4 Viewing corneal fluorescein staining .............................................................................. 17 
1.4.5 Methods of recording fluorescein corneal staining ......................................................... 19 
1.5 Fluorescein staining associated with dry eye ......................................................................... 22 
1.6 Fluorescein staining associated with contact lens wear ......................................................... 24 
1.7 Fluorescein staining associated with contact lens care products ............................................ 27 
 xi 
1.8 Cellular significance of fluorescein staining .......................................................................... 29 
1.9 Aims of the thesis ................................................................................................................... 35 
Chapter 2 The CORE Corneal Staining Scale .................................................................................. 37 
2.1 Abstract ................................................................................................................................... 37 
2.2 Introduction ............................................................................................................................ 37 
2.3 Scale development .................................................................................................................. 38 
2.4 Application of CORE corneal staining scale .......................................................................... 43 
2.4.1 Clinical records ................................................................................................................ 43 
2.4.2 Reporting the staining ...................................................................................................... 44 
2.5 Discussion ............................................................................................................................... 46 
Chapter 3 Agreement Experiment: The CORE Corneal Staining Scale ........................................... 49 
3.1 Introduction ............................................................................................................................ 49 
3.2 Methods .................................................................................................................................. 54 
3.2.1 Images .............................................................................................................................. 54 
3.2.2 Observers ......................................................................................................................... 56 
3.2.3 Grading sessions .............................................................................................................. 56 
3.2.4 Analysis ........................................................................................................................... 58 
3.3 Results .................................................................................................................................... 59 
3.3.1 Inter-observer agreement ................................................................................................. 60 
3.3.2 Intra-observer agreement ................................................................................................. 71 
3.3.3 Use of the steps of the scale ............................................................................................. 83 
3.4 Discussion ............................................................................................................................... 85 
Chapter 4 Geographic Distribution of Corneal Staining in Symptomatic Dry Eye .......................... 89 
4.1 Abstract ................................................................................................................................... 89 
4.2 Introduction ............................................................................................................................ 90 
4.3 Methods .................................................................................................................................. 91 
4.3.1 Selection of studies .......................................................................................................... 91 
4.3.2 Symptomology inclusion criteria ..................................................................................... 91 
 xii 
4.3.3 Corneal staining .............................................................................................................. 92 
4.3.4 Statistical analysis: Bayesian estimation of the proportion counts ................................. 93 
4.4 Results .................................................................................................................................... 94 
4.4.1 Areas of worst staining .................................................................................................... 94 
4.4.2 Bayesian analysis .......................................................................................................... 100 
4.5 Discussion ............................................................................................................................ 103 
4.6 Conclusion............................................................................................................................ 105 
Chapter 5 Effect of Lens and Eye Rinsing on Solution Induced Corneal Staining (SICS), a Pilot 
Study .................................................................................................................................................. 107 
5.1 Abstract ................................................................................................................................ 107 
5.2 Introduction .......................................................................................................................... 108 
5.3 Methods and materials ......................................................................................................... 111 
5.3.1 Participants .................................................................................................................... 111 
5.3.2 Study outline ................................................................................................................. 111 
5.3.3 Assessment technique for corneal epithelial disruption and staining ............................ 112 
5.3.4 Assessment technique for limbal hyperaemia ............................................................... 113 
5.3.5 Symptomatology ........................................................................................................... 113 
5.3.6 Assessment technique for hyper-reflective (HR) cells .................................................. 114 
5.3.7 Data analysis ................................................................................................................. 114 
5.4 Results .................................................................................................................................. 115 
5.4.1 Corneal staining ............................................................................................................ 115 
5.4.2 Limbal hyperaemia ........................................................................................................ 118 
5.4.3 Symptomology .............................................................................................................. 120 
5.4.4 Hyper-reflective cells .................................................................................................... 121 
5.5 Discussion ............................................................................................................................ 123 
Chapter 6 SICS: Investigating the Staining Pattern and Repeatability .......................................... 129 
6.1 Introduction and purpose ...................................................................................................... 129 
6.2 Study selection criteria ......................................................................................................... 130 
6.2.1 Study products ............................................................................................................... 132 
 xiii 
6.2.2 Staining grading ............................................................................................................. 133 
6.2.3 Participant inclusion/exclusion ...................................................................................... 134 
6.3 Analysis of staining patterns: donut-ring versus pan-corneal staining ................................. 136 
6.3.1 Objective ........................................................................................................................ 136 
6.3.2 Methods ......................................................................................................................... 136 
6.3.3 Results ........................................................................................................................... 137 
6.3.4 Discussion ...................................................................................................................... 145 
6.4 Analysis of staining repeatability ......................................................................................... 149 
6.4.1 Objective ........................................................................................................................ 149 
6.4.2 Methods ......................................................................................................................... 149 
6.4.3 Results ........................................................................................................................... 150 
6.4.4 Discussion ...................................................................................................................... 154 
Chapter 7 Discussion, Future Work & Summary ........................................................................... 157 
Letters of Copyright Permission ..................................................................................................... 161 
References ...................................................................................................................................... 175 
 
 xiv 
List of Figures 
Figure 1-1: Schematic showing the five corneal layers. Image reproduced from: 
https://www.allaboutvision.com/resources/cornea.htm.3 ................................................................................... 1 
Figure 1-2: Corneal layers of a primate cornea. Electron micrograph, magnification x100. Image courtesy of Jan 
P. G. Bergmanson.7 ................................................................................................................................................ 3 
Figure 1-3: Epithelium of a primate, illustrating the epithelial layers from the columnar, basal cells (B), to wing 
cells (W) ending with the flatter, anterior surface, squamous cells (S). Electron micrograph, magnification 
x11,000. Image courtesy of Jan P. G. Bergmanson.7 ............................................................................................. 4 
Figure 1-4: Human epithelium and anterior stroma. Light microscopy, magnification x400. Image reproduced 
from: Becker U, Ehrhardt C, Schneider M, Muys L, Gross D, Eschmann K, Schaefer UF, Lehr CM. A comparative 
evaluation of corneal epithelial cell cultures for assessing ocular permeability. Alternatives to laboratory 
animals. 2008. 36(1):33-44.9 .................................................................................................................................. 5 
Figure 1-5: Representative images of the corneal endothelial mosaic appearance changes with age. Image 
reproduced from: Rannou K, Crouzet  E, Ronin C, Guerrero P, Thuret G, Gain P, et al. Comparison of corneal 
endothelial mosaic according to the age: The CorImMo 3D Project. IRBM. 2016;37:124-30.22 ........................... 7 
Figure 1-6: Slit-lamp biomicroscope. Image courtesy of CORE. ............................................................................ 9 
Figure 1-7: Molecular structure of sodium fluorescein. ...................................................................................... 11 
Figure 1-8: Top left: conjunctival staining (image courtesy of CORE); top right: tarsal roughness (image 
courtesy of Lyndon Jones); bottom left: rigid lens fit (image courtesy of CORE); bottom right: applanation 
tonometry (image reproduced from https://en.wikipedia.org/wiki/Ocular_tonometry34). ............................... 12 
Figure 1-9: Peak excitation and emission spectra of fluorescein; position of yellow barrier filter. .................... 14 
Figure 1-10: Slit-lamp biomicroscope view of epithelial staining with blue filter over illumination: left image 
with no yellow filter; right image with yellow filter in front of observation system. Images courtesy of L Jones, 
CORE. ................................................................................................................................................................... 14 
Figure 1-11: Fluorescein strips. ............................................................................................................................ 15 
Figure 1-12: Application of a wetted fluorescein strip to the lower tarsus. Image courtesy of CORE. ............... 16 
Figure 1-13: Fluorescein average fluorescence intensity profiles, by instillation method. ................................. 17 
Figure 1-14: Image of ocular surface with fluorescein instilled and viewed with cobalt blue and yellow filters: 
the tear film appears green. ................................................................................................................................ 18 
 xv 
Figure 1-15: Slit-lamp image of cornea, 2mm beam width, 20x magnification, blue light and yellow filter, 
fluorescein instilled: Bright green epithelial punctate fluorescein staining is visible against the pale green tear 
film. Image courtesy of CORE. .............................................................................................................................. 19 
Figure 1-16: Two examples of different staining presentations. Left side: superficial punctate staining limited 
to the inferior peripheral region. Right side: denser, more coalescent staining that impinges on the visual axis. 
Images courtesy of CORE. ..................................................................................................................................... 21 
Figure 1-17: Diffuse stromal fluorescein glow surrounding the discrete punctate staining. Image courtesy of 
CORE. .................................................................................................................................................................... 22 
Figure 1-18: Conjunctival staining in dry eye: left image with lissamine green; right image with fluorescein. 
Images courtesy of CORE. ..................................................................................................................................... 24 
Figure 1-19: Contact lens edge associated conjunctival staining. Image courtesy of CORE. ................................ 25 
Figure 1-20: Conjunctival indentation associated with contact lens wear. Image courtesy of CORE. ................. 25 
Figure 1-21: Contact lens related fluorescein patterns: top left: foreign body tracks; top right: superior arcuate 
epithelial staining (SEAL); bottom left: dehydration or ‘smile’ stain; bottom right: fluorescein pooling 
associated with mucin balls. Top left image courtesy of Lyndon Jones, others courtesy of CORE. ..................... 27 
Figure 1-22: Examples of the two patterns of SICS. Left image: pan-corneal punctate staining. Right image: 
peripheral annulus or ‘donut’ pattern punctate staining. Images courtesy of CORE. .......................................... 28 
Figure 1-23: Diffuse fluorescein is observed throughout the cytoplasm and nucleus of an epithelial cell 
collected from an eye with SICS. Confocal microscope images at depths in 4µm steps from 4µm (A) to 24µm 
(F). Image reproduced from Gorbet M, Peterson R, McCanna D, Woods C, Jones L, Fonn D. Human corneal 
epithelial cell shedding and fluorescein staining in response to silicone hydrogel lenses and contact lens 
disinfecting solutions. Curr Eye Res. 2014;39:245-56.7 ........................................................................................ 31 
Figure 1-24: Appearance of ‘white light’ corneal staining using a slit-lamp. Image courtesy of CORE. ............... 33 
Figure 1-25: Hyper-reflective surface epithelial cells of the cornea. Confocal microscope in-vivo image, 
courtesy of CORE. ................................................................................................................................................. 34 
Figure 2-1: Schematic illustration of the five corneal zones. ............................................................................... 40 
Figure 2-2: Image references for staining types. .................................................................................................. 41 
Figure 2-3: The blue outline illustrates the extent to be allocated to punctate stain, Extent=20........................ 42 
Figure 2-4: An example of a clinical recording table for CORE corneal staining scale. ......................................... 44 
 xvi 
Figure 2-5: An example of staining and the representative ZSS’s and GSS. ........................................................ 45 
Figure 3-1: Schematic illustration of of the five corneal zones. .......................................................................... 49 
Figure 3-2: Example of staining record sheet, which includes the descriptions associated with the grade of the  
type of staining. Image courtesy of CORE. .......................................................................................................... 50 
Figure 3-3: Illustration of the border defining the extent of staining. Image courtesy of CORE. ........................ 51 
Figure 3-4: Illustration of the stromal glow around the discrete punctate stain, indicative of a corneal insult 
that is deeper than the superficial epithelium. Image courtesy of CORE. ........................................................... 52 
Figure 3-5: Instructions for the agreement experiment. ..................................................................................... 56 
Figure 3-6: Recording sheet for Week-1. ............................................................................................................. 57 
Figure 3-7: Mean (Week-1 and Week-2) TYPE grade per observer (observer A-O), by image. Images ordered 
along x-axis according to the group mean grade. ............................................................................................... 61 
Figure 3-8: Mean (Week-1 and Week-2) EXTENT grade per observer (observer A-O), by image. Images ordered 
along x-axis according to the group mean grade. ............................................................................................... 61 
Figure 3-9: Mean grade for all images, both weeks, for each observer: ............................................................. 62 
Figure 3-10: Count of the individual TYPE grades used. ...................................................................................... 84 
Figure 3-11: Count of the individual EXTENT grades used................................................................................... 84 
Figure 4-1: Distribution of subjects exhibiting Rank-1 (worst staining) grades in each zone, as a percentage of 
the total number subjects (count), n=368 subjects. ............................................................................................ 96 
Figure 4-2: Graphical representation of counts of Rank-1 staining (worst) to Rank-4 staining plus count of zero 
staining, by corneal zone, n=368 subjects. .......................................................................................................... 97 
Figure 4-3: Count of eyes exhibiting two peripheral zones of Rank-1 staining, per zone combination. The 
number in parentheses indicates the count of eyes where each 2-peripheral zone combination presented with 
Rank-1 central zone staining as well. ................................................................................................................... 99 
Figure 4-4: Count of eyes exhibiting three peripheral zones of Rank-1 staining, per zone combination. The 
number in parentheses indicates the count of eyes where each 3-peripheral zone combination presented with 
Rank-1 central zone staining as well. ................................................................................................................. 100 
Figure 4-5: Posterior distribution of count proportions for each cell of the contingency table. Pattern: CP 
indicates subjects with central zone staining WITH one region of non-central zone staining. Pattern: P indicates 
 xvii 
subjects with one zone of non-central staining alone. The red triangle indicates the actual data proportions. 
INF: inferior zone, NAS: nasal zone, SUP: superior zone, TEMP: temporal zone. .............................................. 102 
Figure 5-1: Corneal epithelial disruption (“white light staining”) following lens removal and before instillation 
of fluorescein, after two hours of lens wear. ..................................................................................................... 116 
Figure 5-2: Typical example of a cornea demonstrating fluorescein staining over 85% of cornea following lens 
removal and instillation of fluorescein, after two hours of lens wear. .............................................................. 116 
Figure 5-3: Mean & SD of the percentage area of corneal staining, before and after lens wear for the untreated 
and treated eyes, Phases 1 and 2. Phase 1 treatment = one lens rinsed before wear; no statistical difference 
between eyes after lens removal, p=0.06; Phase 2 treatment = one eye rinsed following lens removal; no 
statistical difference between eyes after lens removal, p=0.92......................................................................... 118 
Figure 5-4: Mean & SD of the overall ocular hyperaemia grades, 0-100 integer scale where 0 is totally white, 
before and after lens wear for the untreated and treated eyes, Phases 1 and 2. Phase 1 treatment = one lens 
rinsed before wear; no statistical difference between eyes after lens removal, p=0.74; Phase 2 treatment = 
one eye rinsed following lens removal; no statistical difference between eyes after lens removal, p=0.11..... 119 
Figure 5-5: Mean & SD subjective comfort score at each time-point, 0-100 integer scale where 100 is perfect 
comfort, Phases 1 and 2. Phase 1 treatment = one lens rinsed before wear; no statistical difference between 
eyes at any time-point, all p>0.05; Phase 2 treatment = one eye rinsed following lens removal, no statistical 
difference between eyes at any time-point, all p>0.05. ..................................................................................... 121 
Figure 5-6: Typical image of superficial epithelial cells, showing hyper-reflective cells, in a cornea exhibiting 
SICS, Phase 3. Left image: Contact lens is in situ, no anaesthetic or fluorescein was instilled; Right image: 
Contact lens removed, anaesthetic instilled, no fluorescein. ............................................................................ 123 
Figure 6-1:The two commonly reported SICS patterns; left image shows the donut-ring pattern, right image 
shows the pan-corneal pattern. ......................................................................................................................... 130 
Figure 6-2: The blue line defines the outer border of the area of punctate staining, inferior zone. ................. 134 
Figure 6-3: Example of punctate staining over approximately 65% of the corneal area. .................................. 138 
Figure 6-4: Example of punctate staining over approximately 75% of the corneal area. .................................. 142 




List of Tables 
Table 2-1: CORE staining grade for the type of fluorescein staining, 0-100 integer scale. .................................. 41 
Table 2-2: CORE staining grade for the depth of corneal staining, 0-4 integer scale. .......................................... 43 
Table 3-1: Data set for each image, ordered by ascending mean grade for type. * indicates differences are 
converted to absolute values. .............................................................................................................................. 63 
Table 3-2: For each image: mean grade, mean standard deviation (StDev), 95% confidence interval (CI). ........ 71 
Table 3-3: Staining TYPE by observer, ordered by years of experience: concordance graphs and Tukey plots 
with elliptical limits of agreement. Obs: observer; Exp: number of years of experience with the CORE staining 
scale; CCC: concordance correlation coefficient; r: Pearson’s correlation coefficient; Accuracy: chi, χa. ........... 73 
Table 3-4: Staining EXTENT by observer, ordered by years of experience: concordance graphs and Tukey plots 
with elliptical limits of agreement. Obs: observer; Exp: number of years of experience with the CORE staining 
scale; CCC: concordance correlation coefficient; r: Pearson’s correlation coefficient; Accuracy: chi, χa. ........... 78 
Table 3-5: Concordance indices for each observer; observers ordered by years of experience. ......................... 83 
Table 4-1: Incidence by corneal zone for: Rank-1 AND zero staining in all other zones; Count of Rank-1, 
independent of staining in other zones; count of Rank-1 as a percentage of ALL Rank-1 counts; count of Rank-1 
as a percentage of ALL subjects analyzed; mean OSDI of subjects with Rank-1 in each zone. ............................ 95 
Table 4-2: Percentage (count) of specific staining patterns. ................................................................................ 98 
Table 5-1: Percentage area of cornea (per zone: nasal, temporal, central, superior, inferior), demonstrating 
fluorescein staining at post-lens wear assessments (mean and standard deviation). Phase 1 treatment = one 
lens rinsed before wear; Phase 2 treatment = one eye rinsed following lens removal. .................................... 117 
Table 5-2: Count of participants during Phase 1 and Phase 2 who reported either no symptoms or symptoms of 
stinging, burning and/or itching at each time-point, in both the untreated and the treated eye. Phase 1 
treatment = one lens rinsed before wear; Phase 2 treatment = one eye rinsed following lens removal. ......... 120 
Table 5-3: Number of hyper-reflective (HR) cells (per eye) of each participant as determined by confocal 
microscopy in Phase 3: both eyes were exposed to the same lens and solution combination for 2 hours. “n/a” 
describes cases in which no images were obtainable due to participants’ inability to tolerate the imaging 
procedure. A score of “0” indicates that clear images were obtained and no hyper-reflective cells were 
observed. *NOTE: Percentage of eyes exhibiting HR cells does not include those “n/a” eyes in which no images 
were obtained. ................................................................................................................................................... 122 
Table 6-1: Details of studies or study arm meeting the inclusion criteria for analysis. ...................................... 131 
 xx 
Table 6-2: Details of PureVision contact lens worn in all studies listed in Table 6-1. ........................................ 132 
Table 6-3: Details of Renu brand PHMB-preserved products used in the studies listed in Table 6-1. .............. 133 
Table 6-4: Studies providing data for pattern analysis. ..................................................................................... 136 
Table 6-5: Mean area of staining by zone (standard deviation) and range, per study, n=88 (0-100). .............. 138 
Table 6-6: Count of eyes with: a) SICS: defined as 4 zones with ≥10% staining area; b) donut-ring SICS: defined 
as central zone has <10% staining area; c) pan-corneal SICS: defined as all 5 zones with ≥10% staining area. 140 
Table 6-7: Using the SICS definition of 4 zones or more with ≥10% area staining, count of corneal zones 
exhibiting <10% staining area in eyes exhibiting SICS, by study and for all studies combined, n=71. .............. 141 
Table 6-8: Using the SICS definition of 4 zones or more with ≥10% area staining, mean area of staining 
(standard deviation) per corneal zone in eyes exhibiting SICS, by study and for all studies combined, n=71. . 141 
Table 6-9: Using the SICS definition of 4 zones or more with ≥10% area staining, count of Rank-1 labels 
allocated to each corneal zone in eyes exhibiting SICS, by study and for all studies combined, n=71. ............ 143 
Table 6-10: Using the SICS definition of 4 zones or more with ≥50% area staining, count of eyes with: a) SICS: 
defined as 4 zones with ≥50% staining area; b) donut-ring SICS: defined as central zone has <50% staining area; 
c) pan-corneal SICS: defined as all 5 zones with ≥50% staining area. ............................................................... 144 
Table 6-11: Across all studies, for eyes exhibiting SICS according to the definition of 4 zones or more with 50% 
area staining,: a) count of eyes per zone with <50% staining area; b) mean area of staining (standard deviation) 
per corneal zone; c) count per zone of Rank-1 labels. n=58.............................................................................. 145 
Table 6-12: Subjects identified as being in repeated SICS-inducing studies (n=7). ........................................... 149 
Table 6-13: Grades of staining areas arranged by subject, per study and by zone; SICS confirmation and pattern 





List of Abbreviations 
 
ANOVA Analysis of variance 
CCC  Correlation coefficient of concordance 
CCLR  Centre for Contact Lens Research 
CORE  Centre for Ocular Research & Education 
DE  Dry eye 
DEWS II Dry Eye Workshop II 
FDA  Food and Drug Administration 
HR  Hyper-reflective 
MPS  Multipurpose solution 
OSDI  Ocular Surface Disease Index 
PATH  Preservative associated transient hyperfluorescence 
PHMB  polyhexamethylene biguanide 
SD  Standard deviation 
SICS  Solution induced corneal staining 
SiHy  Silicon hydrogel 
TFOS  Tear Film and Ocular Surface 





Background and Literature Search 
The eye is a complex matrix of many different tissues, structures and systems. A failure in one tissue 
or structure has potential for serious impact on the eye’s primary function – vision. The cornea is the 
most anterior structure of the eye and it is exposed the external environment, protected only by the 
tear film and the eyelids. The cornea is composed of five layers and the outermost layer is the corneal 
epithelial layer, Figure 1-1. Sodium fluorescein is a liquid dye that has been routinely used in clinical 
practice for over fifty years to assess the health of the ocular surface, particularly the corneal 
epithelium.1, 2 This thesis explores aspects of sodium fluorescein staining of the corneal epithelium in 
the presence of symptomatic dry eye and in the presence of solution induced corneal staining (SICS).  
 
 





1.1 Corneal structure and relationships 
The cornea is the anterior face of the eye, which acts as one of several ‘windows’ through which 
vision is possible. Because light passes through the cornea on the way to the retina, it is vital to visual 
function that the cornea remains as optically clear and free from distortion as possible. The 
requirement for clarity means the cornea is avascular. It draws nutrients from its surrounding 
environments; tear film, aqueous humour, limbal blood vessels and inner tarsal blood vessels.  
From the frontal view, the cornea appears as a round disc of clear tissue, situated directly in front of 
the iris and pupil, which meets the sclera and conjunctiva at its circumference, a junction called the 
limbus. From the lateral perspective, the cornea appears as a dome structure of smaller radius of 
curvature than the rest of the eyeball. Remaining distortion free while maintaining a vertically 
oriented, curved shape requires a robust structure. The cornea is approximately 535µm thick at the 
centre, slightly thicker at the periphery and is composed of five distinct layers.4, 5 The corneal 
curvature is largely maintained by the lamellar structure within the thickest corneal layer, the stroma.6 
The five corneal layers are shown in Figure 1-2. The most anterior surface of the cornea is the 
corneal epithelium, which is exposed to the tear film and the external environment. Next is Bowman’s 
membrane, which is also known as the anterior limiting membrane. The stroma is the middle layer 
and makes up the vast majority of the corneal thickness. Posterior to the stroma is the posterior 





Figure 1-2: Corneal layers of a primate cornea. Electron micrograph, magnification x100. Image courtesy 
of Jan P. G. Bergmanson.7 
 
1.1.1 Epithelium 
The epithelium is the outermost layer of the cornea. It is immediately adjacent to the tear film and is 
the external protective layer for the cornea and therefore the eye. The corneal epithelium is 
approximately 51µm thick at the centre of the cornea and thicker at the limbus, where it is continuous 
with the conjunctival epithelium.5 It is made up of 5-7 layers of nucleated, non-keratinised, epithelial 
cells layered according to the three stages of their seven day life cycle; basal, wing and squamous.8 
As the cells age, they migrate towards the anterior surface where they eventually slough off into the 
tear film.  
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There are difficulties obtaining representative images of human epithelial cells before they degrade, 
however the three cell stages can be seen in Figure 1-3, which is a primate cornea and in the light 
microscopy of a human cornea, Figure 1-4, which also shows the anterior stroma.  
 
Figure 1-3: Epithelium of a primate, illustrating the epithelial layers from the columnar, basal cells (B), 
to wing cells (W) ending with the flatter, anterior surface, squamous cells (S). Electron micrograph, 






Figure 1-4: Human epithelium and anterior stroma. Light microscopy, magnification x400. Image 
reproduced from: Becker U, Ehrhardt C, Schneider M, Muys L, Gross D, Eschmann K, Schaefer UF, 
Lehr CM. A comparative evaluation of corneal epithelial cell cultures for assessing ocular permeability. 
Alternatives to laboratory animals. 2008. 36(1):33-44.9 
 
The cells of the apical (anterior) layer are often referred to as squamous cells. They are somewhat 
flattened and lie parallel to the surface. These outermost cells are the oldest and they will slough into 
the tear film as they are replaced from below. The outer-facing membranes of these apical epithelial 
cells are covered with an irregular network of microvilli, believed to be fundamental to tear film 
adhesion and tear film stability.5 These outer-facing membranes secrete a glycocalyx, or film, which 
serves as an additional barrier and hinders the binding of organisms to the epithelial surface. Recent 
work has highlighted the interactions of three mucins, MUC1, MUC4 and MUC16, with the protein 
galectin-3 as a significant component of this protective layer.10 Within this layer, tight-junctions are 
present between all adjacent epithelial cells, creating an impermeable barrier to the diffusion of 
pathogens and molecules into the intercellular space.10 Desmosomes (anchoring junctions “binding” 
adjacent cells together) and adherens-junctions in the various layers of the corneal epithelium provide 
structural integrity and further prevent fluid from the tear film overhydrating the cornea.10 Cell 
junctions play a key role in corneal integrity.10  
The deepest epithelial layer, also referred to as the basal layer, is comprised of a single layer of 
cells which are columnar in shape and oriented with their long axis perpendicular to the corneal 
surface. These cells secrete the basement membrane to which they are strongly bonded via hemi-
desmosomes. As new cells are produced in this basal layer, the older cells migrate forward and 
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change orientation, forming 2-3 layers of wing cells immediately below the squamous rows.5 In the 
wing and basal cells layers there are no tight-junctions, and therefore some fluid can move from the 
stroma into the epithelium.  
The epithelial layer of the cornea is constantly regenerating, yet in spite of this constant cellular 
movement to the surface, the cell boundaries are extremely strong and the epithelium remains firmly 
anchored to the epithelial basement membrane, which is immediately adjacent to Bowman’s 
membrane. In corneal homeostasis, the replenishment of epithelial cells in this continual shed/renewal 
cycle assists in the maintenance of a uniform structure which, in turn, helps maintain corneal 
transparency.11 The continual replacement of lost cells is possible because of the presence and activity 
of stem cells which are found within the basal epithelial layer, mainly at the conjunctival border, the 
limbus; specifically in the palisades of Vogt, epithelial crypts and stromal projections.12, 13 These stem 
cells, as in other self-regenerating tissues within the body, are capable of unlimited self-renewal.14 
The largest stem cell reservoirs are found at the superior and inferior limbal regions, however the 
annular distribution provides the entire cornea with a constant supply of new cells which migrate 
centrally from this outer annulus.15 Larger corneal epithelial wounds have been shown to heal from 
the outer edges inwards, with faster healing in the peripheral cornea than the central, validating the 
centripetal movement of the stem cells from the limbus.16, 17 The annular stem cell population also 
acts as a barrier to conjunctival cells which may otherwise migrate into the cornea causing a loss of 
corneal transparency.18 It is clear that the role of these stem cells is vital to corneal, and therefore 
ocular, integrity and thus damage to the peripheral epithelium should always be taken seriously.   
1.1.2 Bowman’s membrane 
Bowman’s membrane is an acellular membrane that separates the stroma from the corneal epithelium. 
It is 8-10µm thick and attached strongly to the anterior stromal lamellar.19 It functions as a protective 
layer for the stroma, however once damaged it cannot be repaired and any extensive damage will 
likely result in permanent scarring.1 
1.1.3 Stroma 
The stroma makes up 90% of the corneal thickness and is organized as a matrix of collagen fibril 
lamellae with scattered large flat, paper-thin keratocytes.5 The density of the keratocytes reduces in 
the posterior stroma, where the collagen lamellae become thinner.20 The keratocytes maintain the 
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collagen fibrils.19 The strong structural architecture of the stroma maintains corneal shape and acts as 
a barrier to physical and chemical injury. 
1.1.4 Descemet’s membrane 
This is an acellular layer which acts as the basement layer for the endothelial cells, separating the 
endothelium from the stroma. 
1.1.5 Endothelium 
The endothelium is the innermost layer of the cornea. Just 5µm thick, it is comprised of a single layer 
of squamous cells which do not replicate or reproduce. This monolayer functions as the pump which 
maintains optimal corneal hydration by moving fluid out of the cornea via complex ion transport 
systems.21 This pumping role is vital in maintaining corneal clarity, as excess fluid buildup causes 
clouding of the cornea, called oedema. The endothelium cells are adjacent to the aqueous humour and 
therefore the pump mechanism stops the aqueous humour from flooding through the endothelium 
causing corneal oedema. Throughout life, endothelial cells are gradually lost, causing neighbouring 
cells to stretch to fill the void.21 Thus, the cells of this layer become increasingly polymorphous with 
age, Figure 1-5.21, 22 
 
Figure 1-5: Representative images of the corneal endothelial mosaic appearance changes with age. Image 
reproduced from: Rannou K, Crouzet  E, Ronin C, Guerrero P, Thuret G, Gain P, et al. Comparison of 
corneal endothelial mosaic according to the age: The CorImMo 3D Project. IRBM. 2016;37:124-30.22 
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1.2 Corneal innervation 
The cornea is a densely innervated structure. Axons that mostly originate from the long ciliary nerves 
enter the cornea at the level of the anterior stroma or posterior epithelium, at various positions around 
the limbus. These axons then branch, largely remaining within their layer, thus creating a basal 
epithelial plexus and a less dense anterior stromal plexus.5 There are occasional axons passing 
through Bowman’s membrane connecting these two nerve plexi.4, 5 All the nerves in the epithelium 
lose their protective myelin sheath at the limbus, another structural detail to preserve the optical 
integrity of the cornea, however, the myelin remains around the nerve fibres within the stroma.5 
Stimuli for corneal nerves include touch, cold, osmolality and pH, but all the responses are perceived 
psychologically as ‘pain’, thereby invoking a protective response from the host.23 
 
1.3 Assessing corneal integrity 
As mentioned earlier, the cornea’s integrity is essential to facilitate clear vision and the corneal 
epithelium is the primary barrier to external pathogens. A method for assessing the corneal 
epithelium’s integrity is thus desirable. There are only a few organisms that can invade an intact 
epithelium in a healthy person to cause a scar-inducing infection,24 therefore maintaining tissue 
integrity is an important part of avoiding infection. While corneal trauma and surgery are obvious risk 
factors for infection, exposure keratitis (as in dry eye) and contact lens wear have also been 
recognized as major predisposing factors.25 Therefore, in individuals with a history of dry eye or 
contact lens wear, evaluating the integrity of the corneal epithelium is a very important clinical 
assessment, both for a proactive management approach as well as part of reactive, problem solving 
management.  
The standard equipment for assessing the human cornea in vivo is an optical slit-lamp 
biomicroscope. These microscopes comprise a binocular viewing system coupled with an 
illumination system such that both systems share a centre of rotation and therefore share focusing and 
movement systems.26 The coincident focusing of light and microscope, combined with an easily 
adjusted magnification, make the slit-lamp biomicroscope a fundamental piece of equipment in 
optometry and ophthalmology practices which is used to routinely inspect the anterior eye and 
conduct contact lens follow-up assessments, Figure 1-6.  
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Slit-lamp biomicroscopes produce a focused beam of light but an optional diffuser can be moved in 
front of the illumination system as required. Diffuse illumination allows general observation of the 
surface ocular tissue, tear film and corneal epithelium, best used with low magnification of around 
10x or less. A broad, direct (non-diffused) light beam provides a more intense light source to inspect 
specific structures or layers, typically used with the microscope at the same angle as the light source. 
A focused beam of 2mm width with the observation microscope set at an angle facilitates a view of 
the layers of the cornea as the light beam penetrates the structure, creating a parallelepiped. If the 
beam is narrowed considerably and the magnification is set to 32x or 40x, then an optical section is 
created, and the five layers of the cornea can be observed. With this setting, any distortions or defects 
within the structure become apparent. The maximum magnification for a slit-lamp is 40x, allowing 
resolution as low as 30µm.  
 
 
Figure 1-6: Slit-lamp biomicroscope. Image courtesy of CORE. 
 
Confocal microscopy affords magnification of around 680x, which permits individual corneal cells 
to be imaged. It is a contact microscope requiring anaesthetic and a gel interface between the 
objective lens and the cornea. This method provides images of multiple sections of the cornea which 
are ‘front-on’ sections of a single layer, rather than sections through all the corneal layers. These 
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instruments became available in the late 1990s and more information on the theory behind them is 
summarized elsewhere.27   
High magnification is also afforded by a specular microscope. However, the principles for its use 
rely on a refractive index differential and therefore the endothelium is the structure best viewed with 
this microscope as other corneal layers are too similar in index to their neighbouring layers for good 
resolution.  This makes the specular microscope too limited in application for a practice setting. 
Specular reflection is attained when the angle of illumination equals the angle of the observation 
microscope. Using this technique with a slit-lamp allows observation of the gross appearance of the 
endothelial cells. More detail on specular microscopes can be found elsewhere.28, 29   
The highest magnification of human tissue is achieved with the electron scanning microscope. 
However, these microscopes are only applicable to ex-vivo or cultured tissue. Such high 
magnification of live tissue in situ in the body is not yet achievable. Despite this drawback, much 
detail about the corneal anatomy was learnt using electron microscopy.5  
Due to the need for optical clarity of the corneal structure, in a healthy cornea there is, quite 
literally, very little to see. Areas of the cornea can appear opaque due to the presence of anomalies 
such as scars, foreign bodies and oedema. While the vitality of the entire cornea is important to 
maintain good vision, the epithelium is of particular importance because of its positioning as the 
anterior barrier layer, exposed to the external environment.  The use of stains has become 
commonplace to examine the epithelium because they can assist in screening for early signs of 
damage or aid in diagnosis of disease and/or damage. Sodium fluorescein, rose bengal and lissamine 
green are the three commonly used stains for examining the integrity of the ocular surface in 
conjunction with a slit-lamp biomicroscope.26 Sodium fluorescein is regarded as the most valuable 
stain to assess corneal integrity26 and therefore, as per the scope of this thesis, only the interaction of 
sodium fluorescein with the corneal epithelium will be discussed in more detail below. 
 
1.4 Sodium fluorescein interaction with corneal epithelium 
1.4.1 Sodium fluorescein 
Fluorescein is a manufactured, organic, soluble compound which is used as a dark orange/red dye in 
many applications, ranging from water system leak detection to an injectable medical tracer. 
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The first reported use in the eye was in 1882 by Pfluger.30 He combined fluorescein with sodium to 
improve its solubility, and described the view of “corneal staining” when he instilled it into rabbit 
eyes. It is the sodium fluorescein compound which is the formulation used widely today in the 
optometry and ophthalmology fields to examine the ocular surface. Throughout this thesis the term 
fluorescein is used and refers to sodium fluorescein, also known as fluorescein disodium salt. 
1.4.2 Properties of sodium fluorescein 
Fluorescein has the molecular structure of C20H10Na2O5, Figure 1-7. It has a molecular weight of 376 
daltons and is 50% soluble in water at 15°C, making it more soluble than sodium chloride.30   
 
 
Figure 1-7: Molecular structure of sodium fluorescein. 
 
Fluorescein has many uses in ocular examination. It has been used for over fifty years as an 
injectable in retinal fluorescein angiography to facilitate examination of the retinal and choroidal 
circulation.31 However there are many more ocular uses which are far less invasive and involve 
instilling fluorescein onto the anterior ocular surface and viewing though a slit-lamp biomicroscope, 
using filters that cause the fluorescein to fluoresce a bright green colour (see below for more details). 
In addition to being used to assess corneal epithelial staining, other uses include assessing 
conjunctival staining, tarsal roughness, ocular injury, corneal epithelial dystrophies, tear film 
integrity, as well as assessing rigid contact lens fit and facilitating applanation tonometry, Figure 1-8. 
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All of these uses are possible largely because of the solubility and fluorescent properties of 
fluorescein, coupled with its low toxicity. While there have been reports of some allergic responses 
related to intravenous use of fluorescein,32 the instillation of fluorescein onto the ocular surface is not 
expected to cause any adverse responses, however repeated instillations have been shown to be 
associated with increased corneal staining.33   
 
 
Figure 1-8: Top left: conjunctival staining (image courtesy of CORE); top right: tarsal roughness (image 
courtesy of Lyndon Jones); bottom left: rigid lens fit (image courtesy of CORE); bottom right: 
applanation tonometry (image reproduced from https://en.wikipedia.org/wiki/Ocular_tonometry34). 
 
It is the fluorescence of fluorescein at very low concentrations that has earned fluorescein its broad 
ophthalmic use to ‘visualize’ the tear film and the integrity of the ocular surface.35 Fluorescein 
exhibits maximum excitation when exposed to light of wavelength 495nm, Figure 1-9.36 White light 
sources do provide this 495nm wavelength however, use of a white light source for this purpose is 
less than ideal because the emitted fluorescence from the fluorescein is difficult to discern against the 
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breadth of the background illumination from the broad white light spectra. Thus, observation can be 
optimised by matching the incident light more closely to that of the maximal fluorescein excitation 
wavelength, 495nm. This is achieved by placing a blue filter over the slit-lamp light source, often a 
cobalt blue filter. Many slit-lamps include a blue filter option as standard and ideally this filter would 
have peak transmittance close to 495nm in order to maximise the excitation of the fluorescein., 
however Peterson et al.37 have demonstrated that many slit-lamp blue filters have their peak 
transmittance closer to 450nm, thus offering sub-optimal exitation. Nevertheless, using these blue 
filters is far more effective than observing with a regular white light source, though their low level 
transmittance causes difficulties when attempting photography, and other filters have been 
recommended for this situation.38 
While an incident light source of 495nm is required for optimal excitation, the wavelength of the 
fluorescence emitted is around 510-520nm, Figure 1-9.39 In order to optimise the view of the emitted 
fluorescence, a barrier filter is recommended which blocks the majority of the available light, leaving 
only the fluorescence wavelengths visible. A yellow filter, often a Wratten 12 filter, which blocks 
wavelengths shorter than 500nm, has been traditionally used for this purpose and it is very effective 
in optimising the view of any fluorescence on the corneal surface by enhancing the contrast. Figure 






The intensity of the fluorescence of fluorescein is influenced by pH, layer thickness and 
concentration. The typical pH of the ocular surface is between 6.5 and 8.0 and at this level the light 
absorption peak is still 495nm and the fluorescence appears the familiar green colour.35, 36 As the 
fluorescein stained tear layer becomes thicker, it fluoresces more brightly, a property fundamental to 
its use in rigid lens fit, Figure 1-8. The fluorescence increases with concentration up to a maximal 
concentration of approximately 0.001%, with higher concentrations causing a reduction in 
fluorescence due to a process called ‘quenching’, a phenomenon in which competitive molecular 
emission blocks the fluorescence.30 
1.4.3 Instilling fluorescein into the eye 
Because liquid fluorescein has an affinity for contamination with pseudomonas aeruginosa,40 a 
bacterium which is highly damaging to the cornea, it is rarely used in the multi-dose 2% 
concentration liquid form. It is available in unit dose liquid of either 1% or 2% concentrations, but 
due to the high relative cost of this preparation, in clinical practice fluorescein is most commonly 
sourced in a single use, dry, paper strip preparation. The small paper strips are impregnated with 0.6-
1.0 mg (depending on brand) dry fluorescein compound at one end and each one is individually 
sealed in a sterile envelope, within a multi-envelope box, Figure 1-11. 
 




After removing the strip from its envelope, a small volume of liquid fluorescein dye is applied to 
the ocular surface by wetting the strip with sterile saline and then holding it against the lower lid inner 
tarsal region, or against the lower bulbar conjunctiva. If not controlled carefully, this method of 
fluorescein instillation can deliver quite different volumes and concentrations of fluorescein to the 
eye. CORE uses a standardised fluorescein instillation methodology which was recommended by 
Peterson et al.37 to maximise the fluorescence observed. This procedure involves placing one drop of 
saline (approximately 40µl41) onto the impregnated end of the fluorescein strip and shaking the strip 
vigorously to remove excess fluid. The wetted strip is then brought into brief contact with the lower 
tarsal region, Figure 1-12. 
 
Figure 1-12: Application of a wetted fluorescein strip to the lower tarsus. Image courtesy of CORE. 
 
Abdul-Fattah et al.41 conducted an in vitro quantification experiment to estimate the amount of 
fluorescein delivered by whole and split impregnated fluorescein strips compared to measured 
volumes of 2% w/v liquid fluorescein. They determined that when a full strip was wetted by 50µl 
saline, shaken and then applied across 2mm of damp filter paper, it delivered an amount of 
fluorescein that was equivalent to 3µl of the 2% w/v liquid fluorescein. They also noted that splitting 
the impregnated strips into thinner strips appeared to offer a simple and effective way of controlling 
the amount of fluorescein instilled into the eye. 
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Immediately after initial instillation into the eye the concentration can be higher than optimal and 
lead to quenching, which would cause under-reporting of ocular surface staining. Peterson et al.37 
recommend a wait time of one minute before assessment in order for the concentration to reduce and 
stabilise within the optimal range, Figure 1-13. 
 
Figure 1-13: Fluorescein average fluorescence intensity profiles, by instillation method.  
Graph reproduced from Peterson RC, Wolffsohn JS, Fowler CW. Optimization of anterior eye 
fluorescein viewing. Am J Ophthalmol. 2006;142:572-5.37 
 
1.4.4 Viewing corneal fluorescein staining 
As mentioned earlier, after instillation of fluorescein into the eye, any staining of the corneal 
epithelium is optimally observed after one minute, using a slit-lamp biomicroscope with a blue filter 
over the illumination system and a yellow filter in front of the observation system.42  
Under these viewing conditions, the fluorescein mixes with the tear film causing it to appear green, 
which shows as brighter green in the thicker tear meniscus regions along the lid margins, Figure 1-14. 
If the fluorescein penetrates specific areas of the epithelium, then those areas appear very bright 
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green, and they are easily discernable against the pale green hue of the tear film, Figure 1-15. These 
bright green areas are typically termed areas of corneal epithelial staining and, because it has long 
been believed that fluorescein only enters ocular surface cells if they are damaged,35 then corneal 
staining has been presumed to be evidence of mechanical or biochemical disruption of the epithelium 
cell layers.35 The significance of corneal staining and the epithelial cell interactions with fluorescein 
is described in Section 1.8. 
 
 
Figure 1-14: Image of ocular surface with fluorescein instilled and viewed with cobalt blue and yellow 






Figure 1-15: Slit-lamp image of cornea, 2mm beam width, 20x magnification, blue light and yellow filter, 
fluorescein instilled: Bright green epithelial punctate fluorescein staining is visible against the pale green 
tear film. Image courtesy of CORE. 
 
As described in the previous section, this methodology provides an optimal view of the fluorescein 
staining because the blue filter transforms the incident light to approximate the peak excitation 
wavelength of fluorescein, 495nm. This use of blue illumination transforms the orange fluorescein 
appearance to a bright green, which has greater contrast against the blue incident light than orange 
against a white light background. The yellow filter in front of the observation system improves 
contrast still further by blocking most of the blue light, leaving the bright green fluorescein standing 
out even more defined against a dark background. This observation method is so standard that all slit-
lamps provide a blue light option and most have an internal yellow filter too, which is far more 
convenient than using a separate hand-held one. 
1.4.5 Methods of recording fluorescein corneal staining 
Because any break in the epithelial barrier provides the opportunity for micro-organisms or other 
unwanted substances to enter the cornea, potentially causing damage and scarring, assessing and 
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recording these breaks is important. Recording the degree of epithelial staining provides a 
quantification of the epithelial insult and facilitates monitoring of worsening or recovery. It has been 
said that “a picture paints a thousand words”, however not all practices have the equipment required 
to adequately photograph corneal staining. Born from the need to assess the severity and extent of 
corneal staining to make comparisons over time, several staining grading scales have been developed 
to describe fluorescein staining. 
The early scales were descriptive using terms such as ‘trace’ or ‘severe’. These were followed by 
numeric scales which hold the advantage of lending themselves to statistical analysis. There are 
several numeric scales which provide a single numeric grade for the entire corneal surface and of 
these, some offer integer step scales, such as the Oxford 0-4 scale43 and the Sjogren’s Syndrome 
International Registry Scale44 (0-6 scale) whereas the Efron 0-4 scale45 is designed to be used in 0.1 
steps. Other scales recommend to grade the staining of the cornea in five separate corneal zones, the 
central, superior, inferior, temporal and nasal zones, as first suggested by Josephson and Caffery.46 
Examples of these scales are those of the Food and Drug Administration47, the National Eye 
Institute48, the Brien Holden Vision Institute49 (formerly the CCLRU scale) and the Centre for Ocular 
Research & Education50 (CORE). Chapter 2 describes these in more detail, specifically the CORE 
corneal staining scale (see Chapter 2 and Woods et al.51) that was used in the clinical trials described 
in the following thesis chapters. 
Two examples of quite different staining appearances are shown in Figure 1-16. The most common 
and least concerning form of corneal staining is that of superficial ‘punctate’ staining, which is 
visualised as very small dots of bright green fluorescein hyperfluorescence that may be highly 
localised or widespread across the cornea. It would seem logical that the larger the area of staining, 
the more the corneal surface is compromised. It is also intuitive to be more concerned about corneal 
staining which is closer to the visual axis, because any significant surface disturbance at this location 
could be detrimental to vision. Additionally, the corneal epithelium relies on stem cells to continually 
regenerate and these are primarily located in the limbal regions, with highest populations at the 
superior and inferior limbus. Therefore, staining at the limbus, in particular the superior or inferior 





Figure 1-17: Diffuse stromal fluorescein glow surrounding the discrete punctate staining. Image courtesy 
of CORE.   
 
1.5 Fluorescein staining associated with dry eye 
Dry eye disease has been redefined by the Tear Film and Ocular Surface Society (TFOS) Dry Eye 
Workshop (DEWS) II, Definition and Classification Report52 as follows:  
“Dry eye is a multifactorial disease of the ocular surface characterized by a loss of 
homeostasis of the tear film, and accompanied by ocular symptoms, in which tear film 
instability and hyperosmolarity, ocular surface inflammation and damage, and neurosensory 
abnormalities play etiological roles.”  
 
There are several symptom gathering methods but the most commonly used, validated 
questionnaire is the Ocular Surface Disease Index (OSDI) questionnaire, which has been validated53 
and can identify the severity of the dry eye.4 
This new definition of dry eye disease does not mandate corneal staining to be present to confirm a 
dry eye diagnosis, however, this Report does state that the degree of staining is an important aspect of 
severe dry eye disease. Chalmers et al.55 have specifically reported that the presence of >grade 1 
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overall corneal staining was a useful indicator to distinguish those with dry eye from those without 
dry eye. 
The presentation of corneal staining in those with dry eye can vary considerably and is often 
monitored to review the efficacy of treatment. The corneal staining is presumed to be a sign of 
epithelial insult caused, at least in part, by either low tear volume or poor-quality tear fluid.52 
To meet the new definition, symptoms of dry eye disease must co-exist with an ocular sign. The 
sign does not need to be corneal staining, however corneal staining does very commonly co-exist with 
dry eye symptoms and becomes part of the severity assessment.56-59 However, there is little in the 
literature regarding the typical location of corneal staining in those with dry eye disease. Chalmers et 
al.55 have reported that inferior corneal staining may be indicative of dry eye and Tong et al.60 
recently reported the inferior zone had higher staining levels at baseline in a clinical trial involving 
dry eye subjects. More studies are required to investigate the severity and location of staining in those 
with dry eye symptoms.   
Another common co-existing sign in people with dry eye is conjunctival staining, which can be 
assessed with fluorescein, rose bengal or lissamine green. Rose bengal and lissamine green have both 
been shown to stain mucous strands and dead/damaged cells,61 however rose bengal may also stain 
healthy cells.62 Rose bengal stings on insertion into the eye and has been shown to be detrimental to 
the vitality of epithelial cells.63 The staining appearances using rose bengal and lissamine green have 
been shown to be well correlated,64 and therefore lissamine green is generally favored over rose 
bengal for ocular surface assessments because it is more comfortable. The conjunctival staining with 
either lissamine green or fluorescein is interpreted as identifying tissue that is physiologically 






For fluorescein staining of the cornea in a contact lens wearer, many of the staining patterns are 
indicative of specific contact lens related conditions, Figure 1-21. The staining associated with a 
trapped foreign body trapped under a contact lens presents as characteristic foreign body tracks or 
swirls as the foreign body is moved by the contact lens rotating and moving vertically with the blink 
action. Similar tracks may be caused by foreign bodies without contact lens wear but they tend to be 
smaller because the foreign bodies are swept to the inner canthus more quickly by the tear flow and 
lid blinking actions. A stiff lens has been known to cause superior epithelial arcuate lesions 
(SEALs).26 Soft lens dehydration, sometimes associated with thin lenses, leads to the classic 
appearance of punctate staining in a small area in the mid-inferior corneal region, termed ‘smile 
stain’.68 This can also develop due to partial or incomplete blinking, which in turn causes tear film 
loss below the contact lens and possibly localized drying of the contact lens itself.26 There may also 
be corneal staining associated with wearing a damaged contact lens. For example, a lens torn at the 
edge may cause conjunctival staining whereas a lens torn at the centre may cause central corneal 
staining. Observation of the damaged lens on eye will provide the indication of the cause for this 
staining. 
The introduction of silicone hydrogel lenses towards the beginning of this century, brought a new 
characteristic fluorescein phenomena; mucin ball pooling,69 Figure 1-21. In some wearers, the 
combination of lens movement with the stiffness of the silicone hydrogel material creates sheer forces 
that disrupt the mucin layer on the ocular surface, creating balls of mucin that are discernable on 
careful slit-lamp examination. These mucin balls are trapped beneath the contact lens and they 
become somewhat stuck to the epithelium such that they each create a small area of tissue 
depression.70 When the contact lens is removed and the mucin balls are released, the instilled 
fluorescein fills these tissue depressions creating small pools of thicker tear film which fluoresce 
more brightly than the rest of the tear film, thus simulating the appearance of epithelial staining. 
Ladage et al.71 have reported that these tissue depressions can be several cell layers thick but are not 
associated with cell damage or with fluorescein entering the epithelial cells. Therefore, this 
presentation is described as fluorescein pooling into the mucin ball depressions, not corneal staining. 
There are many variations of the type and pattern of corneal staining associated with contact lens 
wear. No matter whether or not these staining presentations were accompanied by ocular discomfort 




cleaning/storage product with effective disinfection and surfactant cleaning properties while 
minimizing epithelial cytotoxicity. Improvements in the chemical composition of care systems and 
the adoption of frequent replacement contact lenses in the 1990’s largely eradicated this problem.74 
The term solution induced corneal staining (SICS) was used to describe a new contact lens 
associated response where excessive superficial punctate corneal staining was associated with the use 
of, primarily, silicone hydrogel lenses and certain preserved care regimens.75  
 
 
Figure 1-22: Examples of the two patterns of SICS. Left image: pan-corneal punctate staining. Right 
image: peripheral annulus or ‘donut’ pattern punctate staining. Images courtesy of CORE. 
 
After the initial reports of this phenomenon in 2002,76, 77 more investigations were undertaken. 
Garofalo et al.78 conducted an investigation of four care products and three contact lenses and 
reported a temporal pattern to the corneal staining which was maximal between one and six hours 
after insertion, depending on the product combination. Following this work, several other groups 
investigated different combinations of lens and care products. Two of these groups created a matrix of 
staining responses which indicated that, although seen with several combinations, the highest levels 
of temporal course staining were observed when contact lenses of specific silicone hydrogel or FDA 
group II materials were worn for two hours following exposure to care products preserved with 
polyhexamethylene biguanide (PHMB).75, 79-83 Therefore SICS appeared to be not truly product 
specific, but rather it was specific to certain combinations of lens materials and care systems. This has 
since been supported by in vitro work.84 An additional unexplained factor was that products with the 
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same concentration of PHMB produced different levels of corneal staining when used with the same 
contact lens.78, 79, 85 The SICS response has spawned many investigations into the cellular nature of 
fluorescein staining, which is explored further in the next section. 
The corneal staining of SICS is often graded based on the area of the cornea affected45, 49 and 
reporting SICS according to the area of the corneal staining seems appropriate because the staining is 
almost always punctate in nature and therefore it is the area of the cornea affected that is the variable 
factor. The extent of the punctate staining across the corneal surface describes the extent of corneal 
involvement. Jones et al.77 described SICS as a peripheral annular pattern of punctate staining, 
whereas Garofalo et al.78 reported a mix of annular and pan-corneal staining, Figure 1-22. Most of the 
subsequent studies have reported the SICS staining to be a peripheral annular (or donut-ring) pattern 
but some have also reported pan-corneal staining.82, 83, 86-91 There have been no reports of whether the 
SICS staining pattern is repeatable within individuals. Varying the assessment time while inducing 
SICS repeatedly on the same individuals may answer whether the central staining has either a shorter 
duration or a later onset, both of which could explain the higher incidence of the reports of the 
annular staining pattern.   
The evidence of the association of SICS with symptoms of discomfort is equivocal.  The first 
reports by Epstein76 and Jones et al.77 described the presentation as largely asymptomatic, although 
Jones et al.77 mentioned some reports of stinging. SICS is frequently described as asymptomatic 
though, when specifically reported, the symptomology varies from none,92 through mild,78, 79 to more 
clinically relevant levels.86, 93 Situ et al.94 assessed ocular surface sensitivity on eyes with SICS and 
found a positive correlation between the area of corneal staining and the conjunctival chemical 
sensitivity. Interestingly there was no correlation with corneal sensitivity. The symptomology 
associated with SICS is an area that would benefit from further investigation. 
 
1.8 Cellular significance of fluorescein staining 
In 1988, to explain the appearance of corneal staining, Back95 suggested that uptake of fluorescein by 
the epithelial cell layers can occur under three conditions: when the tight junctions between the cells 
are weakened and fluorescein flows between them; when the epithelial cells are lost from the surface; 
when the cell membranes increase in permeability allowing the fluorescein to enter the cells. 
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In 1995, Wilson et al.96 investigated mechanical and chemical induced staining in rabbit corneas 
and determined that, since some of the fluorescence did not rinse away, the fluorescence observed in 
fluorescein staining was intracellular and not simply pooling in the space that cells had vacated. Soon 
afterwards, Ward and Walker97 demonstrated that stratified cultures of human corneal epithelial cells 
were impermeable to fluorescein unless damaged by chemical such as benzalkonium chloride or 
ethanol, highlighting the potential key role of tight junctions. Fluorophotometric techniques have 
been used to evaluate the permeability of the corneal epithelium to fluorescein, which provides 
information for the epithelial layer, rather than individual cells. In 1998, McNamara et al.98 reported 
that overnight closure with a contact lens in place significantly increased the permeability of the 
epithelium, whereas overnight closure with no lens did not. Subsequent work excluded corneal 
hypoxia as the cause of this loss of barrier function.99 A few years later, Miyata et al.100 reported that 
increased levels of central epithelial fluorescein staining were correlated with increased epithelial 
permeability, suggesting physiological compromise. 
The eruption of interest in SICS from 2002 onwards has led to renewed questioning of what 
corneal staining actually represents at the cellular level. Punctate staining had historically been 
recognized as a sign of mechanical or biochemical epithelial damage and therefore was to be avoided 
at all costs. The punctate staining associated with SICS was frequently at a level so alarming (see 
Figure 1-22) that the particular lens-product combination was replaced with another. In recent years 
there has been a mixture of in vivo, ex vivo and in vitro work to investigate the staining observed 
when SICS was induced by specific contact lens and care product combinations. 
Bandamwar et al.101 added more evidence to support the dismissal of corneal staining being caused 
by intra-cellular pooling of fluorescein when they reported that eye rinsing did not reduce the levels 
of SICS in human subjects (also see Chapter 5 and Woods et al.102). The evidence against fluorescein 
being able to seep between corneal epithelial cells, coupled with the findings that fluorescein cannot 
simply be rinsed away, leaves us with the theory that fluorescein binds to the cell membranes in some 
way, or it enters the cell either through diffusion or via a specific transporter mechanism.  
Previous in vitro work by Bandamwar et al.103 reported that live healthy cells absorbed fluorescein 
to a low level that did not give rise to fluorescence, a theory more recently supported by others.104, 105 
The cellular uptake of fluorescein was shown to be an active process, as only metabolically active 
cells stained with fluorescein while necrotic (dead) cells were unstained.104, 106 Bakkar et al.104 




This body of work together with the more recent work by Khan et al.105 have confirmed the 
involvement of some specific cellular transport mechanisms and that cellular damage (apoptosis) is 
associated with SICS. These findings are in contradiction to a recent theory about the passive nature 
of SICS. The latter theory is referred to as “preservative associated transient hyperfluorescence”, or 
PATH,110 and it was developed from in-vitro work using a liposome-based model of the corneal 
epithelium. The PATH theory proposes that corneal staining in SICS is not evidence of epithelial 
damage, suggesting instead that PHMB molecules released from the contact lens bind to 
phospholipids in the bi-layer cellular membrane of the corneal epithelial cells, and fluorescein then 
binds to the phospholipid-PHMB complex and fluoresces.111, 112 Thus the PATH theory concludes that 
the fluorescein-PHMB-epithelial cell binding is inert and does not lead to any cellular compromise. 
Preceeding work by Muya et al.113 had identified an affinity for PHMB to bind to the mucins found 
on the epithelial surface. However, despite some support for the PHMB binding process, PATH does 
not explain why fluorescein is also seen within the epithelial cells104, 107, 109 and appears to be 
associated with apoptosis.103, 107 
A recent report by Khan et al.105 questions the previously presumed link between SICS and PHMB 
and instead presents evidence of a relationship between SICS and the surfactant Tectronic 1107, 
which co-exists with PHMB in SICS inducing care products. This in vitro work demonstrated 
increased fluorescence of epithelial cells when they were exposed to Tectronic 1107. These results 
implicate a dynamin dependant pathway (an active transport mechanism) as responsible for the 
increased fluorescence, but the authors did not observe apoptosis associated with fluorescein uptake 
in their cells, thus casting new doubt on the fact that fluorescein staining was associated with cellular 
damage. Variations in the source of corneal epithelial cells and in experimental protocols are just two 
possible explanations why contradictory results are being reported 
Apart from fluorescein staining, two other epithelial cellular changes have been observed in 
corneas that exhibit SICS: epithelial ‘white light’ staining is evident,101, 108 and hyper-reflective 
epithelial cells have been observed using confocal microscopy.106, 114-116 Both of these observations 
are reported prior to fluorescein instillation and therefore cannot be explained by a fluorescein 
binding action. Their observation in corneas that are subsequently positive for SICS suggests they are 
a cellular response to the lens/care product combination. 
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The ‘white light’ staining can be observed on careful observation with a slit-lamp biomicroscope, 
Figure 1-24. Pale grey punctate disturbances of the epithelium can be seen in the same region that is 
highlighted with any subsequent fluorescein instillation.101, 108.  
 
Figure 1-24: Appearance of ‘white light’ corneal staining using a slit-lamp. Image courtesy of CORE. 
 
The term hyper-reflective epithelial cells refers to individual highly reflective superficial epithelial 
cells that can be viewed using in vivo confocal microscopy, Figure 1-25. Their high level of 
reflectivity has been suggested to indicate that they are apoptotic,103 and they have been reported to be 
visible in association with SICS.106, 114-116 The anesthetic required for confocal viewing has been 
highlighted as a confounding factor, however Situ et al.116 reported on the association of hyper-






Figure 1-25: Hyper-reflective surface epithelial cells of the cornea. Confocal microscope in-vivo image, 
courtesy of CORE. 
 
These clinical and laboratory findings have led to widespread recognition that there is a lot still to 
be discovered about fluorescein interaction with the epithelium, despite it being interpreted and relied 
upon for over a century.35, 62 There is general agreement that corneal fluorescein staining is not 
desirable, yet despite a significant body of work investigating it, this belief is based largely on 
“assumption and intuition”.35 It is fair to say that how fluorescein interacts with the cornea at the 
molecular level remains unclear35, 62, 117 and further investigation is warranted in order to fully 





1.9 Aims of the thesis 
The reviews of the literature described above demonstrate that there are three very specific areas 
concerning corneal staining with fluorescein that warrant additional study. The specific aims of this 
thesis are: 
a) To determine whether the corneal staining of subjects with symptomatic dry eye presents in a 
specific distribution pattern; 
b) To investigate the type, severity and pattern of staining that occurs in SICS; 
c) To assess the impact of SICS on individual epithelial cells using in vivo confocal 
microscropy. 
 
This thesis is organized into seven chapters: 
Chapter 2 describes a grading scale developed for grading corneal staining; the CORE corneal 
staining scale. This chapter describes this 3-factor grading scale, which is the method of staining 
grading used in the studies featured in Chapters 3, 5 and 6.  
Chapter 3 examines the CORE corneal staining scale for agreement across observers with various 
experience. 
Chapter 4 presents a meta-analysis of the corneal staining data across several clinical studies 
involving 368 subjects with symptomatic dry eye. The data were analysed to determine if there was a 
typical staining pattern in subjects who were symptomatic of dry eye. This information will be 
valuable in setting meaningful treatment efficacy targets for the evaluation of new dry eye treatments 
and therapies. 
Chapter 5 reports a three phase experiment designed to evaluate some of the elements of SICS with 
respect to the PATH theory. The first two phases investigated whether the PHMB and other lens care 
components could be either rinsed from the lens before it was inserted to the eye, or rinsed from the 
eye after lens removal, thereby reducing the level of SICS staining. The third phase investigated 
cellular changes in the presence of SICS by employing in vivo confocal microscopy to investigate the 
incidence of hyper-reflective epithelial cells.  
Chapter 6 presents two analyses of the data from several studies that induced SICS using the same 
products and methodology. Firstly, the frequency of central zone involvement is evaluated to explain 
the frequency of peripheral annular pattern staining versus the pan-corneal pattern staining. Secondly, 
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data from participants enrolled in repeated SICS studies were evaluated for the repeatability of the 
corneal staining pattern.  










The CORE Corneal Staining Scale  
THIS CHAPTER IS PUBLISHED AS FOLLOWS:  
Woods J, Varikooty J, Fonn D, Jones L. W. A novel scale for describing corneal staining. Clin 
Ophthalmol 2018;12:2369-2375. 
(https://www.dovepress.com/clinical-ophthalmology-journal) 
Reprinted here with permission under the copyright agreement with Dove Medical Press, 2018   
 
2.1 Abstract 
The assessment of corneal staining is a commonly conducted procedure in both clinical practice and 
as part of various research studies. Different grading scales are employed by many clinicians and 
researchers to undertake this procedure for corneal staining comparisons between eyes, products and 
over time. This paper describes the development and use of a grading scale for corneal staining 
undertaken at an academic research site. The scale employs assessment of three factors across five 
corneal zones; type, area and depth. Staining type and area are graded on a 0-100 scale and depth is 
graded on a 0-4 scale. These factors can be combined to create a 3- or 2-factor staining grade, or the 
factors may be reported individually. An additional benefit of this scale is that the staining scores may 
be reported by zone as ‘zone staining scores’, or the scores of zones may be combined to provide an 
overall corneal ‘global staining score’.  
 
2.2 Introduction 
Over the past few years there has been dispute regarding the conclusions that can be drawn from the 
presence of sodium fluorescein corneal staining.1-3 Despite questions about the clinical significance of 
corneal staining, particularly that associated with contact lens solutions,1, 2 this assessment remains an 
essential element of ocular examination and thus the ability to record the level of corneal staining is 
important in clinical practice and is vital in contact lens and dry eye research.  
 
 38 
Unfortunately, methods of assessing corneal staining are varied in their approach and there is a 
need for this assessment to be standardised.4 While there has been growing interest in the 
development of objective methods to quantify staining and other anterior eye assessments,5-8 these 
have yet to become mainstream and to-date none have been commercialised.  
The challenge is to develop a standardised method that provides high sensitivity to detect change. 
Limitations of current scales prompted discussion within the Centre for Ocular Research & Education 
(CORE), formerly the Centre for Contact Lens Research, around the creation of a new corneal 
staining grading scale that would provide advantages over those available. This scale has evolved 
over several years, being first described in any detail in a paper investigating solution-induced 
staining with silicone hydrogel lenses in 20029 and further described by Woods and co-workers in 
2006.10 This paper describes further evolution and uses of the CORE staining scale. 
 
2.3 Scale development 
When describing and quantifying corneal staining, ideally three elements need to be considered: 
location, area and depth.  
There are many different corneal staining grading scales currently in use. Examples of those that 
provide an integer grade for the entire corneal surface include Oxford,11 and Sjogren’s Syndrome 
International Registry scale (SICCA OSS).12 These scales offer varying ranges for this global corneal 
grade; 0-4, 0-5 and 0-6 integer ranges, respectively. Developed to provide more sensitivity, the Efron 
corneal staining scale13 is a 0-4 global corneal scale which can be used in steps as small as 0.1. Other 
staining scales are based on grading the five corneal zones separately (Figure 2-1).14 Examples of 
scales which employ this zonal grading include the US Food and Drug Administration (FDA), the 
National Eye Institute (NEI) and the Brien Holden Vision Institute (BHVI) scales. In 1994 an FDA 
guidance document to the contact lens industry suggested that reporting the location of corneal 
staining would be beneficial, to allow distinction of central staining from peripheral location and they 
suggested a 0-4 integer scale followed by a letter code for the zone affected.15 The NEI report of 
19954 also suggested a grading by zone, but suggested a 0-3 integer scale. 
The BHVI Grading Scales (formerly the CCLRU Grading Scales) were first described in 199316 
and included a multi-factorial corneal staining grading scale, which offered an increased number of 
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steps compared to previous scales with the intent to provide increased sensitivity.17 This scale 
involved assessment of staining in each of the five corneal zones but instead of just one grade, it 
included three separate staining factors; type, extent and depth. Each criterion is scored on a 0-4 scale, 
with steps as small as 0.1.18 The BHVI three-factor scale provided increased descriptive ability 
compared to a single number scale. However, despite being more descriptive, and providing a greater 
ability to detect change compared to other reduced step scales, it’s sensitivity was still somewhat 
limited by the 41 steps of the 0-4 scale in 0.1 steps and by the separate reporting of the three factors. 
These limitations prompted the creation of the CORE corneal staining scale.  
Scales with a small number of steps, such as the Oxford (0-3 integer) and NEI scale (0-15 integer), 
typically have good repeatability (Intraclass correlation coefficient of 0.97 and 0.98),19 however they 
lack sensitivity.20 Creating a scale with more steps can create the opposite problem i.e. improve 
sensitivity but tend to reduce repeatability.19  
The purpose behind developing the CORE corneal staining scale was to address several needs: 
• increased sensitivity compared to 0-4 scales.  
• enable the location of the staining to be recorded. 
• facilitate grading of individual criteria of the staining.  
• to generate continuous data to facilitate parametric data analysis. 
It was decided to utilize the division of the cornea into five zones, each to be assessed separately: 
the central (C), superior (S), nasal (N), inferior (I), and) temporal (T) zones (Figure 1). This zone 
division had already been described14 and has been supported as being beneficial by a subsequent 
global versus zonal grading comparison.21  
Despite zonal division of the cornea having been described previously, the diameter of the central 
zone relative to the cornea has not been specified. Some have described the zones as being of equal or 
similar size, but have stopped short of being more specific than that.16, 17 In order for the CORE scale 
to be applicable to all size eyes and in all clinical situations, the central zone was specified to have a 
diameter that is one half of the diameter of the cornea. This proportion allows the observer to readily 
visualise the central zone as distinct from the peripheral zones, because from the centre of the cornea, 
the central zone extends half way to the limbus in all directions. This still means that the five zones 
have a similar area, though the central zone is slightly larger than the peripheral zones. For example 
for a corneal diameter of 11.51mm, which is the average of mean Chinese and Caucasian corneal 
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diameters reported by Hickson-Curran et al,22 the area of the central corneal zone is 22.53mm2, and 
the area of each peripheral corneal zone is 20.77mm2 (using ∏ = 3.142). For larger corneas the 
difference in area will increase. 
 
 
Figure 2-1: Schematic illustration of the five corneal zones. 
 
In order to describe the staining as fully as possible it was decided to follow the same multi-factor 
approach as the BHVI grading scale and describe the same three distinct factors of the staining 
appearance, separately across each of the five zones: 
1. the type of staining,  
2. the extent (area) that the staining is spread across, 
3. the depth of the staining.  
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Consideration was given to expanding the scale to improve sensitivity and create continuous data 
points that, if normally distributed, would facilitate parametric analysis. 
The type of staining was allocated a continuous integer scale, from 0 to 100 with anchors as 
described in Table 2-1 and illustrated in Figure 2-2. 
 
Table 2-1: CORE staining grade for the type of fluorescein staining, 0-100 integer scale. 
Grade of TYPE of 
fluorescein staining Description 
0 No staining 
25 Micro-punctate staining 
50 Macro-punctate staining 
75 Coalescent staining 









The extent of staining was also allocated a continuous integer scale, from 0 to 100, to represent the 
percentage area of the individual zone that contains corneal staining. One important feature of the 
extent grade is that it does not represent the area of all the punctate dots pulled together, but rather it 
represents the spread of the staining across the zone (see Figure 2-3). For example, if punctate stain 
was evident across the entire central zone then the extent within that zone would be represented by 
100, despite the staining dots being small and spread apart from each other. 
 
 
Figure 2-3: The blue outline illustrates the extent to be allocated to punctate stain, Extent=20. 
 
The depth of corneal staining was already a part of the BHVI grading scale in the form of a 0-4 
integer scale with distinct descriptors. Given the limited options available to describe the depth of 
staining in terms of the penetration of fluorescein into the cornea, this scale was determined to be 






Table 2-2: CORE staining grade for the depth of corneal staining, 0-4 integer scale. 
Grade of DEPTH of 
fluorescein staining Description 
0 No staining 
1 Superficial epithelial; no stromal glow 
2 Deep epithelial; delayed stromal glow  
3 Immediate localised stromal glow 
4 Immediate diffuse stromal glow 
 
2.4 Application of CORE corneal staining scale 
Because the central zone has a diameter that is approximately half of the diameter of the cornea for 
ease of assessment, then the central zone has a slightly larger area than each of the other four zones.  
2.4.1 Clinical records 
When each zone is graded fully to describe the presence of staining then three values are generated 
for each zone, as shown in the recording form example in Figure 2-4 i.e. for type (1-100), extent (1-
100) and depth (1-4). These values are all that is required on a clinical record to describe the staining 
appearance in each corneal zone and they provide a simple three-factor description, which facilitates 
monitoring and comparison for change at subsequent clinic visits across all three factors of type, 






Figure 2-4: An example of a clinical recording table for CORE corneal staining scale. 
 
2.4.2 Reporting the staining 
The staining can be reported and analysed for the individual zones or for the entire cornea as a 
whole. The scores for the three factors were combined by three-way-multiplication to create an even 
wider spread of data to increase sensitivity. The individual zone score is referred to as the “zone 
staining score”, ZSS, and the scores are abbreviated as CZSS, SZSS, NZSS, IZSS and TZSS for the 
central, temporal, nasal, superior and inferior zones respectively. The mean of all five zone stain 
scores provides the ‘global staining score’, GSS, which represents the cornea as a whole. 
The three values that make up the staining grade can be manipulated in several ways to report the 
staining, depending on the distribution of the data and the key factor of interest among the three 
factors. The three common options are listed here. 
 
3-FACTOR REPORTING OF CORE CORNEAL STAINING SCALE: 
The product of the type, extent and depth grades provides the 3-factor grade for each corneal zone, 
and in this case the ZSS and the GSS are scored out of a maximum of 40,000 (0-100 x 0-100 x 0-4), 
see Figure 5.  
 
Zone stain score = type x extent x depth
CZSS  = 0 x 0 x 0 = 0
SZSS  = 0 x 0 x 0 = 0
NZSS  = 60 x 8 x 1 = 480
IZSS  = 65 x 45 x 1 = 2925
TZSS  = 20 x 2 x 1 = 40
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In studies where variability in the staining depth is anticipated then adding the depth as a third 
factor to reach a full 3-factor staining score (type x extent x depth), as described above, will serve to 
capture the staining more fully and to spread the staining data even wider to aide differentiation 
between eyes/treatments. In practice, if all staining is superficial (i.e. depth grade is 1) then the 2-
factor grade yields the same value as the 3-factor grade.  
 
1-FACTOR REPORTING OF CORE CORNEAL STAINING SCALE: 
There are occasions when the CORE scale has been used to simply report the extent of corneal 
staining over the corneal surface, either by zone or over the cornea as a whole.25 In specific clinical 
research projects where the depth of staining is always grade 1 and the type of staining is consistent 
or of limited interest, it is the extent of the staining that is the key outcome variable. For example, if 
the corneal staining is micro-punctate in all eyes, and is superficial epithelial in all eyes, then the 
variability of the staining score is captured by the extent grade alone. Reporting extent alone has the 
advantage of being easily interpreted by the reader because it can be readily ‘visualised’ as the area of 
the zone, or cornea, which exhibits staining.   
 
2.5 Discussion 
This grading scale has been used extensively at CORE for over a decade, largely because it is flexible 
and lends itself to multiple methods of representing the staining numerically and statistically. The 
expanded scale of 0-100 for the type and extent, and also the manipulation to create the zone and 
global staining scores, all provide a continuous scale for grading the corneal staining. The continuous 
nature of the data opens the possibility for conducting parametric statistical analysis, which is often 
favoured as being more robust. It also affords the potential for increased sensitivity, which is of 
particular benefit when attempting to discriminate responses in clinical trials.  
There are some disadvantages to increasing the number of steps in a scale. For example, 
individuals may prefer to use certain numbers more often than others, thereby reducing the number of 
steps being utilised. It was reported by Fieguth and Simpson that an integer step scale of 0-100 gave 
rise to a preferential use of numbers that were multiples of five.26 Their investigation involved a 
bulbar redness scale, but the preferential use of ‘friendly’ values could also apply to this corneal 
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staining scale. It would perhaps be valuable to conduct a review of historical staining data to 
investigate if this is the case. Another disadvantage of creating a scale with more steps is that 
repeatability and inter-observer concordance is often sacrificed. For this reason the use of this scale 
among multiple observers necessitates pictorial references, particularly for the staining type, and 
ongoing concordance assessment and training.18 Variability may exist between different graders 
(inter-variability), as well as between different time-points for the same grader (intra-variability). 
Using a grading scale to assign a grade to an eye is an inherently subjective task. The key to any 
subjective grading scale being used successfully is to minimise inter- and intra-variability, because it 
is impossible to eliminate it. This can be achieved in both a practice and a research setting by asking 
graders to grade a randomised series of images on two separate occasions. The viewing conditions 
should be controlled between sessions as much as possible, such as using the same room and same 
computer screen. The grading results should be compared and retraining conducted where necessary. 
Variability is a criticism of all grading scales which rely on subjective assessment by an observer.18, 27 
A grading scale which is truly objective, by means of image analysis, can certainly reduce the 
variability, but it becomes more costly in terms of supporting hardware and software, which can be 
prohibitive in a clinical versus research setting.5-8 Furthermore, there is often increased time required 
to apply the software and review the area of interest identified by the algorithm, before a grading 
score can be confirmed.5-8 
The CORE corneal staining scale provides the ability to record the type, extent and depth of 
staining by zone or globally across the entire cornea. Using zone scores it facilitates the reporting of 
the location of corneal staining. It is often important to understand where on the cornea the staining is 
observed, and this information is unavailable in grading systems that provide only a single grade for 
the whole cornea. For example mid-inferior dehydration type staining and superior epithelial arcuate 
lesions both have specific and different implications for a soft contact lens design, and require 
different management strategies.28  
The CORE corneal staining scale has proven to be useful when the location and/or the 
quantification of corneal staining are of key interest, and when more robust, parametric analysis has 
been desirable. Additionally, the scale provides the level of sensitivity often necessary in clinical 
research, while being simple enough to be adopted in a clinical practice setting. The authors believe 









Agreement Experiment: The CORE Corneal Staining Scale 
3.1 Introduction 
Fluorescein corneal staining is presumed to indicate sub-optimal physiology or damage.1 A grading 
scale to record the severity or extent of this staining is valuable to monitor recovery from injury, or to 
measure any negative impact of a medical device like a contact lens. The CORE corneal staining 
grading scale is described in detail in Chapter 2. It is a 3-factor scale which grades the type, extent 
and depth of corneal fluorescein staining,2 in each of the five corneal zones; temporal superior, nasal, 
inferior and central,3,4 Figure 3-1.  
 
 
Figure 3-1: Schematic illustration of of the five corneal zones. 
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The type and extent of the staining are graded on a 0-100 integer scale. The type of staining has 
descriptors at the 0 (none), 25 (micropuncate), 50 (macropunctate), 75 (coalescence) and 100 (patch) 
intervals of the scale, Figure 3-2. 
 
 
Figure 3-2: Example of staining record sheet, which includes the descriptions associated with the grade of 
the  type of staining. Image courtesy of CORE. 
 
The extent of the staining is a grade of the area of the corneal zone affected by the staining. 
Punctate (dot appearance) staining is not graded as if it were confluent packing together of the 
punctate dots. Instead the border of the area of punctate staining is assumed to outline the area of 




Figure 3-3: Illustration of the border defining the extent of staining. Image courtesy of CORE. 
 
The depth of the staining is graded on a 0-4 integer scale and is assessed according to the 
observation of fluorescein into the stromal corneal layer and the speed of this stromal spreading, if 
any, which is often termed ‘stromal glow’, Figure 3-4. Fluorescein that remains within the epithelial 
corneal layer is graded as depth of 1. Where the corneal insult is deeper than the epithelium, the 
fluorescein seeps gradually into the stroma and is visible as a diffuse glow around discrete region of 
epithelial staining. The faster this glow develops, the deeper the corneal insult. Therefore, the depth of 
corneal staining cannot be assessed from a single photographic image because it is not possible to 





Figure 3-4: Illustration of the stromal glow around the discrete punctate stain, indicative of a corneal 
insult that is deeper than the superficial epithelium. Image courtesy of CORE.  
 
Understanding how a grading scale behaves is valuable. In clinical healthcare and research it is 
recommended to conduct regular training to confirm that the measurement skill is maintained and 
optimised.5,6 This training may involve the practical methodology involved in making an assessment, 
as well as evaluating and discussing the grading results to determine accuracy and repeatability.2 In 
an ideal world, clinical assessments would be accurate (match the correct answer) and repeated 
measurements would be precise (repeated measurements would demonstrate good agreement and 
only differ when there is an actual difference in presentation of the staining).  
There is an element of subjectivity involved when using grading scales as they involve matching a 
clinical presentation to a numeric, pictorial or descriptive scale.6,7 A judgement is required in order to 
decide which scale value best matches the clinical presentation. This element of subjectivity has the 
potential to reduce both accuracy and precision because this judgement made by the observer 
unavoidably incurs ‘noise’, rather than there being an absolute value to measure.6  The judgement of 
an observer may be biased due to clinical experience and the level of knowledge of the particular 
scale being used. For example, a red eye may be graded as ‘severely’ red by a clinician who rarely 
sees any red eyes in their practice, yet may be graded as ‘moderately’ red by a clinician who only 
treats red eyes with infections. A reference pictorial scale of eye redness would allow these two 
clinicians to scale their judgements of the redness similarly and more accurately (ie. they grade 
correctly, according to the scale). 
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It is logical that it is easier for clinicians to record the same grade for the same condition if there are 
fewer grading options. From the earlier example, if the red eye grading options were simply ‘yes’ or 
‘no’, the clinicians would have both recorded ‘yes’, and they would have been both precise and 
accurate. However, a binary scale cannot indicate the degree or severity of the condition, such as 
redness, and this missing factor is often necessary for determining urgency of treatment or monitoring 
response to treatment, particularly when a different clinician conducts the post-treatment follow-up. 
Determining the number of steps in a grading scale can be a complex decision. A scale with too few 
steps allows the clinicians to be precise, also called repeatable, but does not provide many options to 
describe the severity and therefore these scales are not very sensitive to changes in severity. 
Increasing the number of steps will increase the options for descriptions, but may also reduce the 
precision, or repeatability both between different clinicians as well as for the same clinician on 
different days.   
The repeatability of a scale can be measured by comparing how an individual observer grades the 
same condition on two different occasions. This comparison is often referred to as the intra-observer 
agreement. By increasing the number of observers, it is possible to assess whether the scale performs 
in a reliable manner between different observers, often called the inter-observer agreement. In both 
cases, a low level of agreement indicates the scale is not performing optimally and that either the 
scale requires modification or the observers require training on how to better use the scale, or perhaps 
both. Agreement is often described by correlation indices, and these range from 0.0, which indicates 
there is no agreement at all, to 1.0, which indicates perfect agreement. While the criticality of the 
measurements being assessed will influence the acceptable value of this index, the commonly 
accepted interpretation of these correlation indices are described by Lin8 as: 
> 0.99  almost perfect 
> 0.95 – 0.99  substantial 
0.90 – 0.95  moderate 
< 0.90  poor 
The subjective nature of grading scales may present an argument for a less strict interpretation of 
the correlation index values.  However, it should be remembered that a value of 0.75 indicates that 
any inferences or conclusions drawn are only supported by 75% of the data, therefore it is unwise to 




In research specifically, if the variable is to be measured by different observers then inter-observer 
agreement should be understood and minimised. Experiments designed to measure differences are 
obviously more sensitive when the methods of measuring are more precise. If inter-observer 
agreement is poor and intra-observer agreement is better, then, if possible, it would be preferable to 
design the experiment such that the same observer grades the response in the same subject over time. 
Analyses of agreement are important and the results provide valuable information to support 
considerations of study design as well as the interpretation of results.  
A repeatability experiment was conducted using the CORE corneal staining grading scale.  The key 
objectives were to evaluate the inter- and intra-observer agreement of the grades for type and extent 




Twenty-two slit-lamp biomicroscope images of corneal staining were sourced. Images were included 
if they had been captured using a blue filter over the illumination system and a yellow barrier filter in 
front of the observation system. This set-up of the slit-lamp biomicroscope optimises the view of 
corneal staining and is the appearance with which all observers are familiar with when grading 
corneal staining. The images were selected by observer O, with the specific intent to represent a 
spread across the entire 0-100 range of the type and the extent grades of the corneal staining. Any 
assessment of a scale should target the entire scale because measures of agreement calculated across 
just one section of a scale cannot be extrapolated to apply across the entire scale.6,9 Additionally, the 
images had to be in clear focus and of sufficient illumination for the borders of the staining regions to 
be easily discernable. 
All images were superimposed with a template of the five corneal zones and red arrows to indicate 
which zone should be graded. Only one zone per eye was graded because, due to the curvature of the 
cornea, it is often not possible to optimise the image of staining in all five zones in a single 
photograph. Additionally, in many images the lid or a light reflex impeded full view of specific zones, 




The images were collated into a PowerPoint presentation, which included three instructional slides 









Figure 3-5: Instructions for the agreement experiment. 
 
3.2.2 Observers  
Fifteen observers (IDs A-O), participated in this agreement experiment. The observers were all aware 
of the CORE corneal staining scale, however, they had differing time periods of experience actually 
using it in clinical research. One observer (ID A) had not used the scale at all and had not received 
any previous training on its use. All other observers had received at least an initial training on the use 
of the scale. The number of years each observer had actively used the scale was recorded.  
3.2.3 Grading sessions 
A research assistant created the PowerPoint presentations, set up the computer and monitored all 
sessions to ensure the observer followed the instructions and that the session experiences were 
uniform. Consent was not required for this experiment because it was an internal training exercise as 
well as an assessment of the grading scale.  
The observers attended two grading sessions, each scheduled at least one week apart. They 
recorded their grades for staining type and extent for all twenty-two images on a paper recording 
sheet which also provided some comments to aid the interpretation of the image, Figure 3-6. At both 
sessions the images were numbered sequentially from one to twenty-two, however the order was 
randomised and the order at Week-1 was not the same as Week-2.  
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Each grading session was held in the same room, on the same computer. All observers were 
allowed to self-regulate their time within each session and could review their grade and/or the 
instructions whenever  needed. The grading session was scheduled to last 45-minutes to avoid anyone 
feeling they had to rush; most observers completed the session within 30-minutes.  
 
 







The grades assigned by all the observers to the same image were compared for their agreement. This 
data will indicate whether certain observers grade higher or lower than others. This may also be 
termed inter-observer repeatability.  
INTRA-OBSERVER AGREEMENT 
All of the analyses and visualisation of the data for intra-observer agreement were carried out in the 
R-statistical software (version 3.5.3).10 
The agreement of the grades assigned by each observer at the Week-1 and Week-2 sessions were 
evaluated in two ways:  
i. Concordance; 
ii. Tukey mean-difference plots.  
The correlation coefficient of concordance (CCC) was calculated for each observer to assess 
concordance between grades across all images of Week-1 compared to Week-2.11, 12  Perfect 
concordance would be indicated by a CCC value of 1.0 (i.e. their grading at Week-1 was identical to 
their grading at Week-2). The scale of the CCC is 0.0 - 1.0, where 0.0 indicates no agreement and 1.0 
indicates perfect agreement. The CCC is the product of the Pearson correlation coefficient (r) and the 
agreement accuracy (χa ) i.e. CCC =  ( r ) x ( χa ). Similarly, r and χa are also scaled from 0.0 - 1.0, 
with the same end-scale descriptors. 
Concordance data were determined using the AgreementInterval package of the R-statistical 
software.13 Using these data, concordance plots for each observer between Week-1 versus Week-2 
were created and are shown in Table 3-3 for the type data and Table 3-4 for the extent data. Each 
image from the grading scale is represented by one data point on the graph. Perfect concordance 
would be demonstrated when the grey, dashed best fit line corresponds exactly with the line of unity, 
the blue diagonal line. The corresponding numerical values for CCC, Pearson’s r and accuracy (χa) 
are annotated on the plot.  
In addition, the data per observer were plotted as Tukey mean-difference plots (also known as 
Bland-Altman plots).14, 15 The Tukey mean-difference plots (hereafter referred to as ‘Tukey plots’) 
illustrate the difference between the grades from each week (Week-1 grade minus Week-2 grade) as a 
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function of the mean grade of both weeks (average of Week-1 and Week-2). In each graph, the mean 
of the differences between Week-1 and Week-2 grades, per image, is indicated by the grey, horizontal 
dashed line. A 95% confidence ellipse was determined for the data, based upon a multivariate normal 
distribution. This procedure determines the Euclidean distance from the centre of the data, for all data 
pairs. If the data were a circular cloud of data points (i.e. with little relationship between the mean and 
the difference), the ellipse would appear circular. In this experiment, as is generally the case for 
Tukey plots where the intention is to examine if the difference varies across the scale range, the data 
were dispersed along the x axis creating an ellipse. In those cases where the relationship between the 
dependent variable (mean grade) and the independent variable (the difference in grades) is constant, 
the ellipse will be oriented with the long axis parallel to the x-axis. Conversely, the relationship 
between dependent and independent variables may vary along the x-axis because the size and/or sign 
of the difference in measures depends on the magnitude of the mean. In such cases, the long axis of 
the ellipse would be tilted relative the x-axis. An ellipse was chosen rather than the more typical 
horizontal limits of agreement (1.96x standard deviation of the differences) because it appeared from 
Figure 3-7 and Figure 3-8 that agreement between weeks followed the latter example and varied as a 
function of the mean grade. If, for example, the ellipse tilts further from zero towards the high end of 
the scale, then agreement is reduced at that high end of the scale only. In the cases that give rise to a 
tilted ellipse, the typical horizontal limits of agreement would be artificially wider to capture the 
horizontal upper and lower limits of the tilted ellipse.   
If the grades of an observer were in perfect agreement between Week-1 and Week-2 for all the 
images, the Tukey plot would show the mean difference line intercepting zero on the y-axis, and all 
data points would lie on this line for the full extent of the measurement scale. If an ellipse were fitted, 
it would be dimensionless in the y-axis and it would extend along the x-axis, also parallel to the x-
axis i.e. without tilt. In such a case of perfect agreement, the typical horizontal limits of agreement 
would be coincident with the mean of differences line.   
 
3.3 Results 
In all graphs and tables the fifteen observers are identified by a letter code, from A to O. These letter 
codes were assigned to indicate the relative level of experience the observer had using the CORE 
corneal staining scale. Observer A had no experience and no prior training, whereas all other 
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investigators experience ranged from less than one year up to ten years for observers M, N and O 
(Table 3-5).  
The twenty-two images were coded with an alpha-numeric code, based on the original source of the 
images.  
3.3.1 Inter-observer agreement 
The mean grades of the Week-1 and Week-2 grading sessions were calculated for each image, for 
each observer. These data per image were graphed to illustrate the inter-observer agreement for each 
image, both for the type data, Figure 3-7, and for the extent data, Figure 3-8. To aid interpretation of 
the data, the images were ordered along the x-axis from lowest to highest according to the mean grade 
from the entire observer group (i.e. the x-axis is ordinal) and the y-axis is continuous to represent the 
0-100 scale.  
The type graph, Figure 3-7, illustrates a typical spread of grades per image to be in the range of 35 
to 40 units. This spread remains similar across most of the scale, with the obvious exception of the 
highest grade, where all observers graded either 90 or 100, a spread of just 10 units. 
The extent graph, Figure 3-8, illustrates that the spread of grades varies as the mean grade increases 
up the y-axis. The first 8 images have mean extent grades below 20 and the observer data is spread 
over approximately 20 units. This inter-observer data spread increases as the mean grade increases, 
with the exception of image L1. In particular, images H1, W1, T1, K1, I1 and B2 all show poor inter-





Figure 3-7: Mean (Week-1 and Week-2) TYPE grade per observer (observer A-O), by image. Images 
ordered along x-axis according to the group mean grade. 
 
 
Figure 3-8: Mean (Week-1 and Week-2) EXTENT grade per observer (observer A-O), by image. Images 












Table 3-2: For each image: mean grade, mean standard deviation (StDev), 95% confidence interval (CI). 
 TYPE EXTENT 




95% CI Mean of Obs 
mean grades 
Mean of  
StDev 
95% CI 
Q1 4.7 9.3 18.2 0.4 0.7 1.4 
A2 16.0 8.9 17.4 5.6 9.2 18.0 
Y1 17.8 9.6 18.8 3.7 3.0 5.9 
M1 18.1 9.5 18.6 2.5 1.5 2.9 
D1 25.4 5.3 10.4 21.0 6.2 12.2 
K1 32.0 5.2 10.2 48.6 12.1 23.7 
F1 33.9 5.9 11.6 20.8 5.5 10.8 
W1 34.5 8.4 16.5 30.6 12.7 24.9 
R1 35.5 10.3 20.2 18.8 6.9 13.5 
T1 35.5 8.9 17.4 42.8 16.3 31.9 
H1 35.7 7.2 14.1 25.4 12.2 23.9 
C2 36.3 8.9 17.4 91.8 6.7 13.1 
C1 37.3 4.8 9.4 42.3 10.3 20.2 
B1 38.9 10.8 21.2 6.9 2.3 4.5 
I1 41.7 11.7 22.9 52.7 12.5 24,5 
J1 41.9 7.8 15.3 17.1 4.4 8.6 
A1 48.5 10.2 20.0 37.1 6.2 12.2 
Z1 46.7 12.6 24.7 17.3 3.8 7.4 
B2 55.2 14.3 28.0 64.9 13.3 26.1 
X1 59.4 9.9 19.4 50.0 8.8 17.2 
L1 62.4 11.2 22.0 42.0 4.6 9.0 
JW1 99.7 1.3 2.5 11.8 5.8 11.4 
 
3.3.2 Intra-observer agreement 
For each observer, two different graphs were plotted to demonstrate different aspects of the intra-
observer agreement; concordance plots and Tukey plots. These were collated into separate tables, one 
to illustrate the agreement for the type data, Table 3-3, and another for the extent data, Table 3-4. In 
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each table, the observers are ordered according to their years of experience with the scale, with the 
least experienced, observer A, listed first. 
The concordance plots show the Week-2 data as a function of Week-1 data. Each image is 
represented by one data point on the graph. Perfect repeatability would be demonstrated if all data 
points lay on the blue diagonal line, the line of unity, which is the line of zero difference between 
grades from Week-1 and Week-2. These plots also display the values for the correlation coefficient of 
concordance (CCC), Pearson’s correlation coefficient ( r) and accuracy (χa) for each observer, also in 
Table 3-5. Perfect agreement between the grades for Week-1 and Week-2 would lead to all three of 
these indices having a value of 1.0. In each concordance plot, if the best-fit data line is coincident 
with the line of unity, then accuracy is 1.0. Pearson’s r describes how closely the data points can be fit 
to a line. The product of accuracy and Pearson’s r provides the CCC value. 
The extent grade concordance plots for observers J and K illustrate the different meanings of these 
indices. Both have accuracy of 1.0, however, the data points of observer J are a closer fit to the line, 
leading to observer J having a higher value for Pearson’s r (0.97 versus 0.94) and thus to a higher 
CCC value (0.97 versus 0.94). The high accuracy is reflected in the Tukey plots by the mean line 
being almost coincident with zero on the y-axis. The poorer line-fit of the data from observer K is 
reflected in the greater vertical spread of the ellipse. 
Observer A is the observer with no previous experience or training with the scale. Their 
concordance plot for type shows a data line that is almost parallel to the line of perfect unity, because 
the Week-2 grades were more commonly higher than Week-1. However, the data points are a poor fit 
to a line (r = 0.73) and, therefore, the Tukey plot resembles a circle, rather than an ellipse, indicating 









Table 3-3: Staining TYPE by observer, ordered by years of experience: concordance graphs and Tukey 
plots with elliptical limits of agreement. Obs: observer; Exp: number of years of experience with the 
CORE staining scale; CCC: concordance correlation coefficient; r: Pearson’s correlation coefficient; 
Accuracy: chi, χa.  
































































Table 3-4: Staining EXTENT by observer, ordered by years of experience: concordance graphs and 
Tukey plots with elliptical limits of agreement. Obs: observer; Exp: number of years of experience with 
the CORE staining scale; CCC: concordance correlation coefficient; r: Pearson’s correlation coefficient; 
Accuracy: chi, χa.  






























































Table 3-5: Concordance indices for each observer; observers ordered by years of experience. 
  TYPE EXTENT 
Obs Exp CCC r χa CCC  r χa 
A 0 0.61 0.73 0.84 0.36 0.47 0.77 
B <1 0.87 0.88 0.99 0.98 0.98 1.0 
C <1 0.91 0.92 0.99 0.81 0.82 0.99 
D 1 0.93 0.94 0.99 0.89 0.94 0.95 
E 1 0.88 0.88 1.00 0.95 0.96 0.99 
F 2 0.92 0.93 0.99 0.90 0.90 1.00 
G 3 0.92 0.95 0.97 0.79 0.85 0.93 
H 5 0.86 0.87 0.99 0.91 0.91 1.00 
I 6 0.89 0.90 0.99 0.96 0.97 0.99 
J 7 0.94 0.94 1.00 0.97 0.97 1.00 
K 8 0.91 0.93 0.98 0.94 0.94 1.00 
L 9 0.96 0.96 1.00 0.94 0.95 0.99 
M 10 0.93 0.93 1.00 0.86 0.91 0.95 
N 10 0.87 0.88 0.99 0.96 0.97 0.99 
O 10 0.86 0.87 0.99 0.98 0.99 0.99 
 
3.3.3 Use of the steps of the scale 
Histograms of all the grades assigned across all images, observers and weeks provides evidence that 
the 0-100 integer scales for type (Figure 3-10) and extent (Figure 3-11) were not used as true 101-step 
scales for selection of images used. There was over sampling of the numbers in steps of 5. The type 
grades were used as integers mainly within the range from 25 to 40, with limited use outside this 
range. The extent grades were commonly used as integers within the 0-15 range, with some use up to 
35, and limited use for grades higher than 35. 
Observer O selected images that covered the range of scale. The histsograms show that the full 
range was indeed covered. The type grades allocated by the observers appear normally distributed 
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around the grade 30. The extent grades used have a flatter distribution, which is biased towards the 
lower end of the scale. 
 
Figure 3-10: Count of the individual TYPE grades used.  
 
  





The images provided a spread of type and extent grades that spanned the entire scales, although both 
show unequal distribution across the scales with bias towards the lower half. The lower to middle 
ranges reflect the level of staining appearance that observers most commonly deal with in clinical 
research and it is within this range of the scale where good agreement is most required in order to 
identify differences between products and/or treatments. The high regions of both scales often relate 
to an adverse response, and would thus typically be excluded from the comparison statistical analysis. 
The inter-observer agreement was not good for either scale factors. The type grade exhibited a data 
spread of close to 40 units across the entire range of the scale. The extent grades showed closer inter-
observer agreement at the lower end of the scale, within 20 units, but the agreement reduced as the 
extent increased. Poor inter-observer agreement for ocular grading scales has been reported 
previously5, 16 and it is possible that more frequent training would improve this agreement. It is 
generally accepted that all grading scales require initial training to establish optimal grading 
techniques, as well as periodic retraining to avoid the observers redefining their internal references 
over time. Observer A was the only observer who had not received prior training and the fact that 
their intra-agreement was by far the lowest provides evidence that the training provided to the other 
observers was somewhat effective.  
The results from observer A remain in the data presented even though there is argument for 
removing this data from the calculations of means due to the obvious lack of intra-observer 
agreement. Similarly, there are several data points that are significant outliers and appear to be blatant 
errors. For example, observer C recorded the extent for image A2 as grade 1 in Week-1 and 75 in 
Week-2, when the observer group mean was approximately 6. Likewise, observer B recorded the 
extent for image H1 as grade 12 in Week-2 and 75 in Week-2, when the observer group mean was 
approximately 25. All obvious outliers were confirmed with the source data, however it is most likely 
that there was an error either in recording the grade against the wrong image on the recording sheet, 
or perhaps grading the wrong zone of the image, despite the red arrows highlighting which zone to 
grade. Leaving these various suspect data in the tables will skew the mean values. The impact of these 
suspect data can be reduced by calculating the means with a ‘bootstrapping’ method.17 This method 
provides a better approximation of the true mean by adjusting for the sample bias, thus reducing the 
impact of outliers. Obtaining a truer estimate of the mean grade will be valuable for future training as 
these means can be used to guide image selection. The distribution of the bootstrapped estimates can 
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be examined for normality; those distributions that are normally distributed around the mean grade 
can be classified as ‘good’ and those images that depart from normality (skewness, kurtosis or high 
standard error) as ‘bad’. The ‘good’ images can then be selected as training images and/or used as 
anchors for the scale at their mean grade. The ‘bad’ images may be valuable for discussion during 
group training sessions in order to establish a more uniform grading approach across all observers.  
The concordance graphs illustrate how closely each observer graded in Week-2 compared to Week-
1. With the exception of observer A, the CCC values are generally close to or above 0.90 (i.e. with 
moderate or better agreement). When viewing these concordance graphs, it is of value to review the 
Tukey plot alongside it, because this plot illustrates how the agreement varied along the scale by the 
tilt of the ellipse, and it also illustrates how much of the scale was utilised by the observer across all 
images. For example the extent Tukey plots of observers B and C show that their grades were 
clustered below 50. It could be argued that good agreement is easier to achieve when using a smaller 
part of the scale, however there is a wide difference between the CCC of observers B and C, 0.98 
versus 0.81. 
The results of this agreement experiment can be used to inform future training. Some images are 
associated with high observer agreement, as indicated by the mean of the absolute differences 
between the  Week-1 and Week-2 grades. A low value of mean difference identifies the images of 
highest inter-observer agreement. Ideally, the images would demonstrate a low mean absolute 
difference grade for both type and extent. Examples of such images include image Q1 (type 0.7, 
extent 0.8), image M1 (type 3.3, extent 1.1) and image JW1 (type 0.7, extent 4.2).  These mean 
absolute difference values may also be smaller when obvious outliers are removed, as explained 
earlier.   
Establishing a reference grade per image can be a helpful strategy to guide the use of the scale and 
future agreement experiments because each observers’ grades would be compared to the reference 
grade. Another approach is to elect one observer to be the ‘gold standard’ observer and compare all 
other observers to this one person. The gold standard observer would be chosen as the person who 
shows the best concordance across the two weeks and who is consistently closest to the group mean. 
It is likely to be more difficult to identify one observer who is consistently closest to the mean across 
the entire range of both grading factors and hence the former method of determining standardised 
images may be more practical.  
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One more point to consider in the development of future training sessions is the difficulty of 
grading a static image when in practice this grading is conducted under ‘live’ conditions i.e. when the 
illumination can be adjusted, and the eye can blink to spread the tear film more evenly. The existence 
of large differences between ‘live’ grading and photographic grading of corneal staining has 
previously been reported by Sorbara et al.18 who showed that photographic grading under-reported 
the staining level. There are assumptions made when grading a photograph that can be eliminated in 
the live scenario. For example, a strand of mucus in the tear film that is blinked away during live 
grading would be ignored, rather than being misinterpreted as staining. Interpreting such a strand or 
other artefact as staining in Week-1 and deciding to exclude it in Week-2 is another potential cause of 
both inter- and intra-observer variability. Using videos for agreement experiments in the future would 
be expected to reduce the variability due to inconsistent interpretation of the photographs. 
When image selection has been optimised, and further training has been conducted on this scale, 
the results from future agreement experiments may be used to further evaluate and refine the CORE 
corneal staining scale. Firstly, a pictorial scale would be advantageous, particularly for the type grade 
which is largely descriptive compared to the more mathematical extent grade. The use of pictorial 
references for grading scales has been recommended by several authors.6, 7, 15 Secondly, the 
appropriate step size of the scale should be investigated. There is a balance to be sought between 
concordance and sensitivity of a grading scale; a low number of grade options provides high 
concordance but is not sensitive to capture small changes. Bailey et al.19 reported that high 
concordance can sometimes indicate that the scale has too few steps and therefore is not attaining its 
full potential for sensitivity. It is possible that the reverse may apply to this scale i.e. there may be too 
many steps, which leads to poor concordance. It may be prudent to consider whether there is a need 
for the same granularity of step size for type grading along the entire scale, particularly as the inter-
observer agreement worsened as the grade increased. Within a research environment, any type 
staining graded at or above 75 would almost certainly represent an adverse event and, as such, this 
data would be excluded from the planned research analyses. This presents a potential argument for 
contracting the scale such that grades of 75 and higher are instead assigned to the highest ‘bucket’ on 
this contracted scale. However, while reducing the steps in the more descriptive type scale may 
provide some advantages and lead to better agreement, there is significant value in maintaining the 
extent grade as a pseudo percentage, because it provides valuable descriptive quality in quantifying 







Geographic Distribution of Corneal Staining in Symptomatic Dry 
Eye 
THIS CHAPTER HAS BEEN SUBMITTED TO THE OCULAR SURFACE JOURNAL. 
 
4.1 Abstract 
Purpose: To describe the geographic distribution of corneal fluorescein staining across the five 
corneal zones, among non contact lens wearers who report symptoms of dry eye. 
Methods: Prior studies conducted at the Centre for Ocular Research & Education, Canada, were 
reviewed for inclusion in the analysis. Each study assessed dry eye symptoms using OSDI and also 
assessed corneal fluorescein staining at study entry in five zones. For each subject, the corneal zones 
were ranked 1-5 according to their relative staining grade, Rank-1 representing the highest grade. 
Results: Data from 13 studies and 368 subjects were included in this analysis. The total number of 
zones assigned Rank-1 designation was 449. The inferior zone had the most Rank-1 counts of all 
zones (193/43%). The nasal zone had 77/21%, followed by temporal (69/16%) and superior zones 
(63/14%). The central zone had the lowest count of Rank-1 designations, at only 47/13%. The 
distribution of the observed data was tested against a model where the probability of staining arising 
in any zone was equal (H0), and was rejected (Multinomial LLR: p<0.001), therefore the higher 
Rank-1 count in the inferior zone was statistically significant. 
Conclusion: Based on these results, in the presence of dry eye symptoms, the inferior zone typically 
presents the most severe grade of corneal staining. This knowledge is valuable when developing a 
strategy to treat dry eye signs as the inferior zone has the highest grade of staining, thus it has the 





Dry eye disease is extremely prevalent worldwide with the prevalence ranging from 5 to 50%.1 The 
extensive Women’s Health Study reported a prevalence of almost 8% in the female US population 
aged 49 years and over.2 A meta analysis conducted by the Tear Film and Ocular Surface Society 
(TFOS) DEWS II epidemiology subcommittee confirmed that prevalence increases with age, 
however signs showed a greater increase per decade than symptoms.1  
Dry eye has been redefined by the DEWS II Report as “Dry eye is a multifactorial disease of the 
ocular surface characterized by a loss of homeostasis of the tear film, and accompanied by ocular 
symptoms, in which tear film instability and hyperosmolarity, ocular surface inflammation and 
damage, and neurosensory abnormalities play etiological roles”.3 Although the DEWS II definition of 
dry eye disease precludes the necessity for corneal staining to be present, it does state that both 
symptoms and signs of ocular surface damage are required for a diagnosis, and that the degree of 
staining is an important aspect of severe dry eye disease.3 Although not exclusively so, dry eye 
symptoms are frequently associated with corneal staining, which is regarded as a standard test to 
visualize the extent of corneal damage and assess the severity of the dry eye disease.4, 5 The panel of 
the ODISSEY European Consensus Group agreed that the severity of dry eye disease can be 
identified from just two criteria, symptomology and corneal fluorescein staining,6 and this 
combination of assessments is frequently combined in optometry and ophthalmology practice to 
assess dry eye.7  
Corneal staining may be graded over the entire cornea as a whole, or in each of five corneal zones: 
superior, inferior, nasal, temporal, central.8 Several publications have described the corneal staining in 
subjects with and without dry eye to be more common in the inferior or vertical aspect of the cornea 
rather than the horizontal.9-12 Chalmers et al.10 reported that the presence of > grade 1 overall as well 
as inferior zone staining was a useful indicator to distinguish ‘normals’ from those with dry eye.  
To aid development, comparison and monitoring of dry eye treatments, it is valuable to understand 
which of the five corneal zones typically exhibit the highest grade of fluorescein corneal staining, 
relative to other zones. Determining the zone with the highest mean staining score in a group of 
subjects exposes the result to bias as it is readily influenced by the actual degree of staining. This bias 
can be avoided by applying a ranking score to the staining in all corneal zones, for each subject. This 
study was developed to investigate the corneal staining from several clinical trials previously 
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conducted at the Centre for Ocular Research & Education (CORE), at the University of Waterloo, in 
order to illustrate the distribution pattern of staining in subjects exhibiting symptoms of dry eye. 
 
4.3 Methods 
4.3.1 Selection of studies 
CORE began to grade corneal staining in five zones in 1995. The grading systems used prior to this 
provided a single overall corneal grade. Therefore the search for relevant clinical trials to include in 
this study was restricted to the years from 1995 to 2015. 
For a clinical trial to be determined eligible for this analysis study, it needed to meet the following 
pre-determined inclusion criteria: 
• Received ethics approval from a University of Waterloo Research Ethics Committee 
• Been conducted in accordance with the tenets of the Declaration of Helsinki 
• Conducted a documented informed consent procedure with all subjects 
• Recruited non-contact lens wearers  
• Determined dry eye symptomology at a baseline visit using the Ocular Surface Disease Index 
(OSDI) 
• Assessed corneal staining using sodium fluorescein viewed using cobalt blue light and a 
yellow barrier filter.   
• Evaluated corneal staining at a baseline visit and graded in five zones; temporal, superior, 
nasal, inferior and central.8 
More than 50 clinical studies were reviewed and 13 were deemed eligible.  
All subject data sets of the identified trials were further reviewed to confirm their data were 
complete and that their symptom score indicated dry eye, regardless of the level of staining. There 
was no requirement of a minimum level of corneal staining. Subjects with diagnosed Sjogren’s 
syndrome were excluded, as were all contact lens wearers. 
4.3.2 Symptomology inclusion criteria 
All eligible clinical trials used OSDI to assess symptomology. This questionnaire has been validated13 
and subjects are considered to have no dry eye if their score is 12 or less, mild dry eye if their score is 
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13 to <23, moderate dry eye if their score is 23 to <33, and severe dry eye if their score is 33-100.14 
To be included in the analysis, subjects had to have an OSDI score of 13 or more, regardless of the 
level of corneal staining they exhibited. 
4.3.3 Corneal staining 
There was no requirement of a minimum level of corneal staining for data to be included in the 
analysis cohort. Due to the highly dependent nature of corneal staining between eyes, only staining 
data from the right eye was analyzed. 
Use of the same staining grading scale was not a requirement for inclusion in this analysis, only 
that the five corneal zones were graded separately. Three methods of reporting corneal staining were 
used in the identified studies, two based on a 0-100 scale and one using a 0-4 scale: 
1) CORE 3-factor grading15: Each zone is graded for staining type (0-100, integer steps), extent 
(0-100, integer steps) and depth (0-4, integer steps). Each zone can be assigned a zonal stain 
score (ZSS) which is the product of the type, extent and depth grade (0-10,000). For all factors 
0 represents no staining. 
2) CORE 2-factor grading15: Each zone is graded for staining type (0-100, integer steps), extent 
(0-100, integer steps). Each zone can be assigned a zonal stain score (ZSS) which is the 2 
factor product of the type and extent grade (0-10,000). For all factors 0 represents no staining. 
3) 0-4, integer steps, grading: 0 = no staining or a single punctate stain; 2 = superficial 
micropunctate stain; 3 = macropunctate staining or minimal coalescence; 4 = coalesced 
staining over half the zone or more. 
For each subject, the five corneal zones of the right eye were ranked from Rank-1 to Rank-5 
according to the degree of staining, where Rank-1 represented the highest level of staining of that 
particular eye, irrespective of the actual staining grade. Where zones within a cornea were graded 
equally, they were assigned the same Rank-number. Therefore some eyes were awarded Rank-1 in 
more than one zone. Here is an example to explain this process further. If the central and inferior 
zones were graded equally at the highest staining grade, the nasal and temporal zones were graded 
equally at a lower grade and the remaining superior zone was graded at the lowest value of all, then 
the zones would be allocated the following ranks: 
• Central & inferior: both designated as Rank-1 (highest) 
• Nasal & temporal: both designated as Rank-2 
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• Superior: designated as Rank-3 
Where a cornea did not exhibit any staining in any of the zones, no ranking was assigned and 
therefore these eyes are not included in the results reporting staining incidence by rank. In those 
corneas where all zones were graded equally, all zones were allocated Rank-1. Thus, there are more 
Rank-1 designations than there are subjects in the cohort.  
4.3.4 Statistical analysis: Bayesian estimation of the proportion counts 
A Bayesian approach was taken to analyse the data, because this paper describes the distribution of 
the staining and generate credible estimates for the proportion of staining observed with each pattern 
of staining and in each zone. A null hypothesis testing and/or confidence interval paradigm were not 
used for the analysis because the former tests only a single model or point estimate, and the latter 
does not provide a distribution of the credible values.  
The observed data was taken as representative of the underlying distribution of staining across 
zones. The analysis determines whether pattern (ie. with or without central staining) or zone 
(peripheral spatial area) contribute independent influences on the probability distributions. In 
addition, we generated posterior predictions, with credible intervals, for the proportion of counts in 
each zone.  
Data were included from individuals in the total sample who exhibited Rank-1 staining in only one 
peripheral zone of the cornea, with or without Rank-1 staining in the central zone. Therefore, for the 
data included in the model, each count represents a single individual and all counts were independent 
of each other. This sub-sample comprised 171 individuals of the total sample (n=368). 
The count of the staining in each peripheral zone is the predicted variable. It was based on two 
predictor variables: (i) the pattern of staining, i.e. whether it includes central staining or not, and (ii) 
the zone of staining, i.e. where in the non-central region the staining occurred (SUP, INF, NAS, 
TEMP). Both predictors are nominal in scale. The data were arranged as a contingency table with 8 
cells (4 zones x 2 patterns). 
Specific contrasts were made between pattern of staining and zones of staining. To undertake a 
contrast, joint probability distributions of the credible differences were generated with 95% highest 
density interval (HDI). For all contrasts, a broad region of practical equivalence (ROPE), was set up 
around a difference of zero with margins of ±0.40 (i.e. ±50% change in the counts). If the ROPE 
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completely overlaps with the 95% HDI of the differences, then the contrast is practically equivalent to 
zero difference (analogous to ‘accepting the null’ hypothesis in inferential statistics). Conversely, if 
the ROPE does not overlap with the 95% HDI of the differences then the contrast is credibly different 
(analogous to ‘rejecting the null’). The Bayesian analysis was carried out using modified source code 
from Kruschke16 in the R statistical programming software17. 
 
4.4 Results 
Data was pooled from 13 eligible clinical trials. Subjects were included in the analysis if their 
response to the OSDI survey indicated they fell into the mild, moderate or severe dry eye categories.14 
Those that were categorized as ‘normal’ (ie. score of 12 or less) were excluded from the analysis. The 
total number of eligible subjects (N) was 368.There were 106 in the mild group (OSDI scores 13-22), 
98 in the moderate group (OSDI score 23-32, inclusive) and 164 in the severe dry group (OSDI score 
33 and above).  
104 subjects in the study sample had no staining in any of the five corneal zones. In this group the 
mean OSDI score was 29.8 (SD ±13.9; range 12.5 - 83.3). Comparative data for the remaining 264 
subjects with staining in one or more zones demonstrated a mean OSDI of 34.8 (SD ±15.8; range 12.5 
- 93.8). 
4.4.1 Areas of worst staining 
The number of zones ranked as Rank-1 was 449 in the total subject pool of 368. The count and 
proportion of Rank-1 are presented in Table 4-1 and Figure 4-1. Of all the zones, the inferior zone 
was most frequently graded as having the highest level of staining; the inferior zone was designated 
as Rank-1 a total of 193 times which represents 43% of the total count of the Rank-1 zones. The zone 
with the second highest frequency of Rank-1 staining was the nasal zone, which totaled 77 instances 
out of 449 (17%). As described above, it should be recognized that there are more zones with a Rank-
1 than there are subjects (449 zones designated Rank-1 across the 368 subjects), because a single 






Table 4-1: Incidence by corneal zone for: Rank-1 AND zero staining in all other zones; Count of Rank-1, 
independent of staining in other zones; count of Rank-1 as a percentage of ALL Rank-1 counts; count of 
Rank-1 as a percentage of ALL subjects analyzed; mean OSDI of subjects with Rank-1 in each zone.   
Zone: Temporal Superior Nasal Inferior Central 
Count of staining in ONLY one zone 
(zero staining in all other zones) 
4 6 2 63 7 
Count of Rank-1 staining, per zone 69 63 77 193 47 
Count of Rank-1 staining as 
percentage of total number of Rank-1 
zones (449) 
15.5% 14.0% 17.0% 43.0% 10.5% 
Percentage of subjects of total 
sample (N=368) with Rank-1 
staining in each zone  
18.8% 17.1% 20.9% 52.5% 12.8% 
Mean OSDI for subjects with Rank-1 
in each zone 






Figure 4-2: Graphical representation of counts of Rank-1 staining (worst) to Rank-4 staining plus count 
of zero staining, by corneal zone, n=368 subjects. 
 
The mean OSDI score for the whole cohort was 33.4 (median 31.3; range 12.5 - 93.8). The mean 
OSDI for all subjects with the inferior zone staining categorized as Rank ‘1’ (193 subjects) was 35.4. 
The mean OSDI was calculated for all subjects grouped by whether each zone staining was ranked 
‘1’; the mean values were all similar, and in the lower end of the severe dry eye category, Table 4-1.  
To explore the relationship between the central zone and the peripheral zones as a group as well as 
individually, the incidence of some specific staining patterns involving these zones were calculated, 
Table 4-2. This table counts all staining under the various pattern descriptions, not just Rank-1. These 
results clearly demonstrate that having corneal staining only in the periphery (without central zone 
 
 98 
involvement) was far more common than the reverse observation of staining only in the central zone 
without peripheral zone involvement (count: 178 versus 7). Additionally, the presence of central zone 
staining with zero inferior zone staining only occurred in 10 subjects, whereas the reverse, i.e. 
staining of inferior zone staining with zero central zone staining, occurred in 157 subjects. 
 
Table 4-2: Percentage (count) of specific staining patterns. 
Staining pattern % subjects 
(NTotal=368) 
No staining in any zone 28.3% [104] 
Staining in any zone 71.7% [264] 
Staining in any peripheral zone/s only  
ie. no staining in central zone 
48.4% [178] 
Staining in central zone only  
ie.no staining in any peripheral zones 
1.9% [7] 
Staining in temporal zone only 
ie.no staining in any other zone 
1.1%  [4] 
Staining in superior zone only 
ie.no staining in any other zone 
1.6% [6] 
Staining in nasal zone only 
ie.no staining in any other zone 
0.5% [2] 
Staining in inferior zone only 
ie.no staining in any other zone 
17.1% [63] 
Staining in central zone and zero staining in 
inferior zone  
2.7% [10] 
Staining in inferior zone and zero staining in 





It has been explained previously that, where staining was the worst and equal in more than one 
corneal zone, then all these zones were designated as Rank-1. Given that central zone Rank-1 
incidence was so low, it was of interest to explore the patterns and zone combinations of the 
peripheral zone staining. The zone combinations where only two peripheral zones per eye were 
identified as Rank-1 (36 subjects) are shown in Figure 4-3 and the zone combinations where three 
peripheral zones per eye were identified as Rank-1 (25 subjects) are shown in Figure 4-4. These two 
graphs indicate that the inferior zone features heavily in both of these staining patterns. Twenty-one 
subjects had Rank-1 staining in all four peripheral zones. 
 
 
Figure 4-3: Count of eyes exhibiting two peripheral zones of Rank-1 staining, per zone combination. The 
number in parentheses indicates the count of eyes where each 2-peripheral zone combination presented 





Figure 4-4: Count of eyes exhibiting three peripheral zones of Rank-1 staining, per zone combination. 
The number in parentheses indicates the count of eyes where each 3-peripheral zone combination 
presented with Rank-1 central zone staining as well. 
 
4.4.2 Bayesian analysis 
Figure 4-5 shows the posterior distributions of the count proportions for each zone within both 
patterns investigated: only peripheral zone staining and no central zone staining (Pattern: P); 
peripheral zone staining as well as central zone staining (Pattern CP). Shown on each plot is the mode 
of each distribution and the 95% Highest Density Interval (HDI). It can be seen that individuals 
presenting with a single zone of staining outside the central zone were more likely to present without 
central zone staining and with inferior zone staining. 
Specific distributions were generated for the main effects contrasts in the model. 
Peripheral staining is more likely than central staining (β deflection mode =-2.69; 95% HDI: -3.58 
to -1.95, no overlap with ROPE). Considering the peripheral zones, the inferior zone is more likely to 
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exhibit the worst (R1) staining than the temporal (βIT = 2.06; HDI: 1.07 to 3.08, no overlap with 
ROPE), superior (βIS = 1.74; HDI: 0.81 to 2.67, no overlap with ROPE), and nasal (βIN = +1.22; HDI: 
0.45 to 2.00, no overlap with ROPE) zones.  
For contrasts of the interactions between regions and the two patterns of staining, the ROPE and 
the HDI completely overlapped in all cases, indicating that the differences in staining frequency 
between zones was not dependent on the pattern of staining. We concluded, therefore, that the 





Figure 4-5: Posterior distribution of count proportions for each cell of the contingency table. Pattern: CP 
indicates subjects with central zone staining WITH one region of non-central zone staining. Pattern: P 
indicates subjects with one zone of non-central staining alone. The red triangle indicates the actual data 





This study documented the frequency and pattern of staining in each of five geographic zones of the 
cornea (central, superior, nasal, inferior & temporal) in subjects with symptoms of dry eye disease, by 
retrospective review of data from 13 clinical studies conducted at CORE. Inferior zone staining was 
demonstrated to be the most common location for the worst staining of the entire cornea, whether the 
staining occurred only in one zone or whether it affected multiple corneal zones. 
The findings of this study support previous evidence in the literature of inferior staining being 
highly indicative of dry eye.9,11,18 Chalmers et al.9 concluded that overall and inferior zone staining 
was useful to distinguish dry eye subjects from ‘normals’. Tong et al11 recently published a study 
assessing the effect of punctal plugs and the cohort of 29 moderately severe symptomatic dry eye 
subjects exhibited the highest grade of baseline corneal staining in the inferior zone. Interestingly, 
they also noted that the inferior zone corneal staining appeared to be more resistant to showing 
improvement with the study treatment of punctal plugs. While this current study does not report 
severity of staining, the highest frequency of worst staining being in the inferior zone aligns with 
Tong et al’s results. Tong et al reported the least severe staining in the superior zone and while this 
current study found the lowest Rank-1 incidence in the central zone (demonstrated in 12.8% 
subjects), the superior zone was the second lowest, demonstrating Rank-1 in 17.1% subjects.  
There are several reasons why the inferior corneal zone might show the most severe and/or the 
most frequent staining of all the corneal zones. Firstly, the inferior zone is the one zone that is left 
exposed in situations of incomplete blinking. Incomplete blinks approximately double the duration of 
exposure to evaporation for the over-exposed inferior ocular surface.19 Secondly, while the other 
zones undergo a full wiping effect from the upper lid during the blink movement, which may help to 
remove toxins from the corneal surface and helps to re-establish the tear film, the wiping of the 
inferior zone is more limited because the inferior lid remains fairly static with virtually no wiping 
effect.20 Because of this limited movement of the lower lid, more tear film debris and bacterial toxins 
from the lid may collect along the lower lid margin, especially in those dry eye subjects with reduced 
a tear volume that can flush these away.21 There are conflicting reports about whether the ocular 
bacterial load is higher in subjects with dry eye compared to those without dry eye, with variability in 
the results likely due to variations in the bacteria studied, and also with the confounding presence of 
blepharitis and meibomian gland disorders.22-24  
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The methodology used in this study ranked the staining per zone of each cornea, thereby removing 
the impact of differing grading systems being used across the studies. Additionally, all the scales 
provided central versus peripheral staining data. By these means, estimates of the proportions of the 
location at which the worst staining presented were able to be generated for dry eye subjects with 
symptoms (Figure 4-1). It is clear from the data that central staining is not the most common 
presentation, but this does not imply that central staining is unimportant given its proximity to the 
visual axis. Nevertheless, its low frequency does not make it a good metric to evaluate the 
performance of treatments to alleviate staining in dry eye. This illustrates that it is critical to choose a 
metric that has a scalar extent appropriate for the response that is being evaluated.  
This study provides further support for the inferior zone being the zone most commonly affected by 
corneal staining in people suffering with dry eye. As the most commonly affected zone it becomes 
imperative to evaluate this zone for monitoring treatment effects which has not always been the case 
in previous dry eye research. In order for a dry eye therapy to become approved, the U.S Food and 
Drug Administration (FDA) specify that an improvement should be proven in both symptoms and one 
other validated sign.25 The method of capturing symptomology is not specified. The validated sign is 
not restricted to corneal staining and could be other signs related to the dry eye condition, for example 
Schirmer test, conjunctival staining or bulbar conjunctival redness among others, though corneal 
staining has commonly been used. 
In the past 15 years only two therapeutic topical dry eye treatments have been successful in their 
application for this indication from the FDA; cyclosporine in 2003 (Restasis, Allergan) and lifitegrast 
in 2016 (Xiidra, Shire). In the 13 years between these products coming to market, more than a dozen 
compounds aimed at treating dry eye have initiated the FDA process for approval as a dry eye drug 
but have failed to show efficacy.26 The lack of correlation between dry eye signs and symptoms27 has 
meant that demonstrating improvement in both factors in just one study has been challenging. Some 
dry eye patients could be highly symptomatic but show fewer signs of the disease, while other 
patients may show significant signs, such as corneal staining, but are less symptomatic. Results from 
this study provide further evidence that corneal staining and symptoms do not always co-exist. All 
subjects in this study were symptomatic of dry eye however 104 (28.3%) of the 368 subjects did not 
show any corneal staining at all. 
Restasis, had its treatment efficacy proven based on symptoms, which included using OSDI, plus 
Schirmer test as the sign.28, 29 Notably, a review of clinical evidence from the early randomized 
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controlled trials showed that Restasis also decreased corneal staining in the majority of these trials.28, 
29 The more recent FDA approval of Xiidra was very interesting because it was the first approval 
where the improvement in the dry eye symptom and the dry eye sign were accepted despite them each 
being demonstrated in separate studies. The Xiidra application was supported by symptoms collected 
via visual analogue scales (burning/stinging, itching, foreign body sensation, eye discomfort, 
photophobia, pain) and an overall ocular discomfort score.18, 30, 31 The clinical sign demonstrating 
effectiveness was the inferior corneal staining score.30 
 
4.6 Conclusion 
In conclusion, this study demonstrates that the inferior zone most commonly exhibits the most severe 
staining in symptomatic dry eye disease. Given this information, although severe central zone staining 
is potentially more important for visual outcomes, studies investigating dry eye disease treatments 
should consider targeting improvements in corneal staining in the inferior zone specifically, in order 
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PURPOSE: The main purpose of this study was to determine whether two interventions (rinsing the 
lens prior to lens insertion and rinsing the ocular surface post lens removal) had any impact on 
solution induced corneal staining (SICS). In addition, the presence of hyper-reflective epithelial cells 
in the presence of SICS was investigated.  
METHODS: Twenty subjects wore new balafilcon A lenses, which had been soaked overnight in a 
multipurpose care product containing polyhexamethylene biguanide for 2-hours. The study was 
conducted across three phases. In Phase-1 (investigator and subject masked, randomized eye), one 
lens was rinsed with non-preserved saline prior to lens insertion. In Phase-2 (investigator masked, 
randomized eye) one eye was rinsed with non-preserved saline after lens removal, prior to staining 
assessment. Corneal staining was recorded as the percentage area of the cornea exhibiting superficial 
punctate staining. In both phases, ocular comfort and presence of specific symptoms were captured. 
In Phase-3, there was no randomized treatment; confocal images of the epithelium were obtained after 
2-hours wear. 
RESULTS: In Phase-1 (lens-rinse), there was no significant difference in staining between the treated 
and untreated eyes (84% vs 92%, respectively; p=0.06). In Phase-2 (eye-rinse), there was also no 
significant difference between the treated and untreated eye (86% vs 86%, p=0.92). Most subjects 
 
 108 
were asymptomatic. In Phase 3, images of hyper-reflective cells were captured in 97% of the eyes 
imaged. 
CONCLUSIONS: The two rinsing procedures did not affect the level of the SICS response. Hyper-
reflective epithelial cells were found to be present in a significant number of eyes exhibiting SICS 
and their presence warrants further investigation. 
 
5.2 Introduction 
The development of excessive superficial punctate staining associated with the use of silicone 
hydrogel (SiHy) lenses and certain care regimens was initially reported in 2002,1, 2 and has been the 
topic of much investigation since. The term most commonly adopted to describe this phenomenon is 
“solution induced corneal staining” or SICS.3  
The initial reports on SICS described the corneal staining response when one SiHy contact lens 
material (balafilcon A) was worn following disinfection with a multipurpose solution which 
contained polyhexamethylene biguanide (PHMB).1, 2 A subsequent clinical trial by Garofalo et al.4 
established that the corneal staining response was maximal approximately two hours after lens 
insertion.4 Several studies indicated that the SICS response was greatest when certain SiHy and FDA 
group II (high water content, neutral charge) hydrogel materials were exposed to PHMB-preserved 
multipurpose solutions (PHMB-MPS).4-7 
Following these initial studies, Carnt et al.,3, 8 and Andrasko and Ryen9 conducted experiments 
investigating the staining response to combinations of the most commonly prescribed lenses and care 
products. They found that some combinations led to varying degrees of SICS, while others did not. 
They presented their results in a grid format that indicated the varying severity of the SICS response 
with different product combinations.8, 9 The work by Andrasko and Ryen9, 10 indicated there was a 
greater degree of corneal involvement associated with PHMB-MPS. However, products containing 
the same concentration of PHMB gave rise to widely varying levels of corneal involvement,9-12 which 
remains difficult to explain. It was also shown that certain lens materials in combination with PHMB-
MPS led to higher amounts of SICS than other materials.9, 10, 12 These grids highlighted the fact that 
SICS was not associated with specific lens materials or products, rather it was associated with 
specific combinations of lens materials and care products.  
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The symptoms associated with SICS have been reported as being both non-existent and significant. 
Though the initial publications referred to SICS as an asymptomatic phenomena,1, 2 the Jones et al.2 
paper did report stinging symptoms on lens insertion. SICS has more recently been described as being 
associated with the whole spectrum of symptoms from none,13 to both mild4, 9 and more significant 
symptoms.14, 15  
Retrospective analyses of over 600 participants in clinical trials have shown that SICS is associated 
with a higher frequency of infiltrative events.16-18 A more recent prospective clinical trial of 19 
participants with induced SICS revealed that inflammatory markers in the tears were up-regulated, 
suggesting that there may be an active ocular surface inflammatory response.19 If SICS does indeed 
lead to an inflammatory response, rather than simply being associated with it, then its presence would 
raise concern. However, the co-existence of infiltrates and SICS could be coincidental rather than 
SICS being causative of infiltrates, and recent work has not been able to link SICS and tear film 
inflammatory changes.20 This uncertainty of a link with adverse responses fuels continued 
investigation of SICS. 
Recently, Bright et al.21 have offered a hypothesis which has become known as PATH; 
“preservative associated transient hyperfluorescence”. This hypothesis explains the appearance of 
solution-related corneal staining as being caused by the release of PHMB molecules out of the contact 
lens onto the ocular surface,22, 23 which then bind to the corneal epithelial cells, with fluorescein then 
binding to these epithelial-bound PHMB molecules. The hypothesis further suggests that this 
fluorescein-PHMB-epithelium complex is inert and does not create any physiological distress at the 
cellular level. The reports of minimal associated symptoms seem to support an inert process taking 
place. However, Bright et al.’s theory21 was developed using an in-vitro liposomal-based model and 
has not been replicated in the human eye.  
The PATH theory21 is somewhat compelling24 and may help to explain some of the aspects of 
SICS, notably the lack of major symptoms and the kinetics of the staining response, which 
demonstrate a peak at two hours and subsequent gradual reduction over time.4 However, a few 
unexplained findings remain. If a generalised fluorescein-binding to surface-bound PHMB was 
occurring, then it would be expected that the staining appearance would be fairly diffuse and evenly 
distributed over the entire cornea. However, it is often seen in a “doughnut-like” annulus,2, 12, 14 with 
minimal staining centrally and more exaggerated staining peripherally. The PATH theory only holds 
when fluorescein is present. However, when SICS is induced, changes can be observed on the corneal 
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surface under white light conditions, when no fluorescein has been instilled. These white/grey 
punctate disturbances of the cornea appear to mimic the areas highlighted with subsequent fluorescein 
instillation, as described by Bandamwar and colleagues25 and Maldonado-Codina et al.26 In addition, 
so called “hyper-reflective cells” determined by clinical confocal microscopy have been shown to be 
associated with SICS.27-31 These cells can be observed without fluorescein29, 30 and their level of 
reflectivity suggests that the cells are dying.31 These two epithelial cellular observations, that are both 
observed without fluorescein, provide contrary evidence to the PATH theory, which suggests that 
there is nothing untoward happening to the superficial epithelial cells.  
Bright et al.21 suggested that fluorescein innocuously binds to the outer cell membrane. However, 
following micro-biopsy of a fluorescein-staining cornea, fluorescein has been imaged within the 
epithelial cell cytoplasm, confirming physiological changes within the cell.32 Additionally, 
fluorescein-stained cells collected non-invasively from a cornea exhibiting SICS can be imaged by a 
laboratory scanning confocal microscope. This method has demonstrated that fluorescein is present 
throughout the cell, and was not merely bound to the outer membrane.33  
Clinical observations such as those detailed above, along with the ensuing clinical and laboratory 
trials, have caused the research community to reconsider what corneal staining with fluorescein 
actually represents.24, 34-36 Whereas it was commonly believed that fluorescein was highlighting dead 
epithelial cells, it now appears that cells must be alive with active metabolism in order to absorb 
fluorescein and become ‘stained’.24, 31, 32, 36, 37 One study examined the fluorescein stained cells 
washed from corneas exhibiting SICS and found them to be in a cycle of pre-programmed cell death, 
called apoptosis.38 It is as yet unclear whether these “stained” cells are entering apoptosis at a faster 
rate than they normally would. Despite uncertainties about the mechanism behind SICS and its 
symptomatology, the major question of whether it is clinically relevant remains elusive.  
The purpose of this study was to determine whether two specific interventions had any impact on 
the level of SICS. The first intervention was a thorough rinsing of the lens before it was inserted onto 
the ocular surface and the second intervention was a thorough rinsing of the eye following lens 
removal and prior to fluorescein insertion. The hypothesis was that both of the rinsing interventions 
would remove a significant portion of any PHMB adhered to the lens (prior to wear) or the corneal 
epithelium (post-wear), such that the level of SICS would be measurably reduced in the treated eye 
compared to the untreated eye. If the hypotheses were true, a recommendation to patients to rinse 
their lens or eye would be beneficial in reducing the SICS response. The study design also offered an 
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opportunity to investigate the presence of hyper-reflective (HR) epithelial cells alongside SICS, using 
in-vivo confocal microscopy.  
 
5.3 Methods and materials 
5.3.1 Participants 
Twenty experienced soft contact lens wearers aged 17 years or older with good general and ocular 
health were recruited. All participants were required to demonstrate a good fit with the study lens at a 
screening/eligibility visit. Informed consent was obtained from all participants prior to enrolment in 
the study. The trial was conducted in accordance with the Declaration of Helsinki and ethics 
clearance was obtained through the Office of Research Ethics at the University of Waterloo, prior to 
commencement of the study. 
5.3.2 Study outline 
This study was a prospective, non-dispensing design with three phases. The order of the phases was 
not randomised. In phases 1 and 2, the eye assigned to the treatment was randomly assigned and also 
masked to the primary investigator. Each phase was preceded by a minimum of 24-hours of no 
contact lens wear and the phases were separated by a minimum of one week, during which habitual 
contact lens wear was allowed. During each phase, participants bilaterally wore a pair of new 
balafilcon A lenses (PureVisionTM; Bausch & Lomb, Rochester, NY) which had been pre-soaked 
overnight (for approximately 15 hours) in a 0.0001% PHMB-preserved MPS (renu® freshTM; Bausch 
& Lomb, Rochester, NY). To aid consistency of exposure across participants irrespective of their 
prescription level, all lenses worn in the study were of power -0.25D, and participants wore their 
spectacles over the top. Prior to beginning each phase, the corneas were assessed for epithelial 
disruption under white light, without instillation of sodium fluorescein. This assessment was 
conducted to ensure the cornea was healthy and able to wear a contact lens. Instilling sodium 
fluorescein was avoided prior to lens wear in order that there was no fluorescein present in the eye to 
potentially react with the PHMB following lens insertion. 
In Phase 1, one lens was inserted directly from renu® freshTM (untreated) and the other lens was 
thoroughly rinsed in a non-preserved, borate-buffered saline (Unisol 4; Alcon, Fort Worth, Tx) prior 
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to lens insertion (treated). A new bottle of Unisol 4 was opened on each study day. The treatment lens 
was held in tweezers and rinsed on both sides under a stream of saline for at least five seconds, then 
dipped into a well of fresh saline before being picked up by the tweezers on a new region of the lens 
and being rinsed on both sides again under a second stream of saline for at least another five seconds. 
The treatment lens was not rubbed. Both lenses were worn for two hours before being removed for 
corneal fluorescein staining grading and ocular assessment. The eye that wore the treated lens was 
assigned according to a randomisation table and this was masked from both the participant and 
investigator by enlisting a second investigator to conduct the lens rinsing. 
In Phase 2, both lenses were inserted directly from renu® freshTM. After two hours of lens wear, the 
lenses were removed and one eye (untreated) received no rinsing prior to fluorescein staining 
assessment, while the other eye (treated) was thoroughly rinsed for 3-5 seconds on three successive 
occasions with Unisol 4 prior to fluorescein staining assessment. Once again, the treated eye was 
assigned according to a randomisation table and this was masked from the primary investigator by 
enlisting a second investigator to conduct the eye rinsing. Following rinsing, the primary investigator 
conducted the grading of the corneal staining and ocular assessment. 
In Phase 3, no lenses or eyes were rinsed and both eyes wore lenses that had been pre-soaked 
overnight. This phase investigated the presence of HR superficial epithelial cells and was 
observational in nature, with no direct control for comparison. The pre-soaked lenses were worn for 
two-hours and the anterior epithelial cell layer was imaged through the contact lens using a confocal 
microscope (Confoscan 3; Nidek, Japan) without instillation of anaesthetic. Anaesthetic was initially 
avoided to eliminate any potential image artefacts or epithelial disruption, which may have been 
caused by either the anaesthetic or associated preservatives. Following lens removal, the participant’s 
cornea was then anaesthetised with two drops of a topical anaesthetic (Alcaine 0.5%; Alcon Canada 
Inc, Mississauga, Canada) and the epithelium was re-imaged using the confocal microscope. 
Following this second confocal imaging session, corneal fluorescein staining was graded.  
5.3.3 Assessment technique for corneal epithelial disruption and staining 
Corneal staining was assessed on four occasions, three without and one with fluorescein, during each 
phase. At the beginning of each phase, prior to lens insertion, the cornea was observed with a 
biomicroscope using a broad beam under white light, at 12x magnification. Any areas of reduced 
transparency were recorded as being white light observations of epithelial disruption, or “white light 
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staining”. Corneal disruption was assessed under white light again after two hours of lens wear, first 
with the lens in situ and then again after lens removal. The fourth observation was made following the 
instillation of sodium fluorescein via a fluoret, under 12x magnification, through a yellow barrier 
filter using cobalt blue illumination.39  
During the pre-lens “white light staining” assessment, no grading was attempted but the mere 
presence or absence was noted, and images were taken. For the fluorescein staining assessment, the 
area of the cornea exhibiting disruption or staining was graded as a percentage, in each of five zones; 
temporal, nasal, superior, inferior and central.40 The percentage areas in these zones were then 
averaged to provide the area of disruption across the entire cornea. This subjective area assessment is 
a standard method of corneal staining assessment at CORE,41 and all assessments were conducted by 
a single investigator with over seven years of experience with this methodology.  
5.3.4 Assessment technique for limbal hyperaemia 
Limbal hyperaemia was graded under diffuse white illumination and 8x magnification. The level of 
hyperaemia was graded separately for each quadrant (temporal, nasal, inferior, superior) according to 
the CORE 0-100 integer grading scale, where 0 indicates completely white tissue. This subjective 
hyperaemia assessment is the standard method of hyperaemia assessment at CORE, and all 
assessments were conducted by a single investigator with over seven years of experience with this 
methodology. Assessments took place twice during each phase, first before lens insertion and 
secondly immediately before the grading of corneal staining, which was after the eye rinsing step in 
Phase 2.  
5.3.5 Symptomatology 
During phases 1 and 2, participants were asked to report, for each eye, an overall symptom score 
(using a 0-100 integer scale where 0 represented ‘very uncomfortable’ and 100 represented ‘very 
comfortable’). They were also asked whether three specific symptoms were present or absent; 
burning, stinging and itching.  Participants were asked about their symptomatology on four separate 
occasions during each phase; immediately before and after lens insertion, and immediately before and 
after lens removal.  
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5.3.6 Assessment technique for hyper-reflective (HR) cells 
The Confoscan 3 was set to take an epithelial scan using the automatic focus mode. An attempt was 
made to collect at least one full scan of the central cornea per participant, both with the contact lens in 
situ (without anaesthesia) and then following lens removal, after instilling two drops of Alcaine 
anaesthetic. Although the central cornea was targeted in each case, the exact location on the cornea 
could not be exactly specified. Thus the locations that were sampled with and without the contact lens 
in situ may have differed slightly. The microscope captures a set of 350 images per complete scan, 
with each image offering a viewing area of 450 x 340 µm at a magnification of 500x. Each image 
within these scans was viewed individually to determine whether it was positive for HR epithelial 
cells. For each positive image, the number of HR cells was recorded. Because the number of positive 
images could vary from zero to over thirty in an individual scan, the data presented in this manuscript 
is the maximum count of HR cells viewed in any one image, for each participant. 
5.3.7 Data analysis 
All data was analyzed by CORE at the University of Waterloo using Statistica 10. Descriptive 
statistics are given for the participants’ age and gender, and also for the presence of specific 
symptoms and the count of HR cells. Analysis using paired t-tests were applied to compare corneal 
staining areas and symptom ratings. Changes in symptom ratings over time were analysed using 
repeated measured ANOVA, with Tukey as the post-hoc test. An alpha value of 0.05 was considered 






All twenty participants completed the study; all were female, mean age of 34.2 years (median 34.5 
years, ranging from 18 to 64 years).  
5.4.1 Corneal staining 
During Phases 1 and 2, before lens insertion, corneal assessments were made with white light, as 
previously described. Of the 80 baseline staining observations, most showed no white light staining at 
all (57), while 23 exhibited clinically insignificant white light staining (total corneal area staining 
≤6%). After two hours of lens wear, initial observations of the corneas were made under white light 
with lenses in situ. After lens removal, white light observations were repeated. While it was possible 
to observe epithelial changes through the contact lens, grading and photographic capture proved 
challenging and no reports are included of this. Images were taken with white light following lens 
removal, which revealed epithelial disruption, even though no fluorescein had been instilled. All 
subjects showed some degree of observable white light staining in both eyes. A representative image 
is shown in Figure 5-1.  
After images were taken under white light, corneal staining was graded under cobalt blue light, 
using the procedure previously described in Section 3.3. Figure 5-2 shows a representative image of 
the corneal staining observed. All staining presented as diffuse, superficial and punctate, covering at 
least four of the five corneal zones, and therefore was comparable with that expected with SICS.1-3 
Because all staining was superficial and punctate, for ease of reporting and analysis, the area of the 
cornea exhibiting the staining is the variable used for reporting the amount of staining. Table 5-1 and 
Figure 5-3 report the results of the corneal staining area for Phases 1 and 2. For each phase, after two 
hours of lens wear the area of staining in the treated eyes was not statistically different to that of the 
untreated eyes (p=0.06 in Phase 1, treated 84.0% and untreated 91.8%; p=0.92 in Phase 2, treated 
86.2% and untreated 85.8%.).There was minimal staining observed under white light before lenses 
were inserted in each phase and as a result each phase gave rise to clinically significant increases in 





Figure 5-1: Corneal epithelial disruption (“white light staining”) following lens removal and before 
instillation of fluorescein, after two hours of lens wear. 
 
 
Figure 5-2: Typical example of a cornea demonstrating fluorescein staining over 85% of cornea following 




After images were taken under white light, corneal staining was graded under cobalt blue light, 
using the procedure previously described. Figure 5-2 shows a representative image of the corneal 
staining observed. All staining presented as diffuse, superficial and punctate, covering at least four of 
the five corneal zones, and therefore was comparable with that expected with SICS.1-3 Because all 
staining was superficial and punctate, for ease of reporting and analysis, the area of the cornea 
exhibiting the staining is the variable used for reporting the amount of staining. Table 5-1 and Figure 
5-3 report the results of the corneal staining area for Phases 1 and 2. For each phase, after two hours 
of lens wear the area of staining in the treated eyes was not statistically different to that of the 
untreated eyes (p=0.06 in Phase 1, treated 84.0% and untreated 91.8%; p=0.92 in Phase 2, treated 
86.2% and untreated 85.8%.).There was minimal staining observed under white light before lenses 
were inserted in each phase and as a result each phase gave rise to clinically significant increases in 
corneal staining following the two hours of lens wear (both p<0.01).  
 
Table 5-1: Percentage area of cornea (per zone: nasal, temporal, central, superior, inferior), 
demonstrating fluorescein staining at post-lens wear assessments (mean and standard deviation). Phase 1 
treatment = one lens rinsed before wear; Phase 2 treatment = one eye rinsed following lens removal. 
 Untreated eye Treated eye 
Nasal Temp Cent Sup Inf Mean Nasal Temp Cent Sup Inf Mean 


























































Figure 5-3: Mean & SD of the percentage area of corneal staining, before and after lens wear for the 
untreated and treated eyes, Phases 1 and 2. Phase 1 treatment = one lens rinsed before wear; no 
statistical difference between eyes after lens removal, p=0.06; Phase 2 treatment = one eye rinsed 
following lens removal; no statistical difference between eyes after lens removal, p=0.92. 
 
5.4.2 Limbal hyperaemia 
The mean levels of limbal hyperaemia across all quadrants, before and after lens wear, during Phases 
1 and 2 are shown in Figure 5-4. For each phase, the mean level of hyperemia was within normal 
limits and there was no difference between treated and untreated eyes after the two-hour wear period 








Figure 5-4: Mean & SD of the overall ocular hyperaemia grades, 0-100 integer scale where 0 is totally 
white, before and after lens wear for the untreated and treated eyes, Phases 1 and 2. Phase 1 treatment = 
one lens rinsed before wear; no statistical difference between eyes after lens removal, p=0.74; Phase 2 







The numbers of participants who reported the presence or absence of stinging, burning or itching at 
the various time-points during Phase 1 and Phase 2 is shown in Table 5-2. The majority of 
participants reported no symptoms at each time-point.  
 
Table 5-2: Count of participants during Phase 1 and Phase 2 who reported either no symptoms or 
symptoms of stinging, burning and/or itching at each time-point, in both the untreated and the treated 
eye. Phase 1 treatment = one lens rinsed before wear; Phase 2 treatment = one eye rinsed following lens 
removal. 
PHASE TIME-POINT STINGING BURNING ITCHING NONE 
Untreated Treated Untreated Treated Untreated Treated Untreated Treated 
 
1 
Before CL insertion 0 0 1 1 1 1 18 18 
Post CL insertion 3 0 1 0 3 1 14 19 
Before CL removal 2 1 1 2 3 3 15 14 
Post CL removal 9 5 5 4 0 0 7 12 
 
2 
Before CL insertion 0 0 1 1 0 0 18 19 
Post CL insertion 2 1 0 2 1 0 17 18 
Before CL removal 1 3 3 3 2 1 14 14 
Post CL removal 
 2 5 3 4 1 0 15 13 
 
 
The subjective ocular comfort grades (0-100) at all four time-points, for each phase, are shown in 
Figure 5-5. Over the two-hour wear period, in both phases, both the treated and the untreated groups 
showed a reduction in mean comfort score with the drop in comfort from pre-lens insertion to post 
lens removal as statistically significant (all p<0.04, ANOVA, Tukey post-hoc). There was no 
difference, at any time-point, in either phase, between the comfort scores of the treated and untreated 




Figure 5-5: Mean & SD subjective comfort score at each time-point, 0-100 integer scale where 100 is 
perfect comfort, Phases 1 and 2. Phase 1 treatment = one lens rinsed before wear; no statistical difference 
between eyes at any time-point, all p>0.05; Phase 2 treatment = one eye rinsed following lens removal, no 
statistical difference between eyes at any time-point, all p>0.05.  
 
5.4.4 Hyper-reflective cells 
It was possible to image HR cells through the contact lens without using anaesthetic (Figure 5-6, left) 
but the images were somewhat degraded by reflections from the lens compared to the images taken 
following contact lens removal and instillation of anaesthetic (Figure 5-6, right). Table 5-3 shows the 
maximum count of HR cells in any one image for each individual. Unfortunately, due to the nature of 
this procedure, some participants were unable to maintain steady gaze for long enough to attain any 
images; in these six eyes ‘n/a’ was entered into Table 5-3. The entry of ‘0’ in this table, for ID18, 
indicates that clear images were captured but no HR cells were observed. Of the 34 eyes that were 
successfully imaged, 33 (97%) were observed to contain HR cells. All eyes exhibited typical SICS 




Table 5-3: Number of hyper-reflective (HR) cells (per eye) of each participant as determined by confocal 
microscopy in Phase 3: both eyes were exposed to the same lens and solution combination for 2 hours. 
“n/a” describes cases in which no images were obtainable due to participants’ inability to tolerate the 
imaging procedure. A score of “0” indicates that clear images were obtained and no hyper-reflective cells 
were observed. *NOTE: Percentage of eyes exhibiting HR cells does not include those “n/a” eyes in which 
no images were obtained. 
ID RE LE 
1 3 3 
2 n/a 6 
3 1 4 
4 1 3 
5 n/a n/a 
6 15 10 
7 n/a 4 
8 8 5 
9 5 6 
10 6 10 
11 11 9 
12 4 6 
13 2 10 
14 8 7 
15 n/a n/a 
16 7 15 
17 3 7 
18 14 0 
19 4 5 
20 1 2 
# eyes confirmed with HR cells  












Figure 5-6: Typical image of superficial epithelial cells, showing hyper-reflective cells, in a cornea 
exhibiting SICS, Phase 3. Left image: Contact lens is in situ, no anaesthetic or fluorescein was instilled; 
Right image: Contact lens removed, anaesthetic instilled, no fluorescein. 
 
5.5 Discussion 
This study confirms that SICS can be induced by wearing PureVisionTM lenses that have been pre-
soaked in renu® freshTM. Indeed, each of the twenty participants demonstrated SICS, a higher rate of 
occurrence than reported in some of the earlier publications,2, 4, 6 although Peterson et al.42 also 
reported a high response rate (of 80%) with this particular lens and solution combination.  
The key objective of the study was to determine whether rinsing the lens or eye would change the 
area of the SICS response after two hours of wearing lenses soaked overnight in the PHMB-MPS. 
Rinsing the lens before it was worn had no effect on reducing the area of the cornea exhibiting SICS; 
there was no difference between the area of corneal staining of the eye that had worn the rinsed lens 
and the eye that had worn the non-rinsed lens. Similarly, rinsing the eye after lens removal and before 
corneal staining assessment was made, had no effect on reducing the area of the cornea exhibiting 
SICS; there was no difference between the area of corneal staining in the eye that been rinsed and the 
eye that had not been rinsed. In both phases, the mean corneal areas of staining in the treated and 
untreated eyes were high and at >85%, and thus would be considered clinically relevant. Future 
studies should give consideration to the effect size that would be meaningful to their experiment. For 
this pilot study, given the mean staining areas and the standard deviation recorded, a difference of just 
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9% would have given rise to a statistically significant result, however, it is not likely that reducing the 
staining level from say 85% to 76% would be considered clinically relevant. 
Therefore, the mechanism that causes the appearance of superficial punctate corneal staining in 
SICS is not affected by copious rinsing of either the lens or the eye. This finding does not rule out the 
causative mechanism being a leaching of PHMB out of the lens, which subsequently binds to the 
corneal epithelium. Rather, it infers that if this is the mechanism behind SICS, then the PHMB is not 
easily rinsed out of the lens with saline and/or that any PHMB which has adhered to the epithelium is 
resistant to being rinsed off with saline following lens removal.  
A study published by Peterson et al.42 showed that using a rub-rinse step before overnight lens 
storage caused a significant reduction in the SICS appearance. The authors noted that this finding was 
difficult to explain but they proposed that the rub-rinse may have caused a change in the surface 
properties of the lens, which in turn changed the uptake and release profile for PHMB.  
In this current study, the pan-corneal SICS presentation was more common than peripheral annular 
staining with a clear central corneal zone. There have been mixed reports regarding the typical 
presentation of SICS, with some reporting annular staining with central corneal sparing, some 
reporting pan-corneal staining (which was either evenly distributed or more dense closer to the 
limbus) and others reporting a mixture of both patterns.2, 4, 6, 7, 18, 42-45 Given the small sample size of 
this study, it is possible that this group of participants may not be fully representative of the contact 
lens wearing population. A much larger incidence study is required to provide more conclusive 
evidence of the relative distribution of staining patterns among SICS responders. It is also possible 
that the pattern of the staining is not simply subject dependent, but that the patterns interchange with 
observation time. To date, there is no evidence of whether the pattern is repeatable within individuals. 
Future clinical trials of repeated exposures on the same participants would provide evidence of 
whether the pattern of staining is repeatable and consistent. Varying the assessment time for repeated 
study of the same individuals would perhaps help us understand whether staining has a shorter 
duration in the central zone than in the peripheral zones, thus explaining the reports of a higher 
incidence of the annular pattern.  
The evidence of punctate epithelial disturbance under white light suggests that the epithelial cells 
have already been affected by some mechanism, which may be related to the preservative PHMB. 
The loss of transparency appears as a punctate pattern where the ‘punctate dots’ are equivalent in size 
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to individual superficial epithelial cells.26 This suggests that whatever the SICS response is, it is 
occurring at the cellular level.  
Phase 3 of this pilot study investigated the presence of HR superficial epithelial cells after wearing 
the pre-soaked contact lenses. Mocan and Irkec46 used confocal microscopy to look for HR superficial 
epithelial cells among three subject groups. Before the instillation of fluorescein, they reported 
incidences of 0% in normals, 17% in those with keratoconus and 40% in those with overt 
epitheliopathy.46 In this study, HR epithelial cells were confirmed in most (97%; 33 of 34 eyes) of the 
participants imaged, a much higher incidence than that observed in damaged corneas by Mocan and 
Rikec. Topical anaesthetic is known to cause corneal staining in some people, though any 
confounding effect of this causing HR cells can likely be excluded because Mocan also used a topical 
anaesthetic, though a different one to that used in this study. Furthermore, the anaesthetic used in this 
study was also used by Schneider,29 who also reported an increase in HR cells in the presence of 
SICS. In this study the epithelial cells were imaged only in the central region, which tended to be the 
region with the lowest area of epithelial staining. It is uncertain whether the HR cell count would 
have been higher if the imaging took place in a region exhibiting higher staining levels. The presence 
of such HR cells has been previously shown to be associated with the presence of SICS27, 28, 30 and, as 
in this study, it has previously been reported that there can be variability in cell count among 
individuals.29 It has been suggested that these cells become hyper-reflective because of their apoptotic 
condition (programmed cell death).31, 47 Additionally, in animal studies, the cells that exhibit hyper-
reflectivity have been shown to be those cells that stain with fluorescein.30 Their presence in 
association with SICS appears to provide further evidence of some level of physiological change to 
the epithelial cells. 
It would be reasonable to anticipate that damage to the corneal tissue, particularly peripheral 
corneal tissue, would give rise to a noticeable increase in limbal hyperaemia due to the blood vessel 
dilation component of the wound healing response. It is therefore surprising that the presence of 
punctate staining seen in this study, over such large areas of the corneal surface in both eyes, does not 
appear to be associated with any major change in the limbal hyperaemia from the pre-lens wear 
levels. The lack of such a response would suggest that either there is no trigger for the healing 




An absence of symptoms has been used to support the PATH theory that SICS is a harmless 
phenomena of molecular binding to the corneal epithelial surface.21 Although SICS has not been 
associated with extreme levels of discomfort, some clinical trials have reported reduced comfort 
and/or increased dryness4, 9, 14, 15 while others have reported no affect on comfort.2, 13 This study has 
shown that while some participants experienced reduced comfort and specific symptoms in 
conjunction with SICS, others were asymptomatic.  
This study reports a statistically significant drop in comfort ratings between the pre-insertion rating 
and the post-removal comfort of both eyes in both phases. This comfort drop is also arguably 
clinically relevant at ≥9 points on the 100-point scale. However, because both treated and untreated 
eyes exhibited a SICS response, there is no non-lens wearing control to identify whether the reduced 
comfort was due to the contact lens or the corneal staining response. 
The area of corneal staining was fairly consistent across participants, but the comfort ratings data 
show considerable variation; some individuals reported ratings below 60/100, while others rated their 
comfort above 90/100. Comparing subjective ratings between individuals can be misleading, however 
the variability in the comfort ratings contrasts with the consistency of the areas of corneal staining. 
Although reduced comfort has been associated with SICS, the high variability of the comfort scores 
have prevented correlations with staining extent to be found.1, 2, 4, 6, 9, 10, 14, 15 It seems that there may be 
a factor other than the corneal disruption which is responsible for symptoms in certain individuals. 
The ‘burning’ and ‘stinging’ sensations reported in this study upon lens removal are difficult to 
explain. It is possible that the lens was acting as a ‘bandage’ lens while in situ which led to immediate 
discomfort following removal, though to date this has not been investigated. The previously 
mentioned literature only reports comfort ratings while the lenses were in situ on the eye, and did not 
investigate symptomology upon lens removal, as was done in this study. 
This pilot study has a number of potential issues in its design that could be addressed in future 
studies investigating the SICS phenomenon. The study participants were all female and although 
Young et al.48 showed no association between gender and SICS, it is unknown whether enrolling only 
a single gender may bias the results. A limitation of the study design is its contralateral comparison, 
which relies on the two eyes having a similar SICS response. Using a contralateral design in SICS 
studies was supported by the results of Luensmann et al.49 and randomisation of the treatment eye 
was used to help mitigate any bias of unequal response between eyes. Phase 3 can be criticised for not 
having a comparison or control phase to assess HR cells in the participant when no lens was worn. 
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The only comparison for these findings of high incidence is the result from another report,46 which 
suggests that normal healthy corneas do not commonly exhibit HR cells. 
This study has demonstrated that rinsing the lens before wear or rinsing the eye after lens removal 
has no effect on the area of the cornea exhibiting SICS. Historically and intuitively, corneal staining 
this widespread across the cornea has been regarded as “corneal damage”, which typically co-exists 
with both discomfort and clinically significant limbal hyperaemia, neither of which were evident in 
this study. The clinical appearance of epithelial disturbance across such large areas of the cornea, both 
with and without sodium fluorescein, does not seem to be in sync with the lack of associated 
hyperaemia and the few symptoms. Recent review papers have highlighted how little we actually 
understand about the role of sodium fluorescein as a diagnostic tool in eyecare.24, 34, 35 Furthermore, 
evidence has shown that the epithelial disturbance of SICS will reach a peak and will then show signs 
of resolving  despite continued lens wear.4 There have been no specific investigations into whether 
repeated days of wear when SICS is present will cause an increase in signs or symptoms, although 
Jones et al.2 reported that staining levels were similar after a 2-week and a 4-week exposure to SICS-
inducing products. The exact mechanism of corneal staining in general, as well as specifically in 
SICS, remains unclear and requires more investigation. It is important to understand what is 
happening at the cellular level in SICS in order to draw conclusions about the long-term implications 









SICS: Investigating the Staining Pattern and Repeatability 
6.1 Introduction and purpose 
As described in Chapter 1, the cause of solution induced corneal staining (SICS) is still being 
debated,1, 2 and the physiological implications of the epithelial staining involved are not fully 
understood.3-5 Previous investigations have provided sound, repeatable information regarding the 
products involved and the levels of staining observed. As mentioned in Chapter 1 and in the 
introduction to Chapter 5, SICS has been shown to be more severe with specific products, including 
contact lenses of group II hydrogel or silicone hydrogel materials soaked in care products preserved 
with PHMB or PolyQuad.6-11 Additionally, the SICS associated with PureVision contact lenses and 
the two lens care products ReNu MultiPlus and renu fresh have been shown to cause the most severe 
level of SICS of all the product combinations and also shown to have a specific temporal course, with 
maximal staining occurring between 1 and 4 hours of lens wear.6, 12  These two care products have an 
identical chemical composition; ReNu MultiPlus was renamed as renu fresh and repackaged into a 
different style of bottle. The term ‘Renu’ is used throughout this chapter to refer collectively to ReNu 
MultiPlus and renu fresh lens care products. 
Despite so many studies being reported, the typical presentation of this corneal staining 
phenomenon requires more investigation.  There is consensus that the staining is punctate in nature, 
however how widespread this staining is across the cornea remains in question. In one of the first 
reports in 2002 by Jones et al.13, SICS was described as a peripheral annulus of staining close to the 
limbus, typically being that shown in Figure 6-1. Many reports of SICS since have also described the 
staining as a peripheral annular pattern (also described as a “donut-ring” pattern), with central zone 
staining being either absent or occurring at a much lower intensity than that seen in the peripheral 
zones.6, 14 A few years later, Garofalo et al.12 described SICS presenting in both annular and diffuse 
“pan-corneal” patterns. Since then, SICS has become known as the donut-ring stain pattern, however 
the reported data often supports a mix of patterns.7, 14-19 It has been difficult to explain the reasons for 
this reporting of minimal involvement of the central zone in the theories explaining SICS. It is unclear 
whether there is sparing of the central zone or whether the staining in the central corneal zone is 





Figure 6-1:The two commonly reported SICS patterns; left image shows the donut-ring pattern, right 
image shows the pan-corneal pattern. 
 
This chapter reports retrospective data analyses conducted on data from studies conducted at 
CORE which intentionally induced SICS. These analyses were designed to explore: 
• the frequency of the donut SICS pattern relative to the pan-corneal pattern;  
• the repeatability of the staining pattern across individuals. 
 
6.2 Study selection criteria 
Many studies were reviewed to assess their acceptability for the inclusion of their data in this chapter, 
Table 6-1. The selection criteria used to determine the inclusion of studies were: 
1. Received ethics approval from a University of Waterloo Research Ethics Committee; 
2. Was conducted in accordance with the tenets of the Declaration of Helsinki; 
3. Conducted a documented informed consent procedure with all subjects; 
4. Recruited healthy participants; 
5. The balafilcon A contact lens (PureVision, Bauch & Lomb) was worn in combination with a 
Renu brand PHMB-preserved care product for 1-3 hours; 
6. Corneal staining was observed using blue light and a yellow barrier filter; 
7. Corneal staining type and staining extent were graded using the 0-100 CORE corneal staining 
scale, and each of the five corneal zones were graded separately; 
8. Lens wear-time was captured at the time of grading corneal staining. 
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Design; products Wear time (WT) 
A 24 Randomized, double masked, 1mth crossover with washout.  
Balafilcon A lenses (as per subject prescription) presoaked for 
>12hrs with ReNu MultiPlus & others.  
Only data from ReNu MultiPlus arm included. 
WT not controlled but captured.  
Only data with reported WT of 
1-3hrs was included in the 
analysis. 
B 35 Non-dispensing, randomized, double masked. 
-0.25 power balafilcon A lenses presoaked for >12hrs with 
renu fresh & another, contralateral wear. 
Only data from renu fresh eyes included. 
WT 2hrs 
C 14 Non-dispensing, randomized, double masked, crossover. 
-0.25 power balafilcon A lenses presoaked for >12hrs with 
ReNu MultiPlus & others, contralateral wear.  
Only data from ReNu MultiPlus eyes included. 
WT 15min,30min,1hr & 2hrs 
Only data from the 2hr WT arm 
was included in the analysis. 
D 20 Non-dispensing, randomized, double masked. 
Bilateral wear of -0.25 power balafilcon A lenses presoaked 
for >12hours with renu fresh.  
Phase 1 & 2 - one eye received rinsed lens/eye. 
Only data from non-rinsed eyes included. 
Note: IDs 1-5 were selected as SICS +ve responders. 
WT 2hrs 
E 6 Non-dispensing; randomized, double masked. 
Balafilcon A lenses presoaked for >12hours with ReNu 
MultiPlus & other solution, contralateral eye design.  
Only data from ReNu MultiPlus eyes included. 
All subjects were selected as SICS +ve responders 
WT 2hrs  
F 5 Non-dispensing; randomized, double masked. 
Phase 1: balafilcon A lenses presoaked for >12hours with 
ReNu MultiPlus & other, contralateral eye design. 
All subjects were selected as SICS +ve responders 
WT controlled to 2, 4 and 6hrs.  
Only data from the 2hr WT arm 
was included in the analysis. 
G  Phase 2: Non-dispensing; randomized, double masked. 
Balafilcon A lenses presoaked for >12hours with ReNu 
MultiPlus & other solutions, contralateral eye design.  
Fluorets and liquid fluorescein randomized. 
Only data from ReNu MultiPlus eyes and fluoret fluorescein 
source included.  




 Non-dispensing, randomized, double masked. 
Balafilcon A lenses presoaked for >12hours with ReNu 
MultiPlus & other solutions, contralateral eye design.  
All subjects were selected as SICS +ve responders 





6.2.1 Study products 
In all studies the contact lens worn was the same brand, PureVision (Bausch & Lomb, NY), Table 
6-2. This silicone hydrogel lens was pre-conditioned prior to wear by soaking in one of two Renu care 
products (Table 6-3) for a minimum of twelve hours prior to being placed onto the eye. The lens cases 
used for the pre-wear soaking also underwent pre-conditioning in all studies. They underwent seven 
consecutive twelve hour periods of being filled with the Renu product, replaced daily, immediately 
before the lens pre-soaking step. The wearing of PureVision lenses pre-soaked in a Renu care product 
was used as a ‘SICS-inducing treatment’ in the studies of Table 6-1. 
The two Renu lens care products used in these studies, described in Table 6-3, are in fact of 
identical chemical composition. The change of name to renu fresh was made as a change in 
packaging was introduced. ReNu MultiPlus remained available in the traditional white plastic bottle, 
while renu fresh was packaged in a transparent plastic bottle.  
 
Table 6-2: Details of PureVision contact lens worn in all studies listed in Table 6-1. 




Bausch & Lomb, Rochester, NY 
 
Material: balafilcon A, FDA group V, 36% water silicone hydrogel 
Dk/t: 99 for -3.00D 










Table 6-3: Details of Renu brand PHMB-preserved products used in the studies listed in Table 6-1. 
Brand name,  
manufacturer 
% PHMB Other ingredients 
ReNu MultiPlus 
Bausch & Lomb, Rochester, NY 
 
0.0001 Surfactant/wetting agent: Hydranate 0.03%, Poloxamine 1.0% 
(Tetronic 1107) 
Buffer: Boric acid, sodium borate 
Chelating agent: EDTA 0.1% 
renu fresh  
Bausch & Lomb, Rochester, NY 
 
0.0001 Surfactant/wetting agent: Hydranate 0.03%, Poloxamine 1.0% 
(Tetronic 1107) 
Buffer: Boric acid, sodium borate 
Chelating agent: EDTA 0.1% 
 
6.2.2 Staining grading 
To be eligible for this analysis, studies were required to record the level of corneal staining using the 
CORE corneal staining scale. This scale grades the cornea separately in each of the five corneal 
zones; temporal, superior, nasal, inferior and central. As described more fully in Chapter 2, the CORE 
corneal staining scale employs 3-factor scoring; type, extent and depth of staining. For SICS, the type 
of staining is superficial and punctate, therefore the type and depth of the staining has minimal 
variance. The factor of main interest to describe the variability in the staining presentation is the 
extent grade, or the area of the cornea exhibiting the staining. The following analyses will report on 
the extent, or area, of staining. 
Punctate staining presents as a region of dots of fluorescein stain and the area of this staining is 
graded by estimating the area within the border of this region of dots. An example is presented in 




SICS staining was maximal after 1 hour, minimal at 6 hours and also by work published by Andrasko 
et al.8 who reported higher levels of SICS after 2 hours of lens wear compared to 4 hours.  
For the repeatability analysis, subjects were included if they had participated in three or more of the 
studies listed in Table 6-1. There was no requirement for them to exhibit a specific level of SICS 
response in order to be included in this analysis. Several studies recruited participants based on the 
knowledge that they had exhibited SICS previously, because the presumed likelihood of repeating the 




6.3 Analysis of staining patterns: donut-ring versus pan-corneal staining 
6.3.1 Objective 
To investigate which corneal staining pattern is the most common SICS presentation, by analyzing 
the frequency of the donut-ring and pan-corneal patterns. 
6.3.2 Methods 
Four of the studies listed in Table 6-1 met the inclusion criteria for this pattern analysis studies, 
providing a sample size of 88 subjects, Table 6-4.  
Study A methodology did not control for contact lens wear time at the study visits, however lens 
wear time at the time of the visit was collected. As described in Section 6.2.3, only those participants 
who attended their study visit between 1 and 3 hours after lens insertion were included in the analysis. 
This range of wear period was based on work by Garofalo et al.,12 who reported maximal staining 
between 1 and 4 hours of wear, and Andrasko et al.8 which supports highest level of SICS after 2 
hours wear, which was at a reduced level after 4 hours lens wear. Twenty-four subjects met this 
criterion. 
Study B controlled for lens wear time in the study design, therefore all 35 subjects were included in 
this analysis. 
Study C assessed staining after 4 time periods of lens wear but only the data collected at the 2 hour 
wear period was included in this analysis.  
Study D selected the first five participants from Study B in order to have known SICS responders 
among the cohort. To avoid repeated inclusion of participants, data from the first five were not 
included in this pattern frequency analysis, leaving a sample of 15 eligible to be analysed.  
Table 6-4: Studies providing data for pattern analysis. 









The type of staining in SICS is generally superficial and punctate in nature,13, 15 therefore the type 
and depth of staining shows little variability. The staining variable analysed to investigate the 
frequency of staining pattern was the area of staining grade for each zone. For studies with bilateral 
SICS-inducing treatment where data was eligible from both eyes, only the right eye data was included 
in the analysis, due to the expectation that the staining response would be similar between eyes. 
Several of the trials were of contralateral design, therefore the data is from a mix of right and left 
eyes. 
An early definition of SICS was provided by Carnt et al.9 in 2007, with reference to the CCLRU 
grading scale:  
“… diffuse punctate staining (extent grade 1 and above) in at least four of the five regions 
(central, superior, inferior, nasal and temporal) of the cornea.” 
 
Grade 1 extent staining was specified in the CCLRU scale as ‘1-15% surface involvement’. 
Therefore Carnt’s definition specified that diffuse punctate staining in four of the five corneal zones, 
no matter how small an area was affected, could be termed SICS. This seems to be a very broad 
staining area criteria, which would define SICS in subjects with very little staining. 
A few years before Carnt’s definition was published, Garofalo et al.12 presented SICS data from 
their experiment in several ways; the mean staining area per zone, the mean number of zones affected 
by staining and the mean number of zones displaying ≥10% area staining. The retrospective analysis 
described below, which combines data from the four studies listed in Table 6-4, presents the corneal 
staining data in a manner similar to that used by Garofalo et al.12   
 
6.3.3 Results 
The mean staining area grades, by zone and by study, are presented in Table 6-5 for all subjects, 
irrespective of whether they presented with SICs. The average staining area for the entire cornea was 
calculated as the average of the mean areas of the five zones, for all eyes. This value was 65%., 
indicating that on average each eye across all studies exhibited punctate staining covering 65% of the 
entire cornea. Figure 6-3 is a representative illustration of this grade of total corneal staining area. 
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Table 6-5: Mean area of staining by zone (standard deviation) and range, per study, n=88 (0-100). 
Study (n) Temporal Superior Nasal Inferior Central 
A (24) 34 (41) 28 (24) 32 (41) 38 (41) 25 (38) 
B (35) 75 (27) 68 (25) 78 (21) 73 (23) 51 (29) 
C (14) 67 (38) 63 (41) 67 (39) 69 (34) 69 (36) 
D (15) 93 (14) 91 (13) 93 (9) 91 (12) 97 (5) 















Figure 6-3: Example of punctate staining over approximately 65% of the corneal area. 
 
Applying the Carnt et al.9 definition of SICS to this multi-study data (diffuse punctate of 1% or 
more extent across at least four zones), 74 of the 88 eyes (84%) exposed to the balafilcon A lens and 
PHMB care product exhibited SICS. Table 6-6 presents the count of participants who were 
considered to exhibit SICS when applying the slightly tighter definition based on the paper by 
Garofalo et al.,12 which requires the staining to be at least 10% of the zone area in four out of five 
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zones. With this definition, the total number of eyes exhibiting SICS reduced to 71 out of the 88 eyes 
(81%).  
It was of interest to investigate the proportion of these 71 SICS responders that exhibited a donut-
ring staining pattern, given that this had been a common description of SICS. The SICS definition 
chosen for this proportional analysis was based on that first suggested by Garofalo et al.12 such that 
donut-ring pattern was defined as all four peripheral zones exhibiting staining of  ≥10% with either no 
staining or <10% staining area in the central zone. This count is presented in the third column of 
Table 6-6 and, out of the 71 participants with SICS, the donut-ring pattern was only evident in 5 
cases, which represents just 6% of participants. The pan-corneal staining pattern, where all zones 
exhibited  ≥10% staining, was by far the most common, exhibited by 63 eyes, representing 89% of 
the SICS cases and 72% of all eyes.  
Of the SICS responders, the majority exhibited ≥10% staining in all five zones and would be 
considered to exhibit pan-corneal staining. There were just three exceptions, and in each of these it 
was the superior zone that did not meet the staining criteria of being ≥10%. In one of these cases the 




Table 6-6: Count of eyes with: a) SICS: defined as 4 zones with ≥10% staining area; b) donut-ring SICS: 




# (%) with SICS 







pattern ie. ALL 5 
zones ≥10% area 










• 1 eye exhibits 4 zone SICS:  
S=5% area; 






























• 7% of all SICS 
• 6% of all eyes 
63 
• 89% of all SICS 
• 72% of all eyes 
3 
• 4% of all SICS 
• 3% of all eyes 
 
S = superior zone 
*all values rounded to the closest integer 
 
To examine the zone most likely to exhibit low levels of staining in the presence of SICS, as 
defined by Garofalo et al.,12 a count was made, for each study, of the number of each corneal zone 
that showed <10% staining, Table 6-7. In the 71 eyes exhibiting SICS, of the 355 individual zones 
across all eyes, only 8 zones exhibited staining of <10% area; five were the central zone and three 






Table 6-7: Using the SICS definition of 4 zones or more with ≥10% area staining, count of corneal zones 
exhibiting <10% staining area in eyes exhibiting SICS, by study and for all studies combined, n=71. 
Study (n) Temporal Superior Nasal Inferior Central 
A (9) 0 2 0 0 1 
B (35) 0 1 0 0 3 
C (12) 0 0 0 0 1 
D (15) 0 0 0 0 0 
Total (71) 0 3 0 0 5 
 
For those participants with this ‘≥10% definition’ of SICS, the mean area grade of the staining in 
each zone, by study and overall, are shown in Table 6-8. The standard deviation was fairly high in all 
zones across all studies; study C showed the lowest standard deviation values across all zones.  
Among these SICS responders of all studies, the mean zone staining was 75%. This value also 
represents the mean overall corneal staining area across all SICS responders. An observation of 
punctate staining over 75% of the cornea would be of significant clinical relevance. Figure 6-4 is a 
representative illustration of a grade of 75% for the total corneal staining area. While the mean area of 
the central zone was the lowest, it would not be considered a negligible level at 65%. 
 
Table 6-8: Using the SICS definition of 4 zones or more with ≥10% area staining, mean area of staining 
(standard deviation) per corneal zone in eyes exhibiting SICS, by study and for all studies combined, 
n=71. 
Study (n) Temporal Superior Nasal Inferior Central 
A (9) 82 (24) 72 (41) 79 (23) 86 (21) 64 (36) 
B (35) 75 (27) 68 (25) 78 (21) 73 (23) 51 (29) 
C (12) 71 (36) 73 (35) 76 (34) 77 (29) 77 (31) 
D (14) 93 (14) 91 (13) 93 (9) 91 (12) 97(5) 

















Figure 6-4: Example of punctate staining over approximately 75% of the corneal area. 
 
The data from the eyes exhibiting SICS were manipulated to identify which zone exhibited the 
highest extent of staining per eye. To achieve this, the zone or zones with the highest extent were 
allocated a Rank-1 label. For example, if the nasal and temporal zones were graded 75 and the other 
three zones were grade 50, then both the nasal and the temporal zones would be allocated as Rank-1 
for that eye. However, if the nasal zone was graded 75 and the other four zones were graded 50, then 
only the nasal zone would be allocated Rank-1 for that eye. The number of Rank-1 labels per zone 
were then summed to show which zone more frequently exhibited the highest area of staining, Table 
6-9. The data revealed that the central zone is least likely to exhibit the highest extent of corneal 
staining in SICS, with a count of 27 (39%). The second least likely was the superior zone with a count 






Table 6-9: Using the SICS definition of 4 zones or more with ≥10% area staining, count of Rank-1 labels 
allocated to each corneal zone in eyes exhibiting SICS, by study and for all studies combined, n=71. 
Study (n) Temporal Superior Nasal Inferior Central 
A (9) 4 5 4 7 4 
B (35) 21 10 24 15 3 
C (12) 6 7 8 8 8 














It may be argued that using 10% as a minimum staining in four corneal zones to define SICS is too 
low to indicate clinical relevance. Jones et al.13 published one of the first reports of SICS and they 
proposed that punctate staining that affected close to 50% of the corneal area would be deemed 
unacceptable and akin to a solution toxicity reaction. Considering this description of clinical 
significance, the data were reviewed a second time, this time applying a more strict definition of 
SICS: at least four zones exhibit a minimum of 50% area staining ie. minimum of 40% of the corneal 
area affected. Under this more strict definition, the count of eyes exhibiting SICS reduced to 59, or 
67%, of the full cohort of 88. Albeit a slightly reduced number, this strict definition categorizes two 
thirds of eyes with significant corneal staining in response to this particular contact lens and lens care 
product combination. 
Data are presented in Table 6-10 using this more strict SICS definition, and the totals across all 
studies for the donut-ring and pan-corneal patterns have been recalculated. The pan-corneal pattern 







Table 6-10: Using the SICS definition of 4 zones or more with ≥50% area staining, count of eyes with: a) 
SICS: defined as 4 zones with ≥50% staining area; b) donut-ring SICS: defined as central zone has <50% 
staining area; c) pan-corneal SICS: defined as all 5 zones with ≥50% staining area. 
Study (n) # (%) with SICS 







pattern ie. ALL 5 
zones ≥50% area 








































15% of all SICS 
10% of all eyes 
48 
81% of all SICS 
55% of all eyes 
3 
5% of all SICS 
3% of all eyes 
 
 
Data describing the distribution of staining is presented in Table 6-11. The counts of zones with 
<50% staining area was low; nine were the central zone, three the temporal zone. The mean area of 
staining was fairly evenly distributed, with the lowest value (75% area) in the central zone. The 
central zone also had the lowest count of Rank-1 staining area (Rank-1 represented the zone/s with 
the greatest staining area per eye). 
For those eyes exhibiting SICS defined as exhibiting ≥50% area staining in four corneal zones, the 
mean overall corneal staining area, across all studies, was 84%. This value is higher than that 
suggested by Jones et al.13 as representing significant staining akin to toxicity staining, and would 
certainly be considered highly clinically relevant in a consulting room examination. Figure 6-5 
illustrates this level of corneal punctate staining.  
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Table 6-11: Across all studies, for eyes exhibiting SICS according to the definition of 4 zones or more 
with 50% area staining,: a) count of eyes per zone with <50% staining area; b) mean area of staining 
(standard deviation) per corneal zone; c) count per zone of Rank-1 labels. n=58. 
All Studies Temporal Superior Nasal Inferior Central 
Count <50% 
staining area 
3 0 0 0 9 














40 27 40 32 25 
 
 
Figure 6-5: Example of punctate staining over approximately 84% of the corneal area. 
 
6.3.4 Discussion 
This analysis firstly defined SICS in the same way as previously proposed by Garofalo et al.12; at 
least four of the five corneal zones need to exhibit punctate staining over ≥10% area. Of the 88 
subjects eligible for this analysis, 71 met this criteria, indicating an incidence of 81%. Even applying 
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a more strict definition of SICS, which required at least 50% area staining in four of the five corneal 
zones, two thirds (59) of all eyes still met the criteria. This data supports previous reports that SICS is 
commonly induced with the combination of balafilcon A contact lens material and one of the Renu, 
PHMB-preserved care products.6, 7, 9, 10, 17, 20  
Study A gave rise to lower incidence of SICS than any of the other studies. The methodology in 
this study employed a rub step to clean the lenses as part of the pre-soaking process. This rub-step has 
since been investigated by Peterson et al.21 in a group of twenty participants and shown to 
consistently and significantly reduce the SICS response compared to not using a rub step. The 
staining data were reported using a combination grade and therefore cannot be directly compared to 
these results. They proposed potential theories why the rub step made such a difference but no further 
work was published on this particular aspect.  Removing data from Study A because of this difference 
in contact lens preparation would increase the incidence of SICS found in this analysis. However the 
main objective was to investigate the frequency of the pattern of SICS, not the incidence of SICS, 
therefore the sample was included. 
No matter which definition of SICS was applied, the vast majority of subjects exhibited pan-
corneal rather than donut-ring pattern.  
Using the definition of ‘four zones ≥10% staining area’, 63 (or 89%) of the 71 subjects with SICS 
showed ≥10% staining area in all five zones ie. the pan-corneal pattern. When analyzing the staining 
of those subjects with SICS, the lower incidence of staining in the central zone was supported by 
three methods. Firstly, the count of each zone with <10% area staining was the highest for the central 
zone at five, and second highest for the superior zone at three. It is of interest to note that none of the 
other zones showed <10% staining area in any eyes with SICS. Secondly, the mean staining area per 
zone is lowest for the central zone at 66%. The zone with the second lowest mean staining area is 
once again the superior zone at 74%, however the other zones follow closely at 79% (temporal and 
inferior zones) and 80% (nasal zone). The third analysis method employed a staining area ranking 
system where the zone/s of the highest area of staining per eye were allocated a Rank-1 designation. 
Once more, the central zone exhibited the lowest count of Rank-1 at 27, with the second lowest count 
of 29 attributed to the superior zone. For eyes exhibiting SICS according to this definition, while the 
central zone showed the least staining of all the five zones, it was still present at a clinically 
significant level, covering on average, 66% of the central zone area.  
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Applying the more strict SICS definition of ‘four zones ≥50% staining area’, 44 (or 76%) of the 58 
subjects with SICS showed ≥50% staining area in all five zones. As was the case with the less strict 
SICS definition, all three analysis types supported the central zone as being least affected, though 
there is still significant staining in this central zone. The count of zones with <50% staining area was 
nine for central zone, three for temporal and none elsewhere. The central zone had the lowest mean 
staining at 75%, however, this level is clinically relevant and the other zones were even higher, all 
>80%. Also, as previously, the count of Rank-1 allocations were lowest for the central zone, followed 
by the superior zone.  
The data for this analysis are derived from 88 individuals who were exposed to the same 
combination of products, known to induce a SICS response. The fact that SICS was detected was not 
a surprise, indeed it was expected. The unknown factors were the incidence of SICS and the 
frequency of donut-ring pattern compared to pan-corneal pattern. Despite the staining pattern being 
frequently referred to as a donut-ring or peripheral annulus, this study shows the pan-corneal pattern 
to be by far the most typical presentation.  It is unfortunate that the donut-ring term has become 
synonymous with SICS because it is suggestive of minimal or no involvement of the central zone 
when, in fact, SICS commonly displays considerable staining in this zone, albeit often slightly less 
than that in the peripheral zones; 66% or 75% depending on whether the SICS definition is based on 
10% or 50% area of staining in four zones. 
There are limited comparable data in the literature due to the use of different product combinations 
or no control over the wearing time before staining assessment was made. However, Andrasko and 
Ryen8 used the same product combination among the 59 product combinations they tested. They 
reported that the Purevision lens, worn in association with the Renu care products, induced some of 
the highest staining levels after two hours of wear. They also reported the mean overall corneal 
staining response after two hours to be punctate staining covering 73% area. This value is very close 
to the results of this analysis, which was 75%. In one of the first reports of SICS, Jones et al.13 also 
used the same product combination however there was no control over the wear time prior to the 
staining assessment. Despite not targeting observation at what was later recognized as maximal 
staining time, 17 of the 44 subjects (37%) presented with staining levels that warranted 
discontinuation of products. Another observation they made was that the most staining was present in 
the inferior zone. This current analysis does not support this finding, though Pritchard et al.7 also 
reported higher staining inferiorly with SICS. They tested an FDA Group II hydrogel contact lens 
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(alphafilcon A) and reported more corneal staining with ReNu MultiPlus than with either ReNu 
MultiPurpose or OptiFree Express, which contain different preservatives and other ingredients. 
Staining in at least three corneal quadrants was reported in twelve out of the 22 subjects, an incidence 
of 55%. 
In the Garofalo et al.12 study, they included the ReNu MultiPlus care product combined with 
several contact lenses, though they did not use the balafilcon A material. With the hydrogel lenses, 
ReNu MultiPlus was associated with ≥10% area staining in four or five zones in a maximal staining 
period of one to four hours of lens wear. With silicone hydrogels they found a lower staining 
response, with levels of ≥10% area only observed in one or two zones at the maximal staining time of 
two hours wear time.   
The most comment presentation of SICS staining in this analysis was punctate staining over the 
majority of the cornea - a diffuse pan-corneal presentation pattern. The staining frequently presented 
over a slightly smaller area in the central zone than the peripheral zones, however, the grade of the 
central zone staining was still high enough to cause clinical concern. Central staining carries clinical 
significance because of the impact it may have in the short or long term on vision quality. However, 
the peripheral corneal regions close to the limbus host the stem cells responsible for replacing the 
sloughed apical epithelial cells and therefore maintaining corneal barrier function. Therefore, 
significant and chronic peripheral corneal staining should also be viewed as potentially deleterious to 
corneal and ocular health. Of the 88 subjects exposed to this product combination, just over half of 
them, 47 subjects, presented with punctate staining spread, on average, over 84% of their cornea.  
This extent of punctate corneal staining would certainly be regarded as highly clinically significant 
and should cause the practitioner to take remedial actions, likely involving temporary cessation of 






6.4 Analysis of staining repeatability 
6.4.1 Objective 
To investigate the repeatability of the grade of SICS staining extent (area) and the SICS pattern across 
those participants identified as participating in three or more SICS-inducing experiments at CORE. 
6.4.2 Methods 
The CORE studies that met the criteria for further SICS data analysis are listed in Table 6-1. All of 
these studies used the same SICS-inducing treatments, controlled the exposure time to these 
treatments to two hours and used the same methodology for observing and grading the area of 
punctate staining. They were further reviewed to identify participants who had participated in at least 
three studies. This was possible because several of the studies targeted recruitment to those who had 
been identified as a ‘SICS responder’.  
Not everyone participated in every study but the following numeric codes identify the subjects and 
their repeat participation is shown in Table 6-12. Seven participants were identified as being involved 
in three or more studies involving SICS-inducing treatments, which spanned a total of six studies, 
coded C to H, although no participant was enrolled in all seven studies. All of these studies were 
completed within a period of four years. 
The staining data for each subject was compared across the different studies. The data was 
evaluated for the amount of staining ie. the extent grade, as well as the SICS pattern presented; donut-
ring or pan-corneal. 
Table 6-12: Subjects identified as being in repeated SICS-inducing studies (n=7). 
ID Studies # repeats 
C D E F G H 
1 √ √ √ _ √ √ 5 
2 √ _ √ √ √ √ 5 
3 _ √ √ √ √ √ 5 
4 √ √ √ _ _ √ 4 
5 √ √ √ _ √ _ 4 
6 _ √ _ _ √ √ 3 





Each participant’s data is presented separately to allow review of the intra-participant variability 
across the specific studies they participated in, Table 6-13. The individual zone staining extent grades 
are presented as well as the ocular mean staining grade, calculated by summing the zone grades and 
dividing by five. Calculations of the standard deviation across the individual zone scores of all 
studies, as well as across the total cornea mean grades of all studies, provides an indicator of 
variability within the data. With the exception of ID3, the variability of the grades of this 0-100 scale 
is above 30, which is relatively high. The graphs show the zone staining area grades, colour-coded 
according to study. This provides a visual illustration of how the SICS response varied across the 
studies. 
 
Table 6-13: Grades of staining areas arranged by subject, per study and by zone; SICS confirmation and 
pattern description according to the definitions as specified. 
ID 1 Zone extent grade  ≥10% in ≥4 zones ≥50% in ≥4 zones 






C 100 100 100 100 100 100.0 √ X √ √ X √ 
D 100 80 100 80 100 92.0 √ X √ X - - 
E 75 60 75 85 40 67.0 √ X √ √ √ X 
G 5 0 20 5 0 6.0 X - - X - - 
H 100 100 100 100 100 100.0 √ X √ √ X √ 
Mean 76.0 68.0 79.0 74.0 68.0 73       



















ID 2 Zone extent grade  ≥10% in ≥4 zones ≥50% in ≥4 zones 






C 100 100 100 100 70 94.00 √ X √ √ X √ 
E 30 0 0 30 0 12.00 X - - X - - 
F 100 70 100 100 55 85.00 √ X √ √ X √ 
G 100 100 100 100 100 100.00 √ X √ √ X √ 
H 100 100 100 100 100 100.00 √ X √ √ X √ 
Mean 86.0 74.0 80.0 86.0 65.0 78.2       




ID 3 Zone extent grade  ≥10% in ≥4 zones ≥50% in ≥4 zones 






D 90 55 85 100 20 70.0 √ X √ √ √ X 
E 60 45 60 65 25 51.0 √ X √ X - - 
F 80 53 80 55 45 62.6 √ X √ √ √ X 
G 50 60 80 80 30 60.0 √ X √ √ √ X 
H 100 100 100 100 70 94.0 √ X √ √ X √ 
Mean 76.0 62.6 81.0 80.0 38.0 67.5       
































ID 4 Zone extent grade  ≥10% in ≥4 zones ≥50% in ≥4 zones 






C 100 100 100 100 100 100.0 √ X √ √ X √ 
D 100 85 100 85 100 94.0 √ X √ √ X √ 
E 45 45 45 50 40 45.0 √ X √ X - - 
H 60 30 80 100 40 62.0 √ X √ X - - 
Mean 76.3 65.0 81.3 83.8 70.0 75.3       




ID 5 Zone extent grade  ≥10% in ≥4 zones ≥50% in ≥4 zones 






C 100 100 100 100 100 100.0 √ X √ √ X √ 
D 80 90 100 70 90 86.0 √ X √ √ X √ 
E 45 0 25 0 65 27.0 X - - X - - 
G 50 50 50 30 30 42.0 X - - X - - 
Mean 68.8 60.0 68.8 50.0 71.3 63.8       
































ID 6 Zone extent grade  ≥10% in ≥4 zones ≥50% in ≥4 zones 






D 50 50 80 90 100 74.0 √ X √ √ X √ 
G 30 10 20 10 0 14.0 X - - X - - 
H 100 100 75 100 100 95.0 √ X √ √ X √ 
Mean 60.0 53.3 58.3 66.7 66.7 61.0       
StDev 36.1 45.1 33.3 49.3 57.7 42.0       
 
 
     
     
ID 7 Zone extent grade  ≥10% in ≥4 zones ≥50% in ≥4 zones 






D 100 100 100 90 100 98.0 √ X √ √ X √ 
E 3 0 0 0 0 0.6 X - - X - - 
G 0 10 20 10 0 8.0 X - - X - - 
H 100 100 100 100 100 100.0 √ X √ √ X √ 
Mean 50.8 52.5 55.0 50.0 50.0 51.7       

































These seven subjects were invited to participate in repeated studies because they were known to have 
exhibited SICS with the same contact lens and care products. Depending on the definition of SICS 
used (four zones with ≥10% or four zones with ≥50%), the number of participants who consistently 
exhibited SICS across all studies varied from two to none, respectively. 
Viewing the participants’ data tables, there is little repeatability seen. This was very surprising 
given the very similar protocols these studies shared. Perhaps the highest level of repeatability is 
demonstrated by the data of ID3, which has the lowest values of standard deviations. Also, all of their 
study plots follow a similar path, with all the peripheral zone grades close to or above 50, and all the 
central zone grades dropping lower. For this participant, all studies led to a confirmation of SICS 
based on 4 zones ≥10%, however only four of the five studies demonstrated SICS based on 4 zones 
≥50%. Conversely, the data plots from ID7 show two distinctly different responses, evenly divided 
across the four studies; two studies show all zones graded at ≥90%, and the other two show them all 
graded ≤20%. Similarly, both ID 1 and ID2 show a repeatable response across four of their five 
studies with high grades (around 70) across all zones, however they each have one other plot that is 
much lower, with grades around 20. The studies associated with the low grades for these two 
participants are different, and there is no one study that is consistently associated with the lower grade 
responses. Conversely, studies C, D and H seem to be consistently associated with high responses, 
but the reasons for this are unclear. 
 There are several factors that can increase variability in a subjective clinical measure such as 
staining grading. One of the obvious potential causes is that the study protocol was not followed 
properly. This could include the use of incorrect products, errors in the pre-conditioning procedures, 
or use of non-standard methods for the fluorescein instillation and staining observation methods. 
Errors in any of these areas has potential to significantly alter the results. This seems unlikely given 
the experience of the CORE research team and the internal oversight processes. The studies involved 
several different investigators and their inter-investigator variability could have been a contributing 
factor. However, while this may explain a difference between grades of 10 or even 20 between 
studies, it is not likely to be the cause of difference as large as 60 or 80, which is the case for some 
participants, for example ID7 who exhibits staining areas of close to 100 in two studies, yet in the 
other two studies exhibits grades of 20 or less.  
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It is quite plausible that the variability is due to changes within the participant, particularly 
considering the four-year period over which these studies were conducted. If SICS is influenced by 
habitual lens wear, environmental conditions, allergy, tear film quality etc then assessments spanning 
several years may be expected to vary. Health and medications can have a ubiquitous effect on the 
tear film composition and therefore it is feasible that, even though all subjects reported good health 
when they were enrolled, some minor fluctuations and changes may have caused the ocular surface 
response to alter.  
Lastly, there is the possibility that the variation stems from an unexpected source, the between eye 
variability. All but one of the six studies was a contralateral design, therefore the data from the eye 
exposed to the SICS-inducing treatment eye may have come from the right eye in one study and from 
the left eye in another study. While it is generally assumed that a physiological response to this kind 
of stimulus would be similar between eyes, this has never been properly investigated for the SICS 
response. Also, the level of response may vary according to participant criteria such as tear film 
quality, which may vary over time and may also be impacted by environmental conditions, General 
health and medications can impact tear film quality although all participants were healthy at the time 
of enrollment into these studies, therefore it is anticipated that these impacts will be minimal. 
The evidence from this small group of participants unequivocally supports the need for a study 
designed to specifically investigate the repeatability of the SICS response within individuals. This 
study should control for as many factors as possible in an attempt to reduce sources of variability. 
Firstly, the data should be collected within a few months, rather than over years as was the case for 
this analysis. This would minimize environmental and health variations. Secondly, assigning the same 
investigator to each participant would remove inter-investigator grading variability, and prior training 
on the grading scale could be employed to minimize intra-investigator variability. Photographic 
capture of the corneal staining and/or objective grading software may be valuable additions to the 
subjective grading, though recent reports have indicated that grading from photographs is quite 
different to the live situation. Repeated exposure to the same SICS-inducing treatment on at least five 
occasions would be valuable and increasing the sample size would provide more power to the results, 
depending on the variability measured. Only when such a targeted study is conducted, can we gain a 









Discussion, Future Work & Summary 
This thesis targeted specific aspects of corneal fluorescein staining.  
Chapter 1 presents an overview of the importance of maintaining corneal integrity to preserve 
ocular health and good vision. Because the corneal epithelium provides an important barrier function 
to protect the rest of the cornea, and therefore the entire eye, then epithelial integrity is also regarded 
as essential to preserve ocular health and vision. The use of fluorescein to assess epithelial integrity is 
explained and example images of corneal staining related to dry eye and contact lens wear are 
included. Though the exact mechanism of corneal fluorescein staining may not be fully understood, it 
is believed to highlight undesirable physiological responses of the corneal epithelium, and as such 
requires more study. This thesis provides several pieces of information to further the knowledge in 
this area. 
Chapter 2 provided an overview of the various grading scales to record corneal staining and 
introduced and described the CORE corneal staining scale. The CORE scale was the method used to 
record the level of solution induced corneal staining in all the clinical trials featured in Chapters 5 and 
6, and most of those assessing dry eye in Chapter 4. A unique feature of this scale is the grading of 
the ‘extent’ of the staining and the zonal grading provides the ‘spread’ of the staining across specific 
zones, as well as the entire corneal surface. The fact that the extent is graded using a 0-100 scale 
means it can be interpreted as the percentage of the cornea exhibiting corneal staining, which 
translates readily to clinical interpretation.  
The Chapter 3 described an experiment to assess the agreement of fifteen observers using the 
CORE corneal staining scale when they graded 22 photographic images at two separate grading 
sessions. The results unequivocally supported the benefit of prior training, because the one naïve 
observer demonstrated by far the poorest intra-observer agreement. The results also identified future 
opportunities to improve the CORE corneal staining scale. Providing pictorial references and clear 
instructions have both been recommended to be beneficial to all grading scales. The images from the 
experiment that provided low inter-observer grade variability make good candidates for the 
development of a pictorial reference guide. These reference images would need to be assigned a 
grade. However, the mean grade for each image was impacted by outliers and less experienced 
observers in this experiment. Calculating the mean grade for each image using a bootstrapping 
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method would reduce the impact of these outliers. The images with high inter-observer variability are 
valuable for discussions aimed at understanding how the observers approached the grading of these 
images. Such discussions would expand the instructions on the use of the scale and better instructions 
may help to further improve agreement. While the 0-100 scale is somewhat straight forward to apply 
to the extent factor of the staining, applying 101 steps to the type factor is, anecdotally, reported as 
more difficult, perhaps because this factor is more descriptive. Further analysis of the results may 
inform whether the type scale would have better agreement with a reduced number of steps, without 
sacrificing sensitivity.  
Chapter 4 evaluated the distribution of corneal staining in 368 subjects with symptoms of dry eye, 
across 13 studies. Because corneal staining is a common sign used to diagnose dry eye disease, 
understanding the typical presentation is valuable to the planning of assessment strategies. The 
analysis demonstrated that in 52.5 %, of all subjects, the inferior zone was the most common location 
for the greatest degree of staining of the entire cornea. This was true whether the staining occurred 
only in one zone or whether it affected multiple corneal zones. This means that any dry eye treatment 
study should monitor the inferior zone staining. Grading the staining over the cornea as a whole may 
not provide data robust enough to show meaningful change. Also, if the inferior zone is where the 
worst staining is, then improvements in staining in this zone following any treatment will be most 
impactful. 
Chapter 5 reported on a SICS-inducing experiment involving 20 subjects, which investigated 
whether rinsing the lens prior to wear and rinsing the eye prior to staining evaluation would eliminate 
the SICS response. The unilateral rinsing treatment did not eliminate the SICS response, indicating 
that the rinsing procedure was not able to remove sufficient PHMB, and/or other care solution 
components, to change the staining outcome. Irrespective of the rinsing treatment, the test and control 
eyes all exhibited punctate staining over >84% of the entire corneal surface. This study photographed 
the grey punctate ‘white light staining’ and also imaged hyper-reflective epithelial cells prior to 
instilling fluorescein. Both of these provide evidence of a cellular response in the absence of 
fluorescein. Reports of symptoms were collected and though the majority of participants were 
symptom free, there were unexpected reports of stinging and burning immediately after lens removal. 
The high levels of staining suggest high clinical relevance while there are contradictory low levels of 
symptoms and unchanged limbal hyperemia. It appears that SICS may be different to the 
symptomatic staining associated with dry eye and corneal injury. Future explorations of these 
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potential differences may involve collecting corneal cells from participants with corneal staining due 
to dry eye, and comparing them to participants with an induced SICS response and also to cells from 
healthy corneas. It would be useful to compare morphology across these three groups as well as 
whether fluorescein penetrates to the cytoplasm or remains solely membrane bound. 
Chapter 6 analysed the staining patterns reported across several SICS-inducing clinical trials.  The 
presentation of staining has been frequently reported to occur as a characteristic donut-ring pattern, 
implying sparing of the central corneal zone. Contrary to this description, the staining in the 
experiment in Chapter 5 was almost exclusively pan-corneal. Data from several studies that followed 
the same methodology were combined and analysed. The results showed that, no matter which 
definition of SICS was applied, pan-corneal staining pattern was far more common than a ‘donut-
ring’ pattern with central zone sparing. Pan-corneal pattern was present in 89%, or 81% of SICS 
exhibiting eyes, depending on whether the definition of SICS applied was ≥10%, or ≥50% staining 
extent in four of the five corneal zones. An additional analysis was conducted to investigate the 
repeatability of the SICS response within individuals. This was a small sample of only seven 
participants and the results were contrary to expectations; the SICS response among individuals was 
not predictable. There is a general assumption for subjects recruited into such studies that ‘once a 
SICS-responder always a SICS-responder’, and this result challenges this assumption. The small 
sample size and the fact that the assessments are spread across different clinical trials spanning 
several years may all be confounding factors. A better way of assessing repeatability of SICS 
response would be to conduct a project specifically targeted for this purpose. Such a project would 
likely involve five or more repeated SICS-inducing treatments, per participant. Assigning the same 
investigator to conduct all the assessments would be of benefit to avoid inter-observer variability. 





For an assessment technique that has been used for over a century, it is quite remarkable that we still 
do not fully understand how fluorescein interacts with the corneal epithelial cells. This thesis has 
expanded knowledge in certain aspects of this broad topic. 
The CORE corneal staining scale includes an extent grade which provides unique data on the 
percentage area of the cornea affected. This information can be particularly useful in dry eye and 
contact lens clinical trials. Further development of this scale will create a valuable corneal staining 
assessment tool.  
This thesis provided evidence that the most severe corneal staining in patients with symptoms of 
dry eye most often presents in the inferior zone. This information highlights the importance of 
specifically assessing inferior zone corneal staining in future research reporting the efficacy of dry 
eye treatments. 
The SICS-inducing experiment demonstrated that lens rinsing prior to wear, and ocular rinsing 
prior to staining evaluation, do not eliminate the SICS response. Additionally, the presence of ‘white 
light’ staining and hyper-reflective cells in almost every SICS case further supports other reports of 
cellular changes being present prior to the instillation of fluorescein. The multi-study analyses 
demonstrated that the appearance of SICS was more common as a pan-corneal distribution, rather 
than the frequently reported ‘donut-ring’ pattern. Analysis of individuals exposed to the same SICS-
inducing treatment in different clinical trials raised questions about the repeatability of the extent and 
pattern of staining observed. A targeted investigation would be valuable. 
Corneal fluorescein staining has been the subject of much study in recent years, particularly since 
the first reports of SICS. While much has been learned there are still many areas that require more 
investigation. In particular, understanding the cell transport mechanisms involved in fluorescein 
staining through improved in-vitro or ex-vivo techniques, and the development of higher 


































































Chapter 5, manuscript: Effect of Lens and Eye Rinsing on Solution Induced Corneal Staining 
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